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The underlying goal of tissue engineering is to functionally repair and regenerate 
complex tissues and organs. One of the major challenges in engineering viable tissues is 
forming functional and stable blood vessel networks (angiogenesis) within the tissue, 
which supply oxygen and nutrients to the cells. Following implantation, these networks 
must subsequently connect with the body’s existing vasculature (anastomosis) for 
continued survival. Currently, there is no known way to control anastomosis, preventing 
the translation of many potentially useful biomaterials for tissue engineering applications.   
Macrophages, the primary cells of the inflammatory response, are major contributors to 
vascularization and regulate the response to implanted biomaterials; however, 
macrophages are highly plastic cells that alter their behavior in response to local stimuli, 
and the contributions of macrophage phenotype to these processes are poorly 
understood. Therefore, the overarching goals of this work were to (1) understand how 
regenerative biomaterials modulate macrophage behavior and (2) delineate the impact of 
changing macrophage phenotype on biomaterial vascularization. 
 First, the in vitro response of primary human macrophages to biomaterials proven 
to enhance tissue regeneration in animal models was evaluated. Interestingly, 
biomaterials more successful in promoting tissue repair induced a phenotypic shift in 
macrophage behavior toward an anti-inflammatory “M2” state. The modulatory effects of 
these scaffolds were predominantly due to direct cell-scaffold interactions, as only modest 
changes in macrophage gene expression were observed by soluble factors derived from 
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the scaffolds. Importantly, these findings provide evidence that regenerative biomaterials 
modulate macrophage behavior. Then, to elucidate the effects of changing macrophage 
phenotype on biomaterial vascularization, crosstalk between macrophages and vascular 
endothelial cells (ECs) was assessed via transwell co-culture. Interestingly, the angiogenic 
behavior of ECs was differentially influenced by macrophage phenotype; specifically, 
macrophages stimulated toward M1 and M2c activation induced EC up-regulation of 
genes related to vessel sprouting, while M2a and M2f macrophages altered genes related 
to vessel branching and extracellular matrix disassembly, respectively. Finally, the 
functional consequences of changing macrophage phenotype on biomaterial 
vascularization were ascertained through development of a 3D in vitro model of vascular 
growth. Self-assembly of ECs and support cells into vascular structures was achieved by 
co-culture on commercially available Gelfoam® scaffolds, to which macrophages were 
seeded at different stages of vessel development. Consistent with the previous study, M1 
and, to a lesser extent, M2, macrophages increased vessel sprouting and the number of 
connected vessels relative to vascular networks without macrophages. Preliminary 
studies also demonstrated the potential for temporal control over macrophage activation 
to enhance vascularization.  
 Collectively, these findings can be used to inform the design of biomaterials that 
harness the inflammatory response to promote vascularization and improve healing 
outcomes. This work also has important implications for treating diseases characterized 
by extensive blood vessel growth, such as cancer and autoimmune conditions, whereby 
vascularization of the tissue facilitates disease progression.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Tissue Engineering 
 Organ transplantation as a field has achieved major advances over the last several 
decades that have not only allowed for successful long-term survival of transplanted 
tissue, but also significantly reduced the risk of implant rejection. Despite these 
accomplishments, there remains a staggering gap between the number of patients in need 
of life-saving organs and the number of donors worldwide. By the end of 2015, there were 
122,071 patients on the national transplant waiting list in the United States alone [1]; 
however, only 30,975 transplants were performed, with organs recovered from 15,068 
donors. Historically, this gap continues to widen every year, creating a global organ 
shortage crisis. As a result, there is a growing interest in developing engineered tissues 
and organs to meet this rising demand. 
 Tissue Engineering refers to “an interdisciplinary field that applies the principles of 
engineering and the life sciences toward the development of biological scaffolds that 
restore, maintain, or improve tissue function” [2]. The underlying goal of tissue engineering 
is to functionally repair and regenerate complex tissue and organs. This is traditionally 
achieved by combining cells derived from the patient or another individual, with growth 
factors or bioactive signals, on or within a 3-dimensional (3D) support or scaffold that is 
naturally derived or synthetic in origin. The scaffold, also referred to as a biomaterial, 
serves as a template to guide tissue formation and plays a fundamental role in creating a 
suitable microenvironment that orchestrates this process. Biomaterials are generally 
selected for tissue engineering applications based on several criteria, including first and 
foremost, biocompatibility, biodegradability, mechanical properties, and architecture. 
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Biocompatibility refers to the ability of the scaffold or tissue engineered construct to 
perform while eliciting an appropriate host response, which is inevitably initiated upon 
implantation. For many decades, biomaterials were designed with the intention of evading 
or minimizing the host response to avoid potentially detrimental immune reactions that 
could inhibit integration of the implant with the host tissue. Recently, however, there has 
been a paradigm shift away from these immuno-inert materials, toward biomaterials 
designed to harness and direct this response for improved tissue regeneration and healing 
outcomes. 
 
1.2 Host Response to Biomaterials 
  Biomaterial implantation causes injury to vascularized tissue, which activates the 
inflammatory response and subsequent wound healing cascade [3, 4]. This cascade 
involves a series of coordinated events that can be divided into four phases: coagulation, 
inflammation, proliferation, and remodeling with scar tissue formation [5, 6]. The 
coagulation phase begins immediately post-injury, during which platelets adhere to 
damaged blood vessels and initiate a blood-clotting cascade to limit blood loss and provide 
a fibrin-based provisional matrix at the tissue-implant interface [3, 6]. In addition, platelets 
release a multitude of growth factors and cytokines that activate and recruit inflammatory 
cells to the injury site, representing the beginning of the inflammatory phase of healing. 
Neutrophils are the first cells to infiltrate the injury site and clear the wound of bacteria and 
foreign particles via release of enzymes and reactive oxygen species [6]. In the case of 
biomaterials, neutrophils are unable to engulf the implant due to its size, but activate in 
response to proteins that coat the biomaterial surface immediately upon implantation [7]. 
This activation stimulates the release of bioactive signals that recruit macrophages to the 
injury site. Neutrophils later undergo apoptosis and are removed by phagocytosis, or 
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uptake, by infiltrating macrophages. Macrophages are also phagocytic inflammatory cells, 
and act as key regulators in wound healing through release of growth factors that direct 
other cells in the tissue, including keratinocytes, fibroblasts and endothelial cells [6]. 
Following the inflammation phase is the proliferative phase, involving the formation of 
granulation tissue. During this time, fibroblasts are recruited to the injury site and begin to 
deposit extracellular matrix (ECM) that replaces the provisional matrix originally 
established, and further supports migration of dermal and epidermal cells [5, 6].  
A critical component of the wound healing process is the development of an 
adequate blood supply, which not only provides cells with oxygen and nutrients, but also 
removes waste from the tissue. Upon injury to the tissue, the vascular supply is disrupted, 
creating an environment with low oxygen, referred to as hypoxia. The lack of oxygen, in 
addition to blood vessel damage, stimulates the release of signals that initiate vessel 
sprouting from nearby, undamaged vasculature. The establishment of new blood vessel 
occurs during all phases of the repair process and facilitates survival of the tissue and re-
epithelialization [5, 6]. As the granulation tissue becomes vascularized and perfused, the 
surrounding matrix undergoes remodeling through a delicate balance of ECM synthesis 
and degradation by tissue degrading enzymes released by inflammatory cells and 
fibroblasts, and their corresponding tissue inhibitors. The wound begins to contract, which 
further facilitates remodeling and organizing of the matrix as the native tissue properties 
are restored. As healing progresses, fibroblasts undergo apoptosis, leaving behind 
relatively acellular scar tissue with a decreased number of blood vessels [6]. 
With respect to biomaterial implantation, an inability of macrophages to break 
down and phagocytose the material can lead to persistent inflammation. During this 
chronic inflammatory response, macrophages become frustrated and fuse to form 
multinucleated giant cells, which deposit a fibrous matrix around the implant, walling it off 
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from the rest of the body [7, 8]. This is referred to as fibrous capsule formation and 
impedes implant integration with host tissue and consequently, tissue regeneration.  
 
1.3 Vascularization of Engineered Tissues 
1.3.1 Vascularization is Required for Biomaterial-Mediated Tissue Repair 
Despite significant advances in our understanding of the host response to 
biomaterial-tissue interactions, the potential of tissue engineering to develop complex 3D 
tissues has not yet been realized. Indeed, the translation of many regenerative medicine 
strategies has been limited by poor tissue vascularization and perfusion following 
implantation. This is especially true in large implants, as cells within the engineered tissue 
must rely on diffusion of oxygen for survival in the absence of an established vasculature 
network. However, oxygen diffusion is limited to 150-200 µm from the nearest capillary [9, 
10], and vascular ingrowth is limited to several tenths of micrometers per day [11]. As a 
result, it can take weeks for an implanted tissue to be fully vascularized, during which time 
oxygen and nutrient deficiencies deep within the tissue can lead to cell death and impaired 
tissue integration and function. Since the natural rate of vessel growth is often too slow to 
support long-term implant survival, several strategies are being explored to enhance 
engineered tissue vascularization. Importantly, blood vessels must not only form within 
the engineered tissue, a process referred to as angiogenesis, but also connect or 
anastomose with the surrounding host vasculature in order to achieve perfusion and 
continued tissue survival. 
 
1.3.2 Blood Vessel Development 
Blood vessels are tubular structures lined with endothelial cells (ECs) that are 
surrounded by a layer of perivascular support cells and a basement membrane [12]. 
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Formation of blood vessels can occur through two underlying processes: vasculogenesis 
and angiogenesis [9, 13, 14]. Vasculogenesis refers to the de novo formation of blood 
vessels that occurs predominantly during early development [15]. During this process, 
endothelial progenitor cells differentiate into mature ECs, proliferate in avascular areas 
and assemble to create a primitive vessel network [9]. In contrast, angiogenesis refers to 
the sprouting of new capillaries from pre-existing blood vessels and mainly contributes to 
physiological and pathological blood vessel growth that occurs in post-natal life [15]. 
Angiogenesis involves a complex and dynamic multi-stage cascade that broadly 
involves degradation of the basement membrane and surrounding ECM by tissue 
degrading enzymes called matrix metalloproteinases (MMPs), EC migration from the 
vessel walls driven by gradients of vascular endothelial growth factor (VEGF) – a potent 
angiogenic stimulator [16], and EC proliferation and tube formation guided by complex cell 
signaling [17, 18]. Newly formed neighboring vessels then fuse, or anastomose, followed 
by synthesis of a new basement membrane and recruitment of support cells that stabilize 
the vessel wall and regulate blood pressure. During this process, ECs display functional 
heterogeneity, and compete with each other to dynamically acquire specialized 
phenotypes that allow for coordinated blood vessel growth [19, 20]. ECs that lead vascular 
sprouts are called tip cells, which display extended filopodia and migratory behavior, and 
respond to direction cues from the local milieu [19]. Following the tip cells are stalk cells, 
which maintain the integrity of the network [15]. In contrast to tip cells, stalk cells display 
fewer filopodia, and are highly proliferative; additionally, they are responsible for 
establishing tight junctions to maintain the stability and integrity of the new sprout, while 
forming the budding vessel lumen [19]. Once the newly formed vessels have matured and 
blood flow is established, ECs enter a quiescent state during which migration and 
proliferation ceases [13]. 
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The differentiation of ECs into tip and stalk cells is dynamic, and regulated in part 
by the VEGF/Notch pathway. Tip cells are enriched for Delta-like ligand 4 (DLL4), a 
transmembrane protein that binds to Notch receptor on adjacent cells, VEGF Receptor 2 
(VEGFR2, also known as KDR), and platelet-derived growth factor-beta (PDGFB), among 
others [19]; whereas, stalk cells are enriched for the ligand Jagged-1 (Jag1), which also 
binds to Notch receptor but with opposing effects compared to DLL4 [21]. VEGF 
stimulation (usually in response to hypoxia) causes activation of VEGFR2 on tip cells, 
which then induces DLL4 expression. DLL4 on these tip cells subsequently binds to Notch 
receptor on adjacent cells, leading to down-regulation of VEGF receptors, consequently 
reducing their ability to bind to VEGF and activate VEGFR2 [13]. This action ultimately 
impedes the differentiation of these adjacent cells into sprouting tip cells. In contrast, Jag1 
on stalk cells binds to Notch receptor on tip cells, preventing activation of Notch signaling 
on these tip cells. Hence, DLL4 suppresses EC sprouting and proliferation, while VEGF 
and Jag1 promote angiogenic EC behavior. Interestingly, stalk cells also produce 
VEGFR1, which acts as a decoy receptor to locally deplete VEGF and maintain a gradient 
of higher VEGF levels ahead of the sprouting tip cells [13]. Moreover, data suggests that 
although stalk cells proliferate, this proliferation does not push the tip cell forward; rather, 
tip cells are believed to interact with the surrounding matrix and pull themselves in the 
direction of the growing sprout [22]. Nevertheless, proliferation is needed to enable further 
outgrowth of the vessel, as reduced stalk cell proliferation is associated with vessel 
regression [23]. 
When two sprouting vessels come in contact, the tip cells form new inter-cellular 
junctions that facilitate the process of vessel fusion, or anastomosis. Although VE-
cadherin has been implicated in this process [24], the mechanisms behind anastomosis 
remain unknown. Indeed, studies have also implicated other cells, including macrophages, 
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in this process [25], based on the reciprocal expression of several receptor-ligand 
candidates that could facilitate macrophage-EC interaction. For example, Notch, Tyrosine-
protein kinase receptor (TIE2), and C-X-C chemokine receptor type 4 (CXCR4) are all 
expressed on macrophages, while their counterparts DLL4, Angiopoietin-2 (ANGPT2), 
and Stromal cell-derived factor-1 (SDF1) are expressed on endothelial cells [26-29]. 
Post-anastomosis, the immature vessels undergo stabilization through deposition 
of ECM around the vessel and recruitment of mural support cells, such as pericytes, in 
response to tip-cell derived PDGFB [12, 30]. Recruited mural cells are believed to undergo 
differentiation in response to including transforming growth factor-beta 1 (TGFB1) [31], 
and deliver vascular stabilizing factors, such as tissue inhibitor of metalloproteinase 3 
(TIMP3) and ANGPT1. ANGPT1 signaling through TIE on ECs is thought to stabilize the 
vessels and reduce leakiness, possibly by promoting DLL4 and activating Notch signaling, 
which subsequently suppressed VEGFR2 and induced expression of Notch regulated 
ankyrin repeat protein (NRARP) [13, 31, 32]. NRARP promotes Wnt signaling in stalk cells, 
which then leads to stabilization of tight junctions [23]. 
Once the vessels undergo stabilization, remodeling and pruning occur in order to 
facilitate patterning of the vasculature. Currently, the process of vascular remodeling and 
regression is not well understood, and there is a lack of consensus regarding the drivers 
of this process. It is plausible that regression occurs due to the removal or absence of pro-
survival factors like VEGF and VE-cadherin [33], as well as through active signaling 
pathways that induce cell death [34, 35]; however, recent studies suggest that EC 
apoptosis removes only non-perfused vessel segments but does not regulate vessel 
regression in murine retinal angiogenesis [36]. Alternatively, it was recently proposed that 
vessel regression is the result of directed migration of ECs, resembling anastomosis in 
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reverse [37]. In addition to these findings, it has been documented that mechanical 
activation imparted by blood flow also influences EC survival and angiogenesis [38, 39].  
Nevertheless, as the matured vessels become organized and perfused, ECs enter 
a state of quiescence that prevents excessive and aberrant vascularization. 
 
1.3.3 Strategies to Improve Biomaterial Vascularization  
The establishment of a functional blood vessel network within engineered tissues 
is a necessity to ensure survival and integration post-implantation. As a result, strategies 
that improve biomaterial vascularization are paramount to advance the field of tissue 
engineering and regenerative medicine. Significant efforts are being made to address this 
challenge, and for a detailed review of this strategies, the reader is referred to Ref. [9, 10, 
14, 40]; a few of the most common current approach being explored are outlined briefly 
here.  
  
1.3.3.1 Growth Factor-Releasing Biomaterials 
 A common approach to improve vascularization in vivo is to design a system that 
facilitates release of one or more pro-angiogenic growth factors. For example, Cao et al. 
demonstrated that transient exposure of PDGFB and fibroblast growth factor (FGF)-2 in a 
rat or rabbit hind-limb ischemia model promoted the long-term development of stable and 
functional blood vessels, even after removal of the stimuli [41]. Likewise, Awada et al. 
designed a controlled release system for the sequential delivery of VEGF and PDGF [42]. 
By embedding VEGF in a fibrin gel, and PDGF in a heparin-based coacervate distributed 
within the fibrin gel, the authors demonstrated improved angiogenesis and cardiac function 
with reduced fibrosis and inflammation in a rat model of myocardial infarction [42]. In other 
work, simultaneous delivery of VEGF and ANGPT2, followed by delivery of PDGF and 
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ANGPT1 from a macroporous polymer not only enhanced vessel maturation, but also 
promote vascular remodeling following subcutaneous implantation in mice [43].  However, 
the same effects were not observed if all factors were delivered at the time, demonstrating 
that temporal control over growth factor release can be used to control vascularization. 
Similar effects were reported by others following the sequential delivery of VEGF, FGF2 
and PDGF in chorioallantoic membrane (CAM) angiogenesis in vivo [44]. In a slightly 
different approach, Hsu et al. implanted polymeric hydrogel discs containing VEGF or 
PDGF with FGF in a murine cornea model of angiogenesis, and found that the combination 
of PDGF and FGF induced recruitment of macrophages. Interestingly, dynamic 
interactions between macrophages and ingressing blood vessels increased the density, 
organization and perfusion of the vessels, compared to VEGF alone [45].  
  
1.3.3.2 Pre-Vascularization of Biomaterials  
An alternative strategy to delivering growth factors is to form a vascular network 
within the construct prior to implantation. This serves to accelerate anastomosis and 
subsequent perfusion of the implant, and is commonly achieved by co-culturing 
endothelial cells and support cells on a 3D structure to self-assemble into a vascular 
network. The construct is then implanted with the aim of achieving anastomosis between 
the engineered and host vasculature [46]. This concept was demonstrated in seminal work 
by Levenberg et al., in which human umbilical vein endothelial cells (HUVECs) were co-
seeded with myoblasts and embryonic fibroblasts on a porous polymer scaffold comprised 
of poly(L-lactic acid) (PLLA) and poly(lactic-glycolic acid) (PLGA) [47]. After 2 weeks, the 
engineered muscle constructs were implanted subcutaneously in mice, or intramuscularly 
into rat muscle; the authors demonstrated that pre-vascularization significantly improved 
perfusion of the tissue and survival of muscle constructs. A similar concept was explored 
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by Chen et al., in which HUVECs and fibroblasts were seeded together in fibrin gel and 
vascular networks were established over 1 week in vitro [48]. Subcutaneous implantation 
in a dorsal window in mice revealed a significantly greater presence of blood vessels within 
the engineered tissue by day 5, compared to constructs that were not pre-vascularized 
which required 14 days for perfusion. Likewise, HUVECs, embryonic fibroblasts, and 
human embryonic stem cell (hESC)-derived cardiomyocytes have been tri-cultured on 
PLLA/PLGA scaffolds for 2 weeks, and then engrafted to cardiac tissue in rats, resulting 
in formation of donor and rat-derived vasculature within the graft that were functionally 
integrated [49]. More recently, Kusuma et al. demonstrated that human pluripotent stem 
cells (hPSCs), induced to co-differentiate into early vascular cells, can develop into ECs 
and pericytes and self-assemble into microvascular networks on 3D engineered tissue 
[50]; upon subcutaneous implantation in mice, the engineered tissue was integrated and 
perfusable. 
In vivo pre-vascularization approaches have also been explored, to a lesser extent. 
For example, Zhang et al. embedded VEGF in PLGA/poly(ethylene glycol) microspheres, 
and seeded them on a collagen-chitosan scaffold containing human adipose-derived stem 
cells; following implantation around a vascular pedicle in nude rats, the construct 
supported the development of a vascularized soft tissue flap, which has potential to be 
transferred to a recipient site [51].  
 
1.3.3.3 Microfabrication of Engineered Vascularization 
 Vessels have also been engineered using microfabrication techniques. For 
example, Kolesky et al. used 3D bioprinting to generate vascularized tissues exceeding 
1-cm in thickness, that were perfusable on a chip for several weeks [52]. Specifically, 
human mesenchymal stem cells (MSCs) and fibroblasts were co-printed within a cross-
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linked gelatin-fibrin matrix with sacrificial ink, which was removed to create a hollow 
network within the matrix that was subsequently perfused and lined with ECs. The authors 
demonstrated that the engineered tissue supported the differentiation of MSCs. In other 
work, Miller et al. used a biocompatible sacrificial material to 3D print engineered tissues 
containing living cells, thereby generating tubular networks that could be perfused and 
endothelialized [53]. 
  
1.4 Macrophages Regulate Healing 
 As noted earlier, the inflammatory response plays a critical role in the host 
response to implanted biomaterials. Macrophages are monocyte-derived myeloid cells 
originating from the bone marrow, and have long been recognized as the primary cells of 
the inflammatory response and crucial regulators of healing [54]. Indeed, depletion of 
macrophages from wounds has been proven to impair adult salamander limb regeneration 
[55], as well as murine skeletal muscle regeneration [56] and tissue repair post-myocardial 
injury in mice[57]. While macrophage depletion causes drastically reduced angiogenesis 
[25, 58, 59] and healing, exogenous addition of macrophages promotes angiogenesis [60, 
61]. Consistent with these findings, macrophages have been demonstrated to play an 
important role in the repair of bone – one of the most highly vascularized tissues in the 
body. For example, in a murine femoral fracture model, macrophage depletion abolished 
callus formation – which stimulates angiogenesis and the healing cascade, demonstrating 
the importance of macrophages to endochondral ossification [62]. Macrophages also 
mediate in vivo woven bone deposition and mineralization [63] and enhance differentiation 
of mesenchymal progenitors [64] during fracture repair.  
This multifaceted behavior stems from the inherent plasticity of macrophages, 
which exist on a spectrum of activation states or phenotypes [65]. Macrophages exert 
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control over all phases of tissue regeneration and alter their behavior in response to 
changing environmental stimuli [66]. This plasticity suggests that biomaterials that 
modulate macrophage behavior have potential to direct the response to implanted tissues, 
thereby promoting integration and healing outcomes. Although there are a multitude of 
phenotypes that likely exist in vivo, macrophages classification is commonly oversimplified 
to discriminate between classically activated, or pro-inflammatory, “M1” macrophages and 
alternatively activated, or anti-inflammatory, “M2” macrophages. However, the M2 
classification has recently been expanded to include essentially all other distinct 
phenotypes, including M2a, M2c, and M2f, all of which contribute to tissue repair [67-70]. 
There are also several other phenotypes that have been described in response to different 
stimuli [71-73], as well as those associated with tumors [74] and hybrid M1/M2 profiles 
[75]. M1 macrophages are believed to clear the injury of pathogens and cellular debris, 
and can be activated in vitro in the presence of lipopolysaccharide (LPS) and interferon-g 
(IFNg). In contrast, M2 macrophages contribute to tissue repair processes, including tissue 
deposition and breakdown, but their roles are incompletely understood [70]. M2a 
macrophages have been implicated in fibrous capsule formation and fibrosis in various 
tissues [76-78], while M2c macrophages have been shown to display a higher capacity to 
phagocytose apoptotic cells [79], and secrete an array of tissue degrading MMPs [80]. 
M2f macrophages secrete anti-inflammatory mediators and have been linked to 
angiogenesis [Brecht 2011]. M2 macrophages can be stimulated in vitro by the presence 
of interleukin (IL)-4 and IL13 for M2a activation; IL10 for M2c activation; and apoptotic 
cells for M2f activation [Spiller 2014, Voll 1997]. 
Importantly, in the normal healing process of many tissues, including bone, the 
macrophage population shifts from predominantly M1 to predominantly M2 over time [81] 
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[82], which may be related to their proposed roles in angiogenesis [70, 83]. However, it is 
not clear whether phenotypic shifts in macrophage activation result from the same 
macrophage population, or represent a new influx of macrophages recruited to the injury 
site. Moreover, with many studies failing to discern among M2 phenotypes, it is not clear 
if the shift toward M2 activation holds true for all M2 macrophages. In fact, recent studies 
have provided evidence suggesting that M2c macrophages act early in the repair process 
[80, 84]. It is clear that temporal profile of macrophage activation plays a critical role in 
tissue regeneration, as studies have shown that selective depletive of macrophages at 
different times during wound healing drastically alters the repair process [85]. Moreover, 
evidence suggests that the balance of M1 and M2 macrophages can be used to predict 
not only healing in chronic diabetic ulcers [86], but also the extent of biomaterial-mediated 
tissue repair [87, 88].  
 
1.5 Macrophages Affect Biomaterial Vascularization 
It is widely appreciated that inflammation and angiogenesis are intimately linked 
processes [89]. Indeed, studies have shown that pre-seeding monocytes on a biphasic 
bone substitute led to increased vessel ingrowth and maturation upon subcutaneous 
implantation in mice [90]. Likewise, addition of murine-derived macrophages to peptide-
modified PEG matrixes seeded with ECs has been demonstrated to enhance EC tubule 
volume relative to scaffolds without macrophages [91]; moreover, macrophages were 
observed to both wrap around vessels and bridge ECs, as others have shown. 
Nevertheless, the cell-specific contributions between these dynamic processes are still 
unclear. 
Importantly, macrophages have been implicated at multiple stages of the 
angiogenic cascade, and have been called the “architects of development” [92]. Recently, 
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a murine cornea model of macrophage recruitment revealed dynamic interactions of 
macrophages and ingressing blood vessels that simultaneously up-regulated both M1- 
and M2-related genes [45]. This was consistent with prior findings that macrophages can 
act as bridging cells to support anastomosis [25], as well as guide sprouting vessels by 
forming tunnels within the local extracellular matrix [93, 94] However, the relative 
contributions of macrophage phenotypes remain unclear. For example, CCR2+ (M1) 
macrophages are critical for inducing vascular sprouting by VEGF secretion at early 
stages of healing in murine skin wounds [95], and M1 conditioned media has been shown 
to promote vascular tube formation in vitro [70]. In contrast, bone marrow-derived M1 
macrophages inhibited tube formation in a Matrigel plug implanted subcutaneously in 
mice, while M2a and M2c macrophages enhanced angiogenesis, but through different 
mechanisms [96]. Others report the presence of both M1 and M2 phenotypes in 
vascularizing engineered soft tissue flaps, where M2 macrophages were localized in the 
remodeled tissue and M1 were found mostly in the engineered tissue [51]. Recently, it has 
been shown that M1 macrophages stimulated in vitro secrete the highest levels of the 
angiogenic stimulator VEGF, while M2a secrete large quantities of the chemoattractant 
PDGFBB, and M2c produce the highest levels of ECM-degrading MMP9 [70]; not 
surprisingly, several studies have demonstrated that proper temporal regulation of these 
factors is needed for successful angiogenesis [18, 43]. Taken together, these findings 
suggest that M1, M2a and M2c macrophages play unique roles in angiogenesis and 
anastomosis, both temporally and spatially. 
 
1.6 Macrophage Modulation as a Therapeutic Strategy 
Proper temporal control over macrophage activation is crucial for healing. It is well 
established that excessive M1 activation leads to chronic inflammation, while insufficient 
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M1 activation delays healing due to accumulation of cell debris and poor vascularization 
[97, 98]; likewise, excessive M2a activation can lead to fibrosis and encapsulation of the 
implant [99, 100], but insufficient M2a activation disrupts angiogenesis and causes chronic 
wound formation. Based on this precedence, there has been a paradigm shift toward the 
design of biomaterials that pro-actively direct the inflammatory response to promote 
healing of chronic wounds, tissue defects, and inflammatory conditions (Reviewed in [101, 
102]). These includes strategies that modulate M1 activation, M2 activation, or temporal 
modulation of both phenotypes.  
 
1.6.1 Modulation of M1 Activation 
For example, researchers have used biomaterials to delivery anti-TNF small 
interfering RNA (siRNA) in order to inhibit TNF production by M1 macrophages in murine 
models of collagen-induced arthritis (CIA) and inflammatory bowel disease (IBD) [103, 
104]. Inhibition of macrophage TNF prevented arthritis-induced bone loss 7 weeks post-
treatment, and inhibited the onset of colitis. Alternatively, treatments designed to enhance 
IL10 expression, an anti-inflammatory cytokine, have been used to suppress inflammation 
in a rat adjuvant arthritis model [105]. Delivery of nanoparticles containing plasmid RNA 
enhanced expression of M2 marker Cluster of Differentiation 163 (CD163), and reduced 
tissue levels of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF), 
IL6, and IL1B. 
Importantly, inhibiting M1 activation is not always beneficial, despite higher levels 
of baseline inflammatory activity in chronic inflammatory conditions, like diabetic wounds. 
It is suspected that M1 macrophages may enter a state of low-grade chronic inflammation, 
through which they become hypo-responsive to inflammatory stimuli and cannot mount an 
appropriate response to stimulate tissue repair [106-108]. Indeed, administering IL1B-
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stimulated M1 macrophages into subdermal wounds in a diabetic mouse model led to 
increased granulation tissue formation and promoted lymphatic vessel development in 
work conducted by Maruyama et al. [108]. Likewise, Yin et al. have shown that recruitment 
of a fresh population of M1 macrophages via release of monocyte chemotactic protein 1 
(MCP1) from gelatin/polyglycolic acid scaffolds in a diabetic murine model facilitated the 
development of epithelial tissue and improved healing rates [109]. 
Collectively, these and other studies provide evidence that biomaterial-mediated 
modulation of abnormal macrophage behavior in chronically inflamed tissues can promote 
healing. 
 
1.6.2 Modulation of M2 Activation 
As an alternative to inhibiting M1 responses, researchers have also explored 
strategies to promote tissue repair by modulating M2 activation. For example, antibodies 
targeting IL4 – a potent activator of the M2a phenotype in vitro, were injected into 
poly(etherurethane urea cages) implanted subcutaneously in mice, leading to reduced 
foreign body giant formation around the cages [77]. While this study supports the 
contribution of M2a macrophages in fibrous capsule formation, the role of this phenotype 
in the foreign body response is controversial, as others have delivered IL4 from 
chitosan/dermatan sulfate-coated polypropylene mesh implanted subcutaneously and 
demonstrated reduced fibrosis and enhanced tissue remodeling that correlated with 
reduced M1 activation and transiently enhanced M2a activity [110]. Together, these 
studies demonstrate the importance of a properly controlled M2 response to mitigate the 
foreign body response.  
Biomaterial-mediated modulation of M2 activation has also been used to repair 
cardiac tissue post-myocardial infarction (MI). Inspired by the ability of apoptotic cells to 
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promote secretion of anti-inflammatory factors, Harel-Adar et al. prepared liposomes 
presenting phosphatidylserine (PS) – a ligand recognized by macrophages that is 
expressed on the surface of apoptotic cells, to induce M2 activation in a rat model of acute 
MI [111]. Post-intraperitoneal (IP) injection in mice, PS-presenting liposomes elicited 
enhanced macrophage engulfment; moreover, intramyocardial injection of PS-presenting 
liposomes immediately after MI significantly enhanced macrophage production of anti-
inflammatory IL10 and TGFB. Corresponding to these effects, tail vein injection of PS-
presenting liposomes 48 h after MI was also shown to prevent ventricular dilatation and 
remodeling. This work demonstrates that modulation of cardiac macrophages toward M2f 
activation can improve infarct repair. 
 Improved biomaterial-tissue integration has also been demonstrated by release 
of microsphere-encapsulated IL4 from collagen scaffolds implanted subcutaneously in 
mice, which enhanced infiltration of M2a macrophages into the scaffold 24 h post-
implantation [112]; however, up-regulation of genes related to both M1 and M2a activation 
observed after 3 days, which may suggest a synergistic role for multiple macrophage 
phenotypes.  
Taken together, these studies suggest that modulating the behavior of a single 
macrophage phenotype can improve healing outcomes. 
 
1.6.3 Temporal Modulation of M1 and M2 Activation 
Although the strategies described above have potential to enhance tissue repair, 
recent evidence suggests both M1 and M2 phenotypes are required for biomaterial 
integration with host tissue [70]. Indeed, M1 macrophages have been shown to initiate 
angiogenesis [70] and may prime fibroblasts for ECM deposition [113]; and M2a 
macrophages have been suggested to stabilize angiogenesis [70] and promote ECM 
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deposition [114]. These findings, coupled with the known M1-to-M2 phenotypic transition 
that occurs during the normal healing process of many tissues, has motivated researches 
to develop strategies that actively target both M1 and M2 macrophages, in a temporally 
controlled manner, to enhance biomaterial-mediated tissue regeneration. 
This approach was recently explored by Spiller et al. via sequential delivery of M1- 
and M2a-stimulating cytokines from bone scaffolds following subcutaneous implantation 
in mice [83]. The authors first used biotin-streptavidin binding to conjugate IL4, an M2a 
stimulator, to the surface of decellularized bone, followed by physical adsorption of IFNg. 
Although individual release of the cytokines in vitro promoted up-regulation of genes 
associated with the M1 or M2a phenotypes, sequential release of IFNg and IL4 did not 
induce robust activation of either phenotype, perhaps due to overlapping release profiles. 
This study underscores the need for proper temporal control over macrophage phenotype. 
In other work, temporally controlled delivery of MCP1 and IL4 was demonstrated 
using multidomain peptides that self-assemble to form fibrous mesh and, consequently, 
nanofibrous hydrogels [115]. In this study, MCP1 was used to recruit macrophage to the 
implant, while IL4 served to direct M2a activation. Notably, subcutaneous implantation in 
rats demonstrated enhanced macrophage filtration after 3 days, and increased expression 
of M2 markers, CD206 and CD163, by day 7. Moreover, biphasic release of MCP1 and 
IL4 led to distinct blood vessel formation 1 week post-implantation, and were completely 
resorbed by day 14. Overall, these findings provide evidence that temporally controlled 
activation of M1 and M2 phenotypes has potential to enhance biomaterial-mediated tissue 
repair. 
A similar concept was applied by Kim et al. using gelatin hydrogels to 
simultaneously deliver a macrophage recruiting agent, SEW2871, and platelet-rich 
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plasma (PRP), as a means to promote angiogenesis and enhance bone repair in a rat 
critical-size defect. Release of SEW2871 and PRP led to an influx of macrophages and 
enhanced collagen deposition within 3 days post-implantation. Intriguingly, these 
hydrogels also promoted transient up-regulation of pro-inflammatory TNF, and sustained 
up-regulation of IL10 after 10 days in vivo, which correlated with the most pronounced 
bone formation, relative to control constructs. 
Based on these findings, an early but transient M1 response that shifts toward M2 
activation may be a suitable approach to direct biomaterial-mediated tissue repair. 
However, the contributions of macrophage phenotypes are still largely undefined, due in 
part to an underappreciation for the many distinct M2 phenotypes that are simply denoted 
as M2. Nevertheless, it is clear that macrophages play a role in vascularization and 
biomaterial-mediated tissue regeneration. If we can advance our understanding of the 
roles that macrophage phenotypes play in these processes, this knowledge could be 
applied to improve the translation of many biomaterials that are currently unviable due to 
insufficient perfusion and integration with host tissue.  
 
1.7 Bone as a Model Vascularized Tissue 
One approach to understand the relationship between macrophage phenotype, 
vascularization, and tissue repair is to investigate these processes in tissue that has an 
innate ability to heal itself, such as bone. Bone represents a unique tissue with an innate 
capacity to self-repair small fractures, without fibrous scarring [116]; however, large, 
critical-size defects are generally unable to heal without intervention [117]. While treatment 
most commonly involves the transplantation of either allografts or autografts, harvested 
from other locations in the body, into the defect, these strategies are associated with many 
drawbacks, including infection, limited tissue supply, donor site morbidity and poor 
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integration[118]. As a result, tremendous efforts have been made to use tissue 
engineering approaches that can be used to regenerate the native tissue. Most commonly, 
this involves culturing cells on 3D scaffolds in vitro, which are later implanted into the 
defect. Despite major advances in the field, realization of this strategy has been severely 
hampered due to the lack of a functional vasculature supply, which, not surprisingly, is 
considered a major pitfall of engineered bone tissue [119]. This is a major hurdle 
considering that bone is a metabolically active and highly vascularized tissue, in which 
skeletal integrity relies on the close proximity of blood vessels.  
 
1.8 The Inflammatory Response is Critical for Bone Repair 
Upon injury to bone, fracture healing occurs through a complex cascade of events 
that is initiated by a trauma-induced inflammatory response followed by ossification and 
bone remodeling [120-123]. Post-fracture, vascular endothelial damage leads to 
hematoma formation at the injury site, which is then infiltrated by inflammatory cells. This 
cascade leads to formation of an avascular cartilaginous callus and stimulates 
angiogenesis. The fracture callus is subsequently mineralized and replaced by woven 
bone as the fracture site is revascularized [123, 124]. The woven bone is later remodeled 
to restore the original tissue structure and mechanical integrity. Establishment of an active 
blood vessel network is a prerequisite for proper bone repair [125]. Indeed, studies have 
shown that the absence of VEGF reduces angiogenesis, bone formation, and callus 
mineralization; whereas, addition of VEGF enhances blood vessel formation and new 
bone maturation [126]. Similar to other tissues, this process is initiated and regulated by 
the inflammatory response, which consequently plays a central role in bone repair. Indeed, 
it has been shown that, at early times after injury, removal of the fracture hematoma, which 
initiates the inflammatory cascade, impairs healing [127, 128]. Similarly, the absence of 
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pro-inflammatory signals, like TNF, following injury leads to delayed chondrogenic 
differentiation and resorption of the mineralized cartilage, resulting in altered fracture 
healing [129], perhaps due to the role of TNF in coordinating the expression of angiogenic 
factors and MMPs [130]. Alternatively, infusion of TNF to murine bone fractures at early 
times after injury significantly accelerates healing [131], and the addition of inflammatory 
cytokines TNF and interleukin-1b (IL1b) to cell culture media causes increased 
osteogenesis of mesenchymal stem cells (MSCs) [132]. However, prolonged inflammation 
also leads to impaired healing in bone [133]. For example, acute exposure of adipose-
derived stem cells to TNF has been shown to promote vascularization in vitro, whereas 
continuous exposure and high doses inhibit vascular growth [134]. Collectively, these data 
emphasize the importance of a precisely controlled inflammatory response, and 
consequently vascularization, for bone regeneration. 
 
1.9 Macrophage-Biomaterial Interactions Affect Bone Repair 
Given the interplay of the inflammatory response and angiogenesis [135], a 
number of studies have started to explore the interactions of macrophages with 
biomaterials for bone regeneration.  
However, the role of macrophage phenotype in bone repair is still unclear. 
Ceramic-based materials inducing M2c activation have been shown to promote 
osteogenic differentiation of MSCs in vitro [136, 137], whereas others have found that 
increased recruitment of M1 but limited M2 macrophages leads to greater bone formation 
[138, 139]. Unfortunately, many of these studies fail to distinguish between M2a and M2c 
phenotypes, which may account for some of the conflicting literature and may warrant 
further investigation. Moreover, it is still unclear how biomaterials, including ceramic bone 
substitutes, impact the microenvironment to modulate macrophage behavior and affect 
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healing outcomes, though ion release [136, 140], surface topography [141] microstructure 
[142], and mechanical properties [143, 144] have all been shown to influence macrophage 
activation. Identifying the properties of biomaterials that regulate inflammatory cell 
behavior would have important implications for biomaterial-mediated bone repair 
strategies.  
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CHAPTER 2: RESEARCH GOALS 
 
The overarching goals of this work were to 1) understand how macrophages 
respond to biomaterials used in tissue regeneration, using bone as a model vascularized 
tissue, and 2) interrogate the effects of changing macrophage behavior on biomaterial 
vascularization. The overall hypothesis of this work was that sequential activation of M1 
and M2 macrophages promotes enhanced biomaterial-mediated tissue regeneration and 
vascularization. This hypothesis was tested through the following 3 specific aims: 
 
Specific Aim 1: Determine how regenerative biomaterials regulate 
macrophage phenotype over time. Using ceramic scaffolds proven to promote tissue 
regeneration in vivo in comparison to less successful controls, the temporal response of 
unactivated macrophages in direct contact or transwell co-culture with the scaffolds was 
determined. In addition, mechanisms of macrophage modulation were investigated by 
varying scaffold properties. It was hypothesized that scaffolds most successful in 
promoting tissue regeneration induce an M1-to-M2 phenotypic transition over time. 
 
Specific Aim 2: Characterize the effects of macrophage phenotype on 
vascular endothelial cells in vitro. Using a 2D transwell co-culture system in vitro, the 
effects of M1, M2a and M2c macrophages on endothelial cell behavior were assessed. It 
was hypothesized that M1 and M2c macrophages promote up-regulation of genes related 
to tip cell selection and vessel sprouting, while M2a macrophages promote up-regulation 
of genes related to vessel stabilization and maturation.   
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Specific Aim 3: Develop a platform to delineate the contribution of 
macrophage phenotype to tissue vascularization in vitro. A previously established 3D 
model of biomaterial vascularization was adapted for a novel application, the study of 
macrophage phenotype in angiogenesis. This model was subsequently used in vitro to 
identify the individual roles of M1, M2a and M2c macrophages, as well as the effects of 
sequential M1 and M2 activation, in promoting angiogenesis. It was hypothesized that M1 
and M2c macrophages promote sprouting, and M2a macrophages facilitate anastomosis 
and vessel thickening. 
 
Achieving sufficient and functional vascularization is a major challenge in 
engineering tissues for regenerative medicine. Establishing the role of the inflammatory 
response to biomaterial-mediated tissue regeneration can be used to inform the design of 
new biomaterials that promote vascularization and healing. Moreover, understanding how 
the inflammatory response regulates vascularization would have important implications 
for treating diseases and chronic inflammatory conditions associated with extensive blood 
vessel growth, such as cancer and many autoimmune conditions [89], whereby 
vascularization of the tissue facilitates disease progression. 
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CHAPTER 3: TEMPORAL RESPONSE OF MACROPHAGES TO REGENERATIVE 
BIOMATERIALS 
 
3.1 Introduction 
More than 6 million bone fractures occur annually in the United States alone [145, 
146], and 5-10% of these fail to heal adequately due to bone loss, failed fixation, infection 
and poor vascularization [145]. Bone is a unique tissue in that small fractures can self-
repair, without fibrous scarring [116], but large, critical-sized bone defects remain a 
challenge [117]. Therefore, there is a significant need for tissue engineering strategies 
that utilize artificial materials to harness the intrinsic ability of bone to repair itself. Despite 
efforts to engineer bone tissue to address this challenge, the lack of functional vasculature 
remains a major cause of failure [119]. 
Although it is well established that macrophages regulate the inflammatory 
response to implanted biomaterials by rapidly shifting their phenotype in response to 
environmental stimuli [66], it is not clear how biomaterials alter the microenvironment in 
fracture healing to modulate macrophage behavior and affect vascularization and healing 
outcomes. Studies have shown that the structural and mechanical properties of 
biomaterials can induce macrophage activation [142, 147, 148], but such effects are not 
limited to direct contact between biomaterial-cell interfaces, as ions have also been shown 
to modulate macrophage behavior [149, 150]. As an initial step to understand how 
biomaterials regulate macrophage phenotype in bone repair, the interactions between 
macrophages and model biomaterials proven to enhance bone regeneration in animal 
models were studied. 
For this work, Baghdadite (Ca3ZrSi2O9) and Strontium-Hardystonite-Gahnite (Sr-
HT Gahnite, Sr-Ca2ZnSi2O7-ZnAl2O4) scaffolds were selected as two materials that 
enhance bone regeneration in critical size defects compared to clinically used tricalcium 
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phosphate-hydroxyapatite (TCP-HA) manufactured to the same specifications [151, 152]. 
Both Baghdadite and Sr-HT Gahnite have been shown to result in extensive new bone 
formation and complete bridging of critical-sized radial segmental defects in rabbits 12 
weeks post-implantation, compared to only partial bridging demonstrated by TCP-HA 
[151-153]. In sheep segmental defect models, Baghdadite scaffolds also showed 80% 
bridging of the critical-sized defect with evidence of bone infiltration and remodeling within 
the scaffold implant [154]. Baghdadite scaffolds not only supported bioactivity of primary 
human osteoblasts and endothelial cells, but also promoted the differentiation of 
monocytes to form functional osteoclasts in vitro [155]. Intriguingly, while direct contact 
between Baghdadite and either osteoblasts or adipose-derived stem cells (ASCs) 
promoted osteogenic gene expression and bone morphogenetic protein 2 (BMP2) 
secretion in vitro, these scaffolds also modulated the cross talk between osteoblasts and 
ASCs to promote osteogenic behavior in an indirect co-culture system [156]. By 
comparison, the unique microstructural design of Sr-HT Gahnite enabled this scaffold to 
elicit bioactivity with osteoblasts, while reproducing the mechanical properties of native 
bone [152]. Sr-HT Gahnite has also been shown to support adhesion and osteogenic 
differentiation of ASCs, as well as enhanced angiogenic activity by ASCs and human 
microvascular endothelial cells in vitro and in vivo [157]. While these scaffolds are known 
to directly affect osteogenic cells involved in bone formation, their effects on recruited 
macrophages are unknown. 
Therefore, the goal of this aim was to characterize macrophage activation in vitro 
in response to these scaffolds, with the hypothesis that biomaterials with different 
properties induce different macrophage responses, through both direct and indirect 
mechanisms; it was anticipated that these changes would be correlated with the ability of 
the scaffolds to promote bone repair in vivo. To test this hypothesis, the temporal response 
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of unactivated (M0) macrophages in direct contact with the scaffolds was evaluated to 
determine the potential of the scaffolds to modulate macrophage behavior. Then, to 
explore potential mechanisms of macrophage modulation, the effects of soluble factors 
released from the scaffolds on macrophage activation were compared. Finally, scaffold 
grain size was investigated as a potential contributing factor to macrophage modulation, 
since topographical and mechanical cues are known to affect macrophage phenotype.  
Macrophage response was evaluated in terms of gene expression for a panel of markers 
indicative of the M1, M2a and M2c phenotypes, because of their distinct roles in promoting 
vascularization and tissue repair[70], as well as genes involved more generally in 
angiogenesis, tissue remodeling, and osteogenesis. 
This work has been published in the Journal of the Royal Society Interface [158]. 
 
3.2 Experimental Section 
3.2.1 Experimental Design 
A schematic of the experimental design is provided in Figure 3.1. Primary human 
monocytes were differentiated into macrophages in vitro for 5 days. Study 1: Temporal 
effects. Unactivated (M0) macrophages were seeded directly onto Baghdadite, Sr-HT 
Gahnite and TCP-HA scaffolds for 6 days, and macrophage gene expression was 
assessed at early (day 2) and late (day 6) stages of contact. Study 2: Direct vs. indirect 
Interactions. Unactivated macrophages were seeded either directly onto the scaffolds or 
onto the bottom of a 24-well ultra-low attachment plate containing transwell inserts loaded 
with the scaffolds. Macrophage gene expression was evaluated on day 6. Study 3: Grain 
size effects. The grain size of Baghdadite scaffolds was varied and the resulting temporal 
effects on  
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3.2.2 Fabrication of Scaffolds 
TCP-HA, Baghdadite, and Sr-HT-Gahnite scaffolds were prepared by the 
Biomaterials and Tissue Engineering Research Unit at the University of Sydney (PI: Prof. 
Hala Zreiqat) according to previously described methods [151, 152]. A sintering 
temperature of 1380°C was applied for shorter (3 h) or longer (12 h) periods of time to 
vary Baghdadite grain size, yielding 2 µm and 4 µm grains, respectively. All scaffolds were 
autoclaved and pre-equilibrated in media prior to macrophage seeding. 
 
3.2.3 Monocyte Isolation and Differentiation 
Primary human monocytes were either isolated from blood (obtained from the New 
York Blood Center) using sequential density gradient centrifugations of Ficoll-PaqueTM 
PLUS and 46% PercollTM PLUS (GE Healthcare), or purchased from the University of 
Pennsylvania Human Immunology Core (Philadelphia, PA). Monocytes were cultured in 
ultra-low attachment flasks for 5 days in Roswell Park Memorial Institute (RPMI) 1640 
media, supplemented with 10% heat-inactivated human serum, 1% penicillin streptomycin 
and 20 ng/mL macrophage colony stimulating factor (MCSF) to induce macrophage 
differentiation as previously described [70]. Unactivated M0 macrophages were gently 
scraped and collected on day 5. 
 
3.2.4 Temporal Effects of Scaffolds on Macrophage Activation 
M0 macrophages (1´106 cells) were seeded directly onto the scaffolds in 15 µL 
and allowed to attach for 1 h at 37°C and 5% CO2, as described previously [49, 159, 160]. 
After 1 h, the culture media was adjusted to a final volume of 1 mL and the samples were 
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incubated for an additional 2 to 6 days in the presence of 20 ng/mL MSCF. M0 
macrophages exposed to culture media alone served as a control. Media was replenished 
on day 3 and, on days 2 and 6, the scaffolds were transferred into 1 mL TRIzol and stored 
at -20°C until RNA extraction. Control cells, not exposed to scaffolds (M0), were gently 
scraped and collected, and centrifuged at 400´g for 7 min. Cell pellets were re-suspended 
in Buffer RLT (RNeasy Micro Kit, Qiagen), and stored at -20°C until RNA extraction. 
 
3.2.5 Indirect Effects of Scaffolds on Macrophage Activation 
To identify whether any soluble factors released from the scaffolds, such as 
dissolved ions, affect macrophage gene expression, scaffolds were separated from the 
macrophages by placing them in the apical chamber of transwell inserts (Millipore) in 24 
well ultra-low attachment plates in 250 µL culture media. M0 macrophages (1´105 cells) 
were seeded in the basolateral chamber in 750 µL of culture media. The scaffolds and 
cells were co-cultured in this way at 37°C and 5% CO2 for 6 days, with media exchange 
on days 1, 3 and 6. On day 6, cells were lysed directly in the well in Buffer RLT (RNeasy 
Micro Kit, Qiagen) and stored at -20°C overnight. All samples were cultured in media 
containing 20 ng/mL MCSF. 
 
3.2.6 Effects of Grain Size on Macrophage Behavior 
To better understand the material properties that contribute to macrophage 
behavior, the effects of Baghdadite grain size on macrophage activation were studied in 
vitro. Baghdadite was selected for this study based on its ability to modulate macrophage 
behavior in study 1. M0 macrophages (1´106 cells) were seeded directly onto the scaffolds 
in 15 µL culture media and allowed to attach for 25 min at 37°C and 5% CO2. Following 
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attachment, the culture media was adjusted to a final volume of 2 mL, to completely 
submerge the scaffolds, and the samples were incubated for an additional 2 to 6 days, 
with media exchange on day 3. All media contained 20 ng/mL MSCF for macrophage 
differentiation. On days 2 and 6, the media was collected and stored at -80°C for analysis 
of secreted proteins. 
As controls, 0.5´106 M0 macrophages were seeded in a 24-well ultra-low 
attachment plate and differentiated into the M0, M1, M2a and M2c phenotypes in the 
presence of 20 ng/mL MCSF for 6 days. Differentiation was achieved by addition of 
interferon-g (IFN-g, 100 ng/mL) and lipopolysaccharide (LPS, 100 ng/mL) for M1 activation, 
interleukin-4 (IL-4, 40 ng/mL) and interleukin-13 (IL-13, 20 ng/mL) for M2a activation, and 
interleukin-10 (IL-10, 40 ng/mL) for M2c activation [70]. 
 
3.2.7 RNA Extraction and cDNA Synthesis 
Scaffolds in TRIzol were thawed on ice, vortexed briefly and allowed to stand at 
room temperature for 5 min. Chloroform was added to the supernatants and the samples 
were vigorously shaken by hand for 15 s. After an additional 3 min at room temperature, 
the samples were centrifuged at 12,000´g and 4°C for 15 min. The aqueous layer was 
collected, mixed with an equal volume of 70% ethanol and the precipitated RNA was 
purified on an RNeasy mini-spin column (Qiagen) according to the manufacturer’s 
instructions. Cells lysed without scaffolds were thawed on ice, vortexed briefly, mixed with 
an equal volume of 70% ethanol and directly loaded onto an RNeasy mini-spin column 
(Qiagen) for purification. RNA was eluted in a final volume of 30 µL and stored at -80°C 
until used for reverse transcription. The RNA was subsequently quantified on a 
NanoQuant plate (Tecan) and treated with DNAse I, Amplification Grade (Invitrogen) for 
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DNA removal according to the manufacturer’s protocol.  cDNA was synthesized from 1 µg 
RNA (A260/280 > 1.8) using a High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) according to the manufacturer’s protocol and stored at -80°C until analysis of 
gene expression. 
 
3.2.8 Gene Expression Analysis 
Quantitative RT-PCR was performed using 20 ng cDNA and Fast SYBR Green 
Master Mix (Applied Biosystems) according to the manufacturer’s protocol, with n=2 
technical replicates. Mean quantification cycle (Cq) values were calculated and the 
expression of target genes was normalized to the reference gene, GAPDH. Data shown 
represent the mean fold change ± SEM (n≥4). All primers (Table 3.1) were synthesized 
by Life Technologies. 
 
3.2.9 Principal Component Analysis 
To visualize the global representation of gene expression data and emphasize 
variation in macrophage behavior, principal component analysis (PCA) was implemented 
using Matlab® software (MathWorks, Natick, MA). PCA is a multivariate data analysis 
approach that reduces the dimensionality of a data set by capturing most of the variation 
in the data set into new variables known as principal components [[161]]. Samples can 
then be plotted using a few of these uncorrelated principal components in order to detect 
the hidden phenomena in the data set, including similarities and dissimilarities among 
samples. Prior to analysis, the data were standardized using z-scores to enable 
comparison across the data set. 
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3.2.10 Combinatorial M1/M2 Scoring 
The relative M1 and M2 character of macrophages in response to the scaffolds 
was determined by combining data from a panel of genes into a single M1/M2 score, 
based on an algorithm that has been previously shown to accurately predict healing of 
human diabetic ulcers [86]. The score is defined as the ratio of the sum of the raw values 
of M1 gene expression (CCR7, IL1B, TNF, and VEGF) to the sum of the raw values of 
M2a gene expression (MRC1, PDGFB and TIMP3) such that higher scores represent 
increased pro-inflammatory (M1) behavior with respect to M2a behavior. 
 
3.2.11 Protein Secretion 
Media collected from the scaffolds or cells was analyzed for the presence of 
proteins using commercially available kits, according to the manufacturers’ instructions. 
Human tumor necrosis factor (TNF), vascular endothelial growth factor (VEGF), platelet-
derived growth factor beta polypeptide (PDGFB) and bone morphogenetic protein 2 
(BMP2) Mini ELISA Development kits were purchased from Peprotech (Rocky Hill, NJ). 
Human matrix metalloproteinase 7 (MMP7) and matrix metalloproteinase 9 (MMP9) 
Quantikine ELISA kits were purchased from R&D Systems, Inc. (Minneapolis, MN). TIMP 
metalloproteinase inhibitor 3 (TIMP3, MIG-5) Human ELISA kits were purchased from 
Abcam® (Cambridge, MA). 
 
3.2.12 Statistical Analysis 
Data are represented as mean ± SEM. Statistical analysis for all studies was 
performed in GraphPad Prism (GraphPad Software, Inc., La Jolla, CA). Prior to analysis, 
fold change in gene expression data were log-transformed. Data were analyzed using 
one-way or two-way ANOVA, with Tukey’s post-hoc analysis. A multiple t-test analysis 
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was performed on protein secretion data using the Holm-Sidak method. In all analyses, 
p<0.01 was considered significant. 
 
3.3 Results and Discussion 
3.3.1 Temporal Effects of Scaffolds on Macrophage Activation 
3.3.1.1 Principal Component Analysis and Combinatorial Scoring 
To test the hypothesis that Baghdadite, Sr-HT-Gahnite, and TCP-HA scaffolds 
differentially regulate macrophage behavior, the response of primary human monocyte-
derived macrophages on these scaffolds was evaluated over time in vitro. 
Principal component 1 (PC 1) captured 25.6% of the variance within the gene 
expression set, and clustered the data based on time (Figure 3.2a). Interestingly, PC 2 
distinguished the M0 control on day 2 from all other macrophage responses, which 
accounted for 20.9% of the variance in the data. Not surprisingly, these results indicate 
that macrophages behave very differently when cultured in 3D on ceramic scaffolds 
compared to 2D culture on ultra-low attachment plastic. The leading drivers of the variance 
retained within PC 1 were MARCO, BGLAP, TNFSF11 and VCAN, while MMP9, TGFB1, 
TIE1 and MMP7 were major contributors to the variance of PC 2; coefficients of all genes 
projected onto the principal components are provided in Figure 3.3a. Extending the 
analysis to PC 3 and PC4, which captured 14.3% and 9.7% of the variance, respectively, 
revealed scaffold type as the third largest source of variation in the data (Figure 3.2b). 
More specifically, PC 3 separated macrophage interactions with Baghdadite scaffolds 
from all other groups at both time points.  PC 3 also separated macrophage interactions 
with TCP-HA scaffolds from all other groups on day 6. The genes most contributing to the 
variance of PC 3 were CD163, CCR7, VEGF and SPP1; genes driving the variance of PC 
4 included CCL22, ALPL, and TIMP3 (Figure 3.3b). Importantly, these results show that 
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Baghdadite scaffolds elicited different macrophage activation compared to Sr-HT-Gahnite, 
and both scaffolds were different in their responses compared to TCP-HA scaffolds, 
strongly suggesting that scaffold chemistry differentially regulates macrophage 
phenotype. 
Intriguingly, Baghdadite scaffolds resulted in a significant reduction in the M1/M2a 
score over time (Figure 3.2c), which may suggest that these scaffolds promote a 
phenotypic transition in macrophage activation. In contrast, TCP-HA scaffolds appeared 
to promote prolonged pro-inflammatory activation with an increasing M1/M2a score 
between days 2 and 6, which was significantly higher than all other groups. 
 
3.3.1.2 Temporal Changes in Gene Expression 
Analysis of expression levels of individual genes revealed interesting differences 
between macrophages cultured on the different scaffolds. Compared to the M0 control, 
TCP-HA scaffolds caused up-regulation of the pro-inflammatory M1 markers TNF at day 
2, and VEGF and IL1B at day 6 (Figure 3.4). CCR7 was downregulated at day 6 by 
macrophages on TCP-HA scaffolds. Baghdadite caused up-regulation of TNF at day 2 
and of IL1B at day 6, with down-regulation of VEGF at day 2 relative to the M0 control. Sr-
HT-Gahnite caused up-regulation of TNF at day 2 and down-regulation of CCR7 at day 6. 
Differences in gene expression of M1 markers between scaffolds were also noted, with 
Baghdadite promoting higher expression of CCR7 and TNF relative to TCP-HA at day 2, 
which then returned to baseline by day 6. 
TCP-HA scaffolds promoted significant down-regulation of all M2a markers at day 
6 (Figure 3.5), which was likely the major contributing factor to the increasing M1/M2a 
score over time. All scaffolds promoted down-regulation of the M2a marker CCL22 
compared to the M0 control at both days 2 and 6, with the exception of Sr-HT-Gahnite 
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scaffolds at day 2. Gene expression of M2a markers PDGFBB and TIMP3 was unaffected 
by Baghdadite scaffolds at either time point, but MRC1 was down-regulated at day 6 
relative to the M0 control. Sr-HT-Gahnite scaffolds promoted down-regulation of CCL22, 
MRC1, and TIMP3 at day 6. With respect to differences between scaffolds, macrophages 
cultured on TCP-HA scaffolds expressed lower levels of 3 of the 4 M2a markers compared 
to macrophages on Baghdadite or Sr-HT-Gahnite scaffolds at both time points. 
In addition to promoting down-regulation of many M2a markers, TCP-HA scaffolds 
also promoted down-regulation of several M2c markers at day 6 (CD163, MMP7, MMP9, 
and SPP1) relative to the M0 control (Figure 3.6). In contrast, Baghdadite scaffolds 
promoted up-regulation of two M2c markers at day 6 (CD163 and VCAN), as well as down-
regulation of MARCO at day 2 and MMP7 at day 6, although to a lesser extent than TCP-
HA. Sr-HT-Gahnite scaffolds promoted down-regulation of MMP7 and MMP9 at day 6, 
also to a lesser extent than did TCP-HA scaffolds. In general, macrophages cultured on 
Baghdadite scaffolds expressed higher levels of the M2c genes than macrophages on the 
other scaffolds, especially at the later time point. While the role of M2c macrophages in 
tissue regeneration is still poorly understood, recent studies suggest that they are involved 
in tissue remodeling [162], which plays an important role in bone repair. The fracture 
healing cascade involves formation of a cartilaginous fracture callus, mineralization and 
resorption of the callus, and production of woven bone as the fracture site is 
revascularized, which is later remodeled through a coordinated process of bone resorption 
and formation to restore the native tissue. Several studies have shown that the absence 
of the tissue-remodeling enzyme, MMP9, following injury delays endochondral ossification 
and alters healing [163, 164]. Similarly, the absence of osteopontin, encoded by SPP1 
and believed to facilitate the uptake of mineralized matrix [165], causes altered tissue 
remodeling in mice and, consequently, reduced biomechanical properties [166]. 
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Taken together, these results suggest that TCP-HA scaffolds promote the highest 
levels of M1-related gene expression, while Baghdadite and Sr-HT-Gahnite scaffolds 
promote a shift toward M2-related gene expression, especially at the later time point. On 
the other hand, the only genes that showed different trends in terms of direction of 
expression for Baghdadite and TCP-HA, relative to the M0 control, were CCR7 and 
CD163, and hybrid activation states that were not distinctly M1 or M2 were observed for 
all scaffolds. The fact that many genes were regulated in the same direction and to similar 
extents suggests that more studies are needed to confirm if these changes correspond to 
functional differences.  
Nevertheless, the potential of these scaffolds to differentially regulate macrophage 
behavior may have important implications for harnessing the natural healing ability of 
bone. Promoting proper vascularization following injury is a major challenge of tissue 
engineering strategies for fracture healing. Considering that the inflammatory response 
plays an important role in stimulating angiogenesis and healing, and previous work has 
demonstrated that sequential M1 and M2 macrophage activation is required to support 
these processes [70, 81], scaffolds that promote early M1- and late M2-like activation 
would also be expected to promote bone repair. Indeed, Baghdadite and Sr-HT-Gahnite 
scaffolds have been previously shown to be more successful in promoting bone 
regeneration in a critical-sized bone defect model in rabbits [151, 152]. However, a direct 
correlation between macrophage phenotype and biomaterial-mediated vascularization in 
bone repair remains to be demonstrated.  
Further extending the analysis to genes more generally related to angiogenesis 
and osteogenic processes revealed only minor changes in markers of angiogenesis, and 
did not provide any indication of osteoblast- or osteoclast-like behavior induced by TCP-
HA, Baghdadite or Sr-HT-Gahnite scaffolds (Figure 3.7). 
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Overall, these findings suggest that different scaffold chemistries differentially 
influence macrophage activation in vitro, which also been shown for materials used in 
chronic wound care [160]. Changing activation states of macrophages in response to 
implanted materials would be expected to have profound effects on bone formation given 
the importance of macrophages for bone repair [81]. 
 
3.3.2 Effects of Soluble Factors on Macrophage Activation 
3.3.2.1 Principal Component Analysis 
Baghdadite, Sr-HT-Gahnite and TCP-HA scaffolds have different mechanical 
properties, microstructure and ion dissolution profiles [158]. As an initial step toward 
investigating why macrophages behaved differently on each scaffold, the effects of 
released soluble factors on macrophage activation were tested by culturing the 
macrophages and scaffolds in separate chambers of a transwell culture system. Again, 
PCA was used to visualize the gene expression data, enabling us to identify patterns and 
emphasize variation among the scaffolds.  
Interestingly, PC 1, PC 2, and PC 3 failed to separate macrophages cultured in 
transwell with any of the scaffolds (Figure 3.8). These three principal components 
captured 88.1% of the variation in the data, suggesting that soluble signals released from 
the scaffolds do not account for differences in gene expression of macrophages. 
 
3.3.2.2 Gene Expression 
Individual gene analysis revealed minor changes in gene expression of CCL22, 
IL1B, and MMP7 by macrophages cultured in transwell with the scaffolds (Figure 3.9, 
Figure 3.10), in agreement with the principal component analysis results. In general, 
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differences in gene expression were much more pronounced for macrophages cultured in 
direct contact with the scaffolds.  
Nevertheless, the immunomodulatory effects of metal ions like titanium, zinc, 
zirconium and strontium are now widely appreciated, resulting in a paradigm shift away 
from inert bone substitutes [167]. In one study, conditioning macrophages in b-tricalcium 
phosphate extracts increased the osteogenic differentiation of MSCs, supporting the role 
of macrophages in biomaterial-induced osteogenesis [136]. Although the mechanisms 
behind metal ion-induced bone regeneration are not well understood (reviewed in Ref. 
[140]), the presence of ions likely affects macrophages. Zirconia (in Baghdadite) has been 
shown to be pro-inflammatory [168], while strontium and zinc (in Sr-HT-Gahnite) have 
been shown to affect bone remodeling [150, 169] and promote anti-inflammatory activity 
[170]. Additional studies are needed to determine if the presence of these ions contributed 
to the differential activation of macrophages observed in this work. 
 
3.3.3 Grain Size Effects on Macrophage Activation 
Considering released factors had only minor effects on macrophage gene 
expression, it was hypothesized that changing topography of the scaffolds would affect 
macrophages in direct contact with the scaffolds. To test this hypothesis, the grain size 
within Baghdadite scaffolds was varied, and protein secretion analysis was implemented 
instead of gene expression analysis to confirm that macrophages secrete the protein 
products of these genes at appreciable levels. While all proteins evaluated were secreted 
at the expected levels based on previous reports [70, 83], varying grain size had only a 
modest effect on macrophage activation (Figure 3.11). For example, macrophages 
cultured on large grain Baghdadite scaffolds secreted higher levels of TNF at day 2 
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(p<0.05). As a comparison, control macrophages cultured on ultra-low attachment plastic 
yielded differential protein production across phenotypes (Figure 3.12). 
While the effects of modifying scaffold architecture on macrophage activation were 
modest in this work, which may be due to the less than marginal change in mechanical 
properties between small and large grain Baghdadite scaffolds [158], others have 
demonstrated that surface topography can alter macrophage phenotype. Previously it was 
shown that macrophages accumulated on rough but not smooth titanium surfaces, though 
both led to bone formation in a rat subcutaneous model, suggesting differences in the 
mechanism of healing [141]. Other studies have also demonstrated the role of 
microstructure and surface topography in promoting anti-inflammatory behavior in human 
macrophages [142, 171, 172]. In this work, only modest effects of changing Baghdadite 
grain size on the activation of macrophages were observed. However, these findings are 
limited to the small region of grain sizes tested in this study and additional work is 
necessary to draw conclusions regarding the influence of grain size on macrophage-
Baghdadite interactions. It is also possible that grain size plays a role in macrophage 
responses to other materials not investigated in the present study. Additional work is 
needed to elucidate the effects of surface topography on M1, M2a and M2c activation in 
greater detail. 
Macrophage regulation could also be caused by mechanical properties. To date, 
the effect of scaffold stiffness on macrophage phenotype has been relatively 
underexplored and remains unclear. Irwin et al. attempted to shed light on the ambiguous 
relationship between inflammatory cells and substrate modulus using the THP-1 cell line, 
a human monocytic cell line that can be differentiated into macrophages [148]. Although 
cells attached preferentially to stiffer substrates, secretion of pro-inflammatory cytokines 
was variable. In contrast, another study found that stiffness of poly(ethylene glycol) (PEG) 
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substrates did not affect in vitro attachment of RAW 264.7 macrophages; however, stiffer 
substrates promoted pro-inflammatory gene expression in primary murine macrophages 
when stimulated with LPS [143]. More recently, Guo et al. showed that the modulus of 
poly(ester urethane) scaffolds implanted subcutaneously in rats can be tailored to 
modulate macrophage phenotype [144]. Given the potential for the ceramic scaffolds 
investigated in the present study to modulate macrophage behavior, future studies to 
specifically isolate substrate modulus would be interesting. 
 
It is worth noting that there were several limitations to this work. Because of the 
complexity of these scaffolds, it was not possible to isolate any one variable that 
contributes to modulation of macrophage behavior. The goal was to explore the response 
of macrophages to different scaffolds that have been successful in regenerating 
vascularized tissue in order to identify the most promising areas for more detailed 
investigation in future studies. Thus, it is recommended that subsequent work focus on 
carefully defining how changing scaffold ion content, topography, and mechanical 
properties affect macrophage activation, which could have major effects on the design of 
scaffolds for bone regeneration. Another major limitation is that only a small subset of the 
thousands of genes involved in bone regeneration were evaluated. Moreover, although 
gene expression has been shown to be an excellent indicator of cell identity and 
physiological state [173], especially for discerning macrophage activation [65, 174, 175], 
additional work is needed to confirm phenotypic changes in macrophages on a functional 
level. Finally, the effects of these scaffolds on only macrophages were investigated, but 
other immune cells, including dendritic cells and resident tissue macrophages, as well as 
cells specific to bone repair, would be expected to interact with macrophages and have 
major effects on bone regeneration. Future studies should explore the interactions 
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between macrophages, activated by bone substitutes, and other cells involved in the 
fracture healing cascade. Despite these limitations, this study suggests that scaffold 
properties differentially activate macrophages, and that with further investigation, it may 
be possible to proactively modulate macrophage behavior using scaffold design as a 
means to promote tissue vascularization and regeneration. 
 
3.4 Conclusions 
In this work, the effects of pro-regenerative scaffolds on macrophage activation 
were investigated. Overall, the findings suggest that macrophage phenotype is influenced 
by scaffold properties. To this end, Baghdadite and Sr-HT-Gahnite scaffolds were shown 
to regulate macrophage responses differently compared to TCP-HA scaffolds, which 
caused up-regulation of inflammatory (M1) genes and down-regulation of M2 genes (both 
M2a and M2c). Though additional work is needed to confirm these findings on a functional 
level, the ability of Baghdadite and Sr-HT-Gahnite scaffolds to modulate macrophage 
behavior would be expected to have important implications for bone regeneration. In 
addition, the ability of these scaffolds to regulate macrophage phenotype was 
demonstrated to result from a combination of direct and indirect cell-scaffold interactions, 
with direct interactions having the dominant effects. 
Although it is currently unknown how these changes in macrophage activation 
subsequently affect biomaterial-mediated tissue regeneration, improved understanding of 
the interactions between scaffolds that regenerate tissue in vivo and cells of the 
inflammatory response can aid in the design of biomaterials that promote healing 
outcomes. 
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Figure 3.1. Schematic of study design. Study 1: Temporal effects. Unactivated macrophages were 
seeded directly on Baghdadite, Sr-HT-Gahnite and TCP-HA scaffolds for 6 days, and characterized 
in terms of gene expression at early and late times of direct cell-scaffold contact. Study 2: Effects 
of soluble factors. Unactivated macrophages were seeded directly onto scaffolds or co-cultured 
using a transwell insert to discern the contributions to macrophage gene expression patterns 
stemming from physical scaffold properties and those resulting from ion dissolution. Study 3: Grain 
size effects. The grain size of Baghdadite scaffolds was varied and the ensuing temporal response 
on macrophage protein secretion was assessed at early and late stages of contact. 
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Table 3.1. Primers used for quantitative RT-PCR. 
Gene Forward Primer (5' - 3') Reverse Primer (5' - 3')
GAPDH AAGGTGAAGGTCGGAGTCAAC GGGGTCATTGATGGCAACAATA
TNF CCTCTCTCTAATCAGCCCTCTG GAGGACCTGGGAGTAGATGAG
CCR7 TGAGGTCACGGACGATTACAT GTAGGCCCACGAAACAAATGAT
IL1B ATGATGGCTTATTACAGTGGCAA GTCGGAGATTCGTAGCTGGA
CD80 AAACTCGCATCTACTGGCAAA GGTTCTTGTACTCGGGCCATA
CCL22 GCGTGGTGTTGCTAACCTTCA AAGGCCACGGTCATCAGAGT
MRC1 AAGGCGGTGACCTCACAAG AAAGTCCAATTCCTCGATGGTG
CD163 TTTGTCAACTTGAGTCCCTTCAC TCCCGCTACACTTGTTTTCAC
VCAN GCAAGTGATGCGGGTCTTTAC TTGCCGCCCTGTAGTGAAAC
MARCO CAGCGGGTAGACAACTTCAC TTGCTCCATCTCGTCCCATAG
VEGF AGGGCAGAATCATCACGAAGT AGGGTCTCGATTGGATGGCA
PDGF CTCGATCCGCTCCTTTGATGA CGTTGGTGCGGTCTATGAG
TIE1 AAGCAGACAGACGTGATCTGG GCACGATGAGCCGAAAGAAG
MMP7 GAGTGAGCTACAGTGGGAACA CTATGACGCGGGAGTTTAACAT
MMP9 GTACTCGACCTGTACCAGCG TCAGGGCGAGGACCATAGAG
TIMP3 ACCGAGGCTTCACCAAGATG CATCATAGACGCGACCTGTCA
ALPL TTTATAAGGCGGCGGGGGTG AGCCCAGAGATGCAATCGAC
BGLAP ATGAGAGCCCTCACACTCCTCG GTCAGCCAACTCGTCACAGTCC
RUNX2 TGGCAGTCACATGGCAGATT GACCCTGACTTTTCGGGGAG
SPP1 TTCCAAGTAAGTCCAACGAAAG GTGACCAGTTCATCAGATTCAT
TNFSF11 TCAGAAGATGGCACTCACTG AACATCTCCCACTGGCTGTA  
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Figure 3.2. Multivariate analysis of gene expression data. (A-B) PCA of the temporal effects of 
Baghdadite, Sr-HT-Gahnite and TCP-HA scaffolds on macrophage gene expression. (A) Score plot 
of PC 1 and 2 depicted, capturing 25.6% and 20.9% of the variance within the data, respectively. 
Solid line encloses all scaffold-activated macrophages on day 2; shaded region highlights 
unactivated M0 control macrophages on day 2; dashed line captures all day 6 responses. (B) Score 
plot of PC 3 and 4, capturing 14.3% and 9.7% of the variance, respectively. Shaded region 
represents Baghdadite-activated macrophages on day 2; dashed lines enclose day 6 macrophage 
responses from Baghdadite (red), TCP-HA (blue) and the M0 control (black). (C) M1/M2 scoring of 
scaffold-activated macrophages over time. Data represent mean score ± SEM.  Statistical analysis 
completed using two-way ANOVA with Tukey’s post-hoc analysis. ***p < 0.001, ****p < 0.0001; n 
= 4. Differences between day 1 and 6 were compared for each scaffold using a multiple t-test 
analysis via the Holm-Sidak method; Baghdadite scaffolds were significantly different (p<0.01). 
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Figure 3.3. Principal component analysis biplots. Plots illustrate the gene loadings for the first four 
principal components projected onto PC 1 and PC 2 (left), as well as PC 3 and PC 4 (right). 
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Figure 3.4. Gene expression of macrophages exposed to Baghdadite, Sr-HT-Gahnite and TCP-HA 
scaffolds over 6 days, based on markers indicative of the M1 phenotype. Data represent mean fold 
change over GAPDH ± SEM.  Statistical analysis was performed on log-transformed data using 
two-way ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.01) relative to the 
M0 control. **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 4. 
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Figure 3.5. Gene expression of macrophages exposed to Baghdadite, Sr-HT-Gahnite and TCP-HA 
scaffolds over 6 days, based on markers indicative of the M2a phenotype. Data represent mean 
fold change over GAPDH ± SEM.  Statistical analysis was performed on log-transformed data using 
two-way ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.01) relative to the 
M0 control. **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 4. 
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Figure 3.6. Gene expression of macrophages exposed to Baghdadite, Sr-HT-Gahnite and TCP-HA 
scaffolds over 6 days, based on markers indicative of the M2c phenotype. Data represent mean 
fold change over GAPDH ± SEM.  Statistical analysis was performed on log-transformed data using 
two-way ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.01) relative to the 
M0 control. **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 4. 
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Figure 3.7. Gene expression profiles of macrophages exposed to Baghdadite, Sr-HT Gahnite and 
TCP-HA scaffolds over 6 days, based on a panel of markers related to bone repair. Data represent 
mean fold change over GAPDH ± SEM.  Statistical analysis was performed on log-transformed 
data using two-way ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.01) 
relative to the M0 control. **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 4. 
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Figure 3.8. PCA of direct and indirect (transwell) interactions on macrophage gene expression. (A) 
Score plot of PC 1 and 2 depicted, capturing 58.0% and 20.9% of the variance within the data, 
respectively. (B) Score plot of PC 1 and 3, which captured 9.2% of the variance. Shaded regions 
highlight direct effects of Baghdadite (red), TCP-HA (blue), Sr-HT-Gahnite (green) and unactivated 
M0 control (black). Solid line indicates clustering of all transwell effects. 
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Figure 3.9. Effects of soluble factors on macrophage gene expression. Data represent mean fold 
change over GAPDH ± SEM. Statistical analysis was performed on log-transformed data using 
one-way ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.01) relative to the 
M0 control. **p < 0.01, ***p < 0.001, ****p < 0.0001; n ³ 4. 
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Figure 3.10. Comparison of direct and indirect effects on macrophage gene expression for 
Baghdadite, Sr-HT Gahnite and TCP-HA scaffolds. Data represent mean fold change over GAPDH 
± SEM. Statistical analysis was performed on log-transformed data using the Holm-Sidak method; 
*p < 0.01, n ³ 4. The dashed line represents the unactivated M0 control. 
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Figure 3.11. Protein secretion analysis for Baghdadite grain size effects on macrophage behaviour 
over time. Proteins measured include TNF (A), VEGF (B), PDGFB (C), MMP7 (D), MMP9 (E), 
TIMP3 (F) and BMP2 (G). Data represent mean±SEM. A multiple t-test analysis was completed 
using the Holm-Sidak method to determine significant differences; *p < 0.01, n = 3.  ‘a’ indicates 
protein secretion below limit of detection; these samples were assumed to be 0 ng/mL. 
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Figure 3.12. Protein secretion for macrophage phenotype controls cultured on ultra-low attachment 
plates for 6 days. Proteins measured include TNF (A), VEGF (B), TIMP3 (C), PDGFB (D), BMP2 
(E), and MMP7 (F). Data represent mean ± SEM. Statistical analysis completed using two-way 
ANOVA with Tukey’s post-hoc analysis. # denotes significance (p < 0.05) relative to all other 
phenotypes. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 3.  
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CHAPTER 4: EFFECTS OF MACROPHAGE PHENOTYPE ON VASCULAR 
ENDOTHELIAL CELLS IN VITRO 
 
4.1. Introduction 
Accumulating evidence suggests that macrophages play important roles during 
vascularization through bidirectional interactions with endothelial cells (ECs), involving 
both direct physical contact as well as crosstalk via paracrine signaling. For instance, 
direct contact with endothelial cells (ECs) in vitro has been shown to instruct macrophage 
differentiation toward an M2-like phenotype, and subcutaneous injection of these 
macrophages with RM1 cancer cells significantly increased tumor vascularity in mice 
[176]. There is also data demonstrating that direct contact with ECs can stimulate the 
differentiation of monocytes and macrophages into endothelial-like cells [177]. However, 
macrophage activation is not limited to direct cell contact as transwell co-culture of ECs 
and human monocytes also modulates the anti-inflammatory behavior of macrophages, 
which has been attributed to the secretion of extracellular vesicles [178]. Notch signaling, 
which is activated in ECs during angiogenesis, is thought to mediate the crosstalk between 
ECs and macrophages [27], and has been shown to control macrophage recruitment in a 
murine model of retinal angiogenesis [26].  
Macrophages also reciprocally act on endothelial cells to promote vascularization. 
For example, M1, M2a and M2c macrophages have been shown to secrete large 
quantities of VEGF, PDGF, and MMPs, respectively [70], all of which are involved in the 
angiogenic cascade. In addition to these factors, TNF, a hallmark indicator of M1 
macrophages, has been proven to induce endothelial tip cell differentiation [18], while 
other pro-inflammatory factors, like FGF, have been shown to prime EC responses to 
cytokines that modulate vascular morphogenesis [179]. Likewise, osteopontin (OPN), 
produced by M2c macrophages [180], is a known immunomodulator that enhances VEGF 
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expression in ECs and promotes proliferation, migration and tube formation of ECs in vitro 
[181].  
In addition to these M1-, M2a-, and M2c-associated factors, macrophages 
activated in response to uptake of apoptotic cells (referred to as M2f) have been shown to 
promote EC migration in vitro and vessel formation in vivo [67]. It is also well established 
that M2f macrophages up-regulate TGFB1 [182], which has been implicated in endothelial 
crosstalk with support cells to modulate vessel stabilization [183].   
Collectively, these studies support the ability of macrophages to respond to signals 
from ECs and facilitate vascularization. However, the unique contributions of macrophage 
phenotype in this process are not well defined and poorly understood. Therefore, the goal 
of this aim was to delineate the effects of M1, M2a, M2c and M2f on regulating the 
angiogenic behavior of endothelial cells, with the hypothesis that macrophage phenotypes 
differentially modulate the endothelial cell gene expression; these phenotypes were 
selected based on their established roles in tissue repair and suspected contributions to 
angiogenesis. To test this hypothesis, macrophage-endothelial crosstalk was assessed 
over 3 days in vitro utilizing a transwell co-culture system to facilitate isolation of cells 
without the need for significant processing. 
 
4.2. Experimental Section 
4.2.1. Neutrophil Culture and Induction of Apoptosis 
Human promyelocytic leukemia (HL-60) cells were purchased from ATCC 
(Manassas, VA) and expanded in Iscove’s Modified Dulbecco’s Medium (ATCC, #30-
2005TM) supplemented with 25% fetal bovine serum (FBS) and 1% penicillin/streptomycin 
in a humidified chamber at 37°C and 5% CO2. Neutrophils were maintained at a density 
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of 1´105 cells/mL via media exchange every 3 days, and trypan blue exclusion was 
performed to assess cell viability, which was routinely > 85%. To induce apoptosis, HL-60 
cells were first re-suspended in culture media without FBS for 2 h for cell synchronization. 
Following serum-deprivation, 800 µM H2O2 (Sigma Aldrich, #H1009) was added to the 
cells and incubated for an additional 3 h. Apoptosis was confirmed via flow cytometry using 
an APO-BrdUTM TUNEL assay kit (Thermo Fisher Scientific, #A23210), according to the 
manufacturer’s instructions, and compared to healthy neutrophil controls. All apoptotic HL-
60 cells were washed in 1X PBS prior to incubation with macrophages, as detailed below. 
 
4.2.2. Monocyte Isolation and Differentiation 
Primary human monocytes from 4 healthy donors were purchased from the 
University of Pennsylvania Human Immunology Core (Philadelphia, PA). Monocytes 
(0.5´106) were cultured at a concentration of 1´106 cells/mL in ultra-low attachment well 
plates for 8 days in RPMI 1640 media, supplemented with 10% heat-inactivated human 
serum, 1% penicillin streptomycin and 20 ng/mL MCSF as previously described [70, 162]. 
Media was replenished on days 3 and 5. On day 5, macrophages were stimulated into the 
M0, M1, M2a, and M2c by addition of IFN-g (100 ng/mL) and LPS (100 ng/mL) for M1 
activation, IL-4 (40 ng/mL) and IL-13 (20 ng/mL) for M2a activation, and IL-10 (40 ng/mL) 
for M2c activation [70]. For M2f activation, macrophages were co-cultured with apoptotic 
HL-60 cells in a 1:5 ratio of macrophages to neutrophils. On day 8, all macrophages were 
washed to remove polarizing stimuli. To confirm differentiation, n=4 biological replicates 
per phenotype were lysed in 350 µL Buffer RLT (RNeasy Micro Kit, Qiagen) and stored at 
-80°C for downstream gene expression analysis. 
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4.2.3. Endothelial Cell Culture 
Human adipose microvascular endothelial cells expressing dTomato fluorescent 
protein (HAMEC-dTom) were generously provided by the Levenberg Lab (Technion, 
Israel) and cultured at 5,000-7,000 cells/cm2 in Endothelial Cell Medium (ECM, SciencCell, 
#1001) supplemented with 5% fetal bovine serum (FBS), 1% endothelial cell growth 
supplement, and 1% penicillin/streptomycin solution. HAMEC-dTom were routinely 
subcultured via trypsinization at 90% confluency and used within 7 passages. All cells 
were cultured in a humidified chamber at 37°C and 5% CO2. 
 
4.2.4. Transwell Assay 
To investigate macrophage-endothelial cell crosstalk, a transwell co-culture 
system was utilized, allowing cell-cell communication via paracrine signaling.  A schematic 
of the experimental design is provided in Figure 4.1. HAMEC-dTom (25,000) were seeded 
in the apical chamber of transwell inserts (0.4 µm pore size, 6.5 mm diameter) in 100 µL 
ECM and allowed to attach for 1 h at 37°C and 5% CO2. Media was removed from all 
macrophage-seeded wells and replaced with 100 µL co-culture media (1:1 ratio of ECM 
to cRPMI 1640 with MCSF) to support cell survival. Transwell inserts containing HAMEC-
dTom were transferred to macrophage-seeded wells (n=4 per phenotype). An additional 
500 µL and 100 µL co-culture media were added to the basolateral and apical chambers, 
respectively. All samples were incubated for 1-3 days at 37°C and 5% CO2. Controls 
included HAMEC-dTom cultured in transwell inserts in the absence of macrophages, as 
well as M0, M1, M2a, M2c, and M2f macrophages cultured in the absence of endothelial 
cells. All controls were cultured in equal volumes of co-culture media to account for 
changes in cell behavior induced by media supplements. 
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On days 1 and 3, transwell inserts were transferred to clean 24-well plates and 
stored on ice. Conditioned media was collected from the basolateral and apical chambers 
and stored at -80°C, and all samples were washed in 1X PBS to remove residual media. 
Macrophages were lysed directly in the wells in 350 µL Buffer RLT (RNeasy Micro Kit, 
Qiagen) with gentle scraping, and HAMEC-dTom were lysed directly in the inserts in 200 
µL Buffer RLT (Qiagen). All lysates were transferred to 1.5 mL PCR-clean tubes and 
stored at -80°C until RNA extraction.  
 
4.2.5. RNA Extraction and Purification 
All HAMEC-dTom and macrophage lysates were thawed on ice and vortexed 
briefly. An additional 150 µL Buffer RLT were added to HAMEC-dTom lysates to bring final 
volume to 350 µL. Samples were mixed with an equal volume of 70% ethanol and directly 
loaded onto an RNeasy mini-spin column (RNeasy Micro Kit, Qiagen) for purification, 
according to the manufacturer’s instructions. RNA was eluted in a final volume of 14 µL 
RNase-free water and stored at -80°C until multiplex gene expression analysis.  
 
4.2.6. Multiplex Gene Expression Analysis 
RNA was thawed on ice and quantified using a NanoDrop 1000 (Thermo 
Scientific). Multiplex gene expression analysis was performed via NanoString using two 
custom nCounter XT CodeSets (NanoString Technologies, Seattle, WA), inclusive of 54 
endogenous genes for macrophage RNA, 38 endogenous genes for HAMEC-dTom RNA, 
4 housekeeping genes, 8 External RNA Control Consortium (ERCC) negative controls, 
and 6 ERCC positive controls. All genes included in the endothelial cell and macrophage 
CodeSets are listed in Table 4.1 and Table 4.2, respectively. These genes were selected 
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based on literature demonstrating their association with various processes involved in 
angiogenesis, including regulation of endothelial cell differentiation into tip and stalk 
phenotypes, regulation of the potent angiogenic stimulator, VEGF, tube formation, vessel 
stabilization and maturation, hypoxia, and apoptosis. Hybridization reactions were 
prepared with 100 ng RNA for all samples, according to the manufacturer’s instructions. 
Raw count data were extracted using nSolverTM Analysis Software 3.0 (NanoString 
Technologies, Seattle, WA). 
 
4.2.7. Data Normalization and Analysis 
Raw count data were first normalized to the ERCC positive controls, as 
recommended by the manufacturer, to normalize all platform associated sources of 
variation. The geometric mean of the positive controls was calculated for each sample, 
and averaged across all samples. This average was divided by the geometric mean of the 
positive controls for each sample, yielding a sample-specific scaling factor. Subsequently, 
all gene counts for each sample were multiplied by corresponding sample-specific scaling 
factor. These data were imported into R studio and normalized using the 
voomWithQualityWeights function within the limma package, which assigns a weight 
factor to each sample before performing a global normalization [184]. Prior to analysis, 
genes not expressed above the ERCC negative controls were identified. The geometric 
mean of the negative controls was calculated for each sample, and averaged across all 
samples. This average was then subtracted from the normalized gene counts for each 
sample, yielding negative count values for genes expressed below the limit of detection. 
Genes with undetectable expression for all samples were excluded from further analysis. 
To better understand how changes in gene expression induced by macrophage-
endothelial cell crosstalk relate to processes involved in angiogenesis, Gene Ontology 
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(GO) Enrichment Analysis was performed on groups of genes up-regulated or down-
regulated in endothelial cells by macrophage phenotype [185-187]. GO enrichment was 
performed via the PANTHER Overrepresentation Test (release 20171205) with the GO 
Ontology database released 2017-11-28. The default homo sapiens reference list, 
including all genes in the database, was used with the GO biological process complete 
data set. Overrepresented genes were determined using Fisher’s Exact with FDR multiple 
test correction for p<0.05. 
 
4.2.8. Statistical Analysis 
All data are represented as mean ± SEM, where a y-axis value of 0 represents the 
limit of detection for gene expression. Statistical analysis of the normalized gene 
expression data was performed in GraphPad Prism (GraphPad Software, Inc., La Jolla, 
CA). To determine the effects of macrophages on endothelial cells, all HAMEC-dTom data 
were analyzed using a two-way ANOVA, and the False Discovery Rate was controlled for 
post-hoc analysis. The two-stage linear step-up method of Benjamini, Krieger and 
Yekutieli was used with Q=0.1 to control for the number of false positives resulting from 
multiple comparisons [188]. To assess changes in macrophage behavior in response to 
endothelial cells, a multiple t-test analysis was performed on all macrophage data using 
the Holm-Sidak method, in which p < 0.01 was considered statistically significant. 
 
4.3. Results and Discussion 
4.3.1. Effects of Macrophage Phenotype on Endothelial Cells 
Of the 38 genes included in the CodeSet to analyze changes in endothelial cell 
(EC) behavior, 6 genes were excluded from the analysis due to undetectable gene count 
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levels. These included CD36, Jag1, MMP9, PDGFB, VEGFD, and WNT7B. For all other 
genes, the effects of macrophage phenotype on ECs are shown in Figure 4.2.  
In general, differential gene expression induced in ECs by macrophage phenotype 
was most notable at the early time point, but abolished by day 3. Specifically, M0 
macrophages down-regulated early EC expression of BAX, KDR, and PECAM1 compared 
to all other phenotypes, as well as NRP1 relative to M1, M2a and M2c, and ANGPT2, 
Endoglin, and ERG relative to M1 and M2c macrophages. In contrast, M1 and M2c 
macrophages up-regulated CXCR4 and NRARP relative to the other phenotypes. Modest 
up-regulation of CTNNB1 was also induced by the M1 and M2a phenotypes. Aside from 
these differences, M1 and M2a macrophages promoted greater expression of NOTCH3 
relative to the M2f phenotype, for which expression was undetectable. After 3 days, the 
only phenotype-specific differences among the groups was down-regulated expression of 
ETS1 induced by M1, relative to M2c macrophages, and down-regulated expression of 
TGFB1 induced by M2f, relative to the M0 phenotype. 
 
4.3.1.1. Effects of M0 Macrophages on Endothelial Cells 
Importantly, while differential effects were observed by different macrophage 
phenotypes, only a few of these changes were different relative to the EC control without 
macrophages. To gain a better understanding of how each macrophage phenotype 
modulates changes in EC behavior, the genes altered by each phenotype relative to the 
EC-only control were identified. As shown in Figure 4.3, 7 out of the 32 genes expressed 
by ECs were altered by the presence of M0 macrophages. By in large, genes affected by 
the M0 phenotype were down-regulated at one or both time points, with the exception of 
pro-apoptotic BAX, which was initially down-regulated on day 1 and later up-regulated on 
day 3. Specifically, M0 macrophages induced early down-regulation of PECAM1 and TEK, 
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late down-regulation of ETS1 and PDGFB, and sustained down-regulation of MMP2 and 
NRCAM.  
PECAM-1, an endothelial cell-cell adhesion molecule, is known to play a 
fundamental role in vessel formation in vitro [189] and in vivo [190], and may stimulate EC 
motility by promoting filopodia formation [191]. TEK, commonly referred to as TIE2, 
belongs to the receptor tyrosine kinase family and is expressed on ECs, as well as pro-
angiogenic macrophages [192-194]. Tyrosine kinase receptors bind angiopoietin 
cytokines, represent a major signaling system in regulating angiogenesis. Indeed, TIE2-
deficiency has been reported to causes aberrant network organization with poor vessel 
branching, remodeling and maturation [195], perhaps related to altered interactions 
between ECs and stabilizing support cells [196]. 
ETS-1 is expressed on stalk cells [197], and has been shown to direct EC 
differentiation into an angiogenic phenotypic [198] and regulate the expression of matrix 
metalloproteinases to facilitate vascular EC migration [198, 199]. In addition to these roles, 
ETS-1 has been linked to EC apoptosis via modulation of apoptosis-related genes [200], 
and was recently reported to play an important role in VEGF transcriptional regulation 
[201]. 
PDGFB is widely appreciated to act on PDGF b-receptor (PDGFR-beta), 
promoting endothelial tube formation in vitro [202]. For example, PDGFB has been 
demonstrated to regulate the release of tube formation-promoting extracellular vesicles by 
mesenchymal stem cells in vitro [203]. In addition, PDGFB plays an important role in 
recruitment of pericytes and vascular support cells that stabilize the vessel wall [30]. 
Expression of MMP2, along with other matrix metalloproteinases, plays a crucial 
role in sprouting angiogenesis that involves degradation of both the basement membrane 
and the surrounding extracellular matrix to create space necessary for lumen formation 
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[204]. Indeed, MMP2 expression is correlated with increased metastasis and angiogenesis 
of lung [205] and gastric carcinomas [206], and in vitro models of retinoblastoma [207]. 
NRCAM is a neural cell adhesion molecule expressed by tubular ECs during the 
early stages of tube formation [208, 209], possibly related to cell-cell communication 
involved in sprouting angiogenesis.  
GO enrichment analysis of EC genes down-regulated by exposure to M0 
macrophages on day 1 confirmed their association with blood vessel development and 
morphogenesis, as well as cell migration. Similarly, analysis of genes down-regulated on 
day 3 indicated their association with vasculature development, as well as the positive 
regulation of vascular smooth muscle cell proliferation. Overall, these data may suggest 
that M0 macrophages induce anti-angiogenic behavior in endothelial cells. 
 
4.3.1.2. Effects of M1 Macrophages on Endothelial Cells 
In contrast, M1 macrophages modulated the expression of 8 out of the 32 genes 
expressed by ECs (Figure 4.4). With the exception of ETS1, which was down-regulated 
on both day 1 and day 3, M1 macrophages promoted up-regulation of markers associated 
with angiogenesis in ECs. These changes included early up-regulation of ANGPT2, 
CDH2, CXCR4, KDR, NRARP, and TP53, in addition to late up-regulation of CTNNB1 as 
a result of EC crosstalk with M1 macrophages. 
As mentioned earlier, ANGPT2 binds to TIE2 on endothelial cells and acts as an 
antagonist to ANGPT1-TIE2 signaling [210]; however, the effects of this interaction are 
largely dependent on the surrounding cytokine milieu. For instance, ANGPT2 promotes 
angiogenesis in the presence of endogenous VEGF in vivo, but induces vessel regression 
in its absence [211, 212]. In addition to its direct effects on ECs, ANGPT2 has been 
reported to enhance the pro-angiogenic behavior of TIE2-expressing monocytes and 
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macrophages [28]. A detailed review of the ANGPT-TIE system has been provided 
elsewhere [213]. 
CDH2 belongs to the cadherin family, and is reported to support angiogenesis by 
mediating intercellular adhesion, as well as regulating expression of monocyte 
chemoattractant protein (MCP1) [214]. For example, inhibition of CDH2 during brain 
angiogenesis in the chicken was correlated with defective adhesion between endothelial 
cells and pericytes, and abnormal vascular morphogenesis [215]. Similarly, CDH2 deletion 
in an in vitro model of embryonic stem cell differentiation confirmed that CDH2 was not 
required for sprouting angiogenesis, but led to impaired pericyte coverage of endothelial 
outgrowths [216]. These data implicate CDH2 in vessel maturation via pericyte interaction. 
CXCR4, a chemokine receptor, is a marker of endothelial tip cells that has been 
shown to play a role in mediating tip cell morphology and vascular patterning in a neonatal 
retina model of angiogenesis [217]. There is also evidence suggesting CXCR4 promotes 
tumor angiogenesis by inducing expression of VEGF [218]. KDR, also called VEGF 
receptor 2 (VEGFR2), is also enriched in tip cells and mediates VEGF-stimulated filopodia 
extension [16]. Studies have demonstrated that KDR not only mediates VEGF-induced 
angiogenesis and tumor development in murine hepatocellular carcinoma [219], but also 
plays a vital role in vasculogenesis in mice [220]. Notably, differential VEGFR levels only 
affect tip cell selection in the presence of Notch signaling by controlling DLL4 expression 
[20]. 
NRARP, or Notch-Regulated Ankyrin Repeat Protein, is expressed in stalk cells at 
branch points and contributes to the regulation of vessel stabilization and regression [221]. 
In order to promote elongation of vessel branches, Notch signaling in stalk cells induces 
expression of NRARP, which subsequently counteracts Notch signaling and promotes 
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Wnt/CTNNB1 signals in stalk cells [23]. This coordination ultimately leads to vessel 
stabilization.  
TP53, also known as p53 tumor suppressor, is appreciated as a protective protein 
that responds to stress signals by inducing DNA repair, cell cycle arrest, and apoptosis. 
However, TP53 has also been linked to many processes involved in angiogenesis, such 
as inhibition of new blood vessel development [222]. Other studies have provided 
evidence for a dual role in regulating VEGF during hypoxia, whereby TP53 initially 
promotes VEGF expression in response to hypoxia but indirectly down-regulates VEGF in 
response to sustained hypoxia [223]. 
Consistent with the individual roles of these genes, GO enrichment analysis on 
genes up-regulated on days 1 or 3 in response to M1 crosstalk linked these changes to 
the positive regulation of chemotaxis and response to stimulus, blood vessel 
morphogenesis, sprouting angiogenesis, vasculogenesis, adherens junction organization, 
the response to hypoxia, cell migration, regulation of cell adhesion, and positive regulation 
of cell differentiation. Collectively, these data support a pro-angiogenic effect of M1 
macrophages on endothelial cells, possibly related to tip cell regulation. 
 
4.3.1.3. Effects of M2a Macrophages on Endothelial Cells 
Changes in EC gene expression caused by M2a exposure are provided in 
Figure 4.5 and included 7 genes. Unlike the M0 and M1 phenotypes, which generally 
induced changes in gene expression in a single direction, M2a macrophages induced both 
up-regulation and down-regulation of genes, and many of these changes occurred only 
after several days of macrophage-endothelial cell interaction. For example, M2a 
macrophages promoted late down-regulation of ANGPT2, ETS1, MMP2, and NRCAM. 
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However, M2a macrophages also supported late up-regulation of CTNNB1, early up-
regulation of NRP1, and pro-longed up-regulation of NRARP.  
As mentioned earlier, ANGPT2 acts as an antagonist to ANGPT1-TIE2 signaling 
[210], to promote angiogenesis or induce vessel regression depending on the presence 
or absence of VEGF [211, 212]. ETS1, a stalk cell marker, and MMP2 facilitate EC 
migration and sprouting [198, 199] [204], and NRCAM is a neural cell adhesion molecule 
related to tube formation [208]. 
CTNNB1 encodes for the Wnt signaling protein beta-catenin, which has been 
proven to modulate vascular remodeling by regulating DLL4 transcription and Notch 
signaling [224]. Indeed, inactivation of CTNNB1 in ECs reduced intercellular adhesion and 
altered the vascular patterning in mice [225].   
Neuropilin 1 (NRP1) encodes for a receptor that interacts with VEGFR2. Studies 
have shown that NRP1 not only promotes endothelial tip cell function during vessel 
sprouting in the brain [226], but also suppresses stalk cell differentiation [227]. Consistent 
with these findings, loss of macrophage NRP1 also has been shown to inhibit tumor 
progression [228]. 
As before, GO enrichment analysis was performed on the genes up-regulated on 
days 1 or 3 in response to M2a macrophages, in order to better understand the collective 
effects of M2a on endothelial cell behavior. The analysis linked these genes to branching 
involved in blood vessel morphogenesis; likewise, analysis of genes down-regulated on 
day 1 in response to M2a macrophages indicated an association with blood vessel 
morphogenesis and development, as well as the response to hypoxia. These data may 
support a role for M2a macrophages in regulating vessel branching.  
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4.3.1.4. Effects of M2c Macrophages on Endothelial Cells 
Similar to the changes observed by the M1 phenotype, crosstalk between ECs and 
M2c macrophages modulated the expression of 6 genes. With the exception of ETS1, 
which was down-regulated on both day 1 and day 3, M2c macrophages promoted early 
or pro-longed up-regulation of genes involved in angiogenesis (Figure 4.6). Specifically, 
CXCR4, KDR, NOTCH1, and NRARP were all enhanced relative to the EC only control 
on day 1, while expression of NRP1 was elevated on both day 1 and day 3.  
As discussed above, CXCR4, KDR, and NRP1 promote tip cell function and 
vascular patterning [16, 217, 226], while NRARP is expressed by stalk cells and regulates 
vessel stabilization and regression [221]. 
Similar to these genes, NOTCH1 encodes for a transmembrane receptor that 
regulates tip and stalk cell selection via interaction with DLL4 and Jagged ligands [21]; 
DLL4-Notch signaling inhibits sprouting, whereas Jagged-Notch signaling promotes 
sprouting. Not surprisingly, Notch1 is indispensable for VEGF-induced angiogenesis [229, 
230].  
GO enrichment analysis indicated association of genes up-regulated by M2c with 
blood vessel endothelial cell differentiation, VEGF signaling and cellular response to 
VEGF stimulus, EC migration involved in sprouting angiogenesis, positive regulation of 
cell junction assembly, branching involved in blood vessel morphogenesis, 
vasculogenesis, and positive regulation of EC proliferation. As with the M1 phenotype, 
these data indicate that M2c macrophages mediate pro-angiogenic endothelial cell 
responses, likely related to tip cell selection and regulation. 
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4.3.1.5. Effects of M2f Macrophages on Endothelial Cells 
With respect to the M2f phenotype, 8 genes were differentially expressed in ECs 
as a result of transwell co-culture (Figure 4.7). Similar to the M2a phenotype, genes 
affected by M2f macrophages were not collectively altered in a single direction. For 
example, BAX, CXCR4 and TIE1 were all up-regulated on day 1, whereas CDH2 
expression was elevated on day 3. In contrast, ANGPT2, TGFB1, and ETS1 were all 
down-regulated on day 3, along with sustained down-regulation of NRCAM at both times.  
With respect to up-regulated markers, BAX is a pro-apoptotic marker, CXCR4 is a 
tip cell marker that mediates vascular patterning [217] and may induce expression of 
VEGF [218], and CDH2 mediates intercellular adhesion [214] and vessel maturation [216]. 
TIE1, as mentioned earlier, is part of the angiopoietin/TIE system that regulates vascular 
remodeling. Recent studies posit a milieu-dependent role of Tie1, in which Tie1 interacts 
with Tie2 during inflammation to regulate ANGPT-induced vascular remodeling, but in the 
absence of an inflammatory environment, Tie1 is cleaved causing a loss of ANGPT activity 
and promoting vascular stability [231, 232]. 
With respect to down-regulated markers, ANGPT2 antagonizes ANGPT1-TIE2 
signaling [210] to promote angiogenesis or induce vessel regression depending levels of 
VEGF [211, 212]. ETS-1 is expressed on stalk cells [197], promotes angiogenic EC 
behavior [198, 199], and has been linked to EC apoptosis via modulation of apoptosis-
related genes [200]. Lastly, TGFB1 (transforming growth factor-beta 1) has been shown 
to induce angiogenesis, but requires VEGF/VEGFR2-mediated apoptosis of endothelial 
cells [233].  
Based on GO enrichment analysis, genes up-regulated in response to the M2f 
phenotype were associated with cellular membrane fusion; whereas, down-regulated 
genes were associated with regulation of extracellular matrix disassembly, regulation of 
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endothelial cell migration, blood vessel morphogenesis, and the response to mechanical 
stimulus and hypoxia. These findings may suggest a role for M2f macrophages in vessel 
regression. 
 
Notably, the changes observed in endothelial cell behavior were different across 
all phenotypes investigated, with M1 and M2c macrophages exerting the most similar 
effects. Although gene expression is thought to reflect cell identify and physiological state 
[173, 209], additional work is required to confirm how these changes affect endothelial cell 
behavior on a functional level. Nevertheless, these data support the notion that 
macrophage phenotypes contribute uniquely to the angiogenic behavior of endothelial 
cells, which would be expected to have profound effects on vascularization. 
 
4.3.2. Effects of Microvascular Endothelial Cells on Macrophages 
Of the 50 genes included in the CodeSet to analyze changes in macrophage 
phenotype in response to ECs, 9 genes were excluded from the analysis due to 
undetectable gene count levels. These included CD200R1, CD80, DLL4, PLOD2, 
PTGER3, RGS5, STAB1, VEGFC, and WNT7B. For all other genes related to 
angiogenesis, the effects of ECs on macrophages are shown in Figure 4.8 as compared 
to untreated phenotype controls. In addition, effects of ECs on macrophages with respect 
to markers indicative of the M1, M2a, and M2c phenotypes are provided in Figure 4.9 -
Figure 4.11; for comparison, M1, M2a, and M2c markers for the macrophage-only controls 
were also evaluated (Figure 4.13 - Figure 4.15).  
Surprisingly, ECs had only modest effects on macrophage phenotype compared 
to corresponding phenotype controls. As Figure 4.8 shows, ECs caused down-regulation 
of CXCR4 expression by M2a macrophages on day 3, as well as down-regulation of Jag1 
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by M0 macrophages on day 1, followed by up-regulation on day 3. In addition to these 
changes, ECs inhibited M2c expression of PDGFA on day 1.  
Similarly, only minor changes in markers of macrophage phenotype were 
detectable. With respect to markers indicative of the M1 phenotype, there were no 
changes in M1 behavior, but transwell co-culture of HAMEC-dTom and M2 macrophages 
significantly enhanced M2a expression of TNF at both time points (Figure 4.9). IL1B and 
CCR7 also appeared up-regulated, though not significantly, compared to M2a-only 
controls on day 1. Yet, early expression of IL6 was reduced in M2a macrophages. With 
respect to markers indicative of the M2a phenotype, there were no observable differences 
between macrophages exposed to HAMEC-dTom compared to their phenotype controls 
(Figure 4.10). Likewise, the only effect of ECs on markers indicative of M2c activation was 
reduced expression of MMP8 by M2c macrophages on day 1 (Figure 4.11). 
All macrophage genes affected by transwell co-culture with HAMEC-dTom are 
summarized according to phenotype in Figure 4.12.  
As discussed above, Jag1 (Jagged1) is a Notch ligand that competes with DLL4 
to regulate blood vessel growth. Deletion of Jag1 in mice not only reduces EC proliferation, 
but also compromises vessel stability [21], which may be related to its role in pericyte and 
vascular smooth muscle cell differentiation [234, 235]. Consistent with these studies, 
Jagged1 has also been demonstrated to antagonize DLL4 regulation of vessel branching 
and modulate vascular growth and maturation to accelerate wound healing in mice [236]. 
Likewise, CXCR4 mediates endothelial tip cell behavior and vascular patterning 
[217], and both CXCR4 and IL6 have been shown to induce VEGF [218, 237]. Recent 
work also supports a role for IL6 in promoting vessel sprouting to a comparable extent as 
VEGF, but these sprouts had aberrant pericyte coverage leading to defective 
angiogenesis [238].  
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MMP8, like other matrix metalloproteinases, plays an important role in 
angiogenesis. There is evidence that knockdown of MMP8 in ECs impedes tube formation, 
cell proliferation and migration in vivo, and is associated with impaired angiogenesis in 
vivo [239]. Other ex vivo work supports a role of MMP8 in vascular smooth muscle cell 
proliferation and migration [240]. 
Lastly, PDGFA has been shown to induce angiogenesis in murine corneas; though 
PDGFA was considerably less potent than PDGFB and other isoforms in promoting 
neovascularization, it was associated with a greater percentage of vessels staining 
positive for mural cells [241]. 
Collectively, these data may suggest that ECs do not significantly influence 
macrophage phenotype through secreted factors; however, the lack of effects observed 
in this study may be attributed to the low seeding density of HAMEC-dTom, especially 
considering that others have demonstrated suppressed M1 activation [178] and enhanced 
M2 activation in response to ECs [176]. 
Evaluation of macrophage phenotypes not exposed to ECs confirmed their 
differential expression of genes indicative of the M1 (Figure 4.13), M2a (Figure 4.14), and 
M2c (Figure 4.15) phenotypes even after 3 days in vitro without polarizing stimuli. 
 
It should be noted that this study has several limitations. For example, the 
investigation of macrophage-EC crosstalk was conducted using a 2D assay without tube 
formation or the presence of other cells, like pericytes and MSCs, which are vital for 
angiogenesis and have been shown to also regulate macrophage recruitment and 
activation [242], [243]. In addition, the co-culture media used was supplemented with 
growth factors to support EC survival and macrophage differentiation. It is conceivable 
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that the presence of these factors supersedes the changes induced by cellular crosstalk, 
thereby masking the effects of macrophage-EC interactions. 
 
4.4. Conclusions 
This study provides evidence that macrophage phenotype differentially influences 
the angiogenic behavior of microvascular ECs. In general, M1 and M2c macrophages 
affected genes broadly associated with tip cell behavior, which may suggest a role for 
these phenotypes in vessel sprouting. In contrast, M2a macrophages affected genes 
related to vessel morphogenesis, perhaps related to vessel branching, while M2f 
macrophages altered genes correlated with apoptosis and vascular remodeling, which 
may implicate M2f in vessel regression. On the other hand, EC down-regulation of genes 
in response to M0 macrophages may suggest that the M0 phenotype is anti-angiogenic. 
Given the distinct effects of macrophage phenotype on endothelial cell behavior, it 
is tempting to speculate that modulation of macrophage behavior can be used to pro-
actively control vascularization, addressing a major challenge for many engineered tissues 
in regenerative medicine. 
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Figure 4.1. Schematic of Study Design. Primary human monocytes were isolated from 4 healthy 
donors and differentiated into M0, M1, M2a, M2c, and M2f macrophages in vitro via stimulation with 
macrophage colony stimulating factor (MCSF) and polarizing factors for 3 days, on ultra-low 
attachment plastic. HAMEC-dTom were subsequently placed in the apical chamber of a transwell 
insert, and co-cultured with M0, M1, M2a, M2c, or M2f macrophages in HAMEC-dTom-macrophage 
co-culture media, containing MCSF, at 37°C and 5% CO2. After an additional 1-3 days, the cells 
were washed and lysed for gene expression analysis via custom nCounter XT CodeSets 
(NanoString Technologies). Untreated macrophages and endothelial cells served as controls.   
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Table 4.1. List of Genes Included in Custom CodeSet for Analysis of Endothelial Cell mRNA. 
Class Name Accession No. Class Name Accession No.
1 ANGPT1(Ang1) Endogenous NM_001146.3 29 PECAM1(CD31) Endogenous NM_000442.3
2 ANGPT2(Ang2) Endogenous NM_001147.2 30 RGS5 Endogenous NM_003617.2
3 BAX Endogenous NM_138761.3 31 TEK(TIE2) Endogenous NM_000459.3
4 CCL5 Endogenous NM_002985.2 32 TGFB1 Endogenous NM_000660.3
5 CD34 Endogenous NM_001025109.1 33 TIE1 Endogenous NM_005424.2
6 CD36 Endogenous NM_000072.3 34 TP53 Endogenous NM_000546.2
7 CDH2(N-Cadherin) Endogenous NM_001792.3 35 VEGFA Endogenous NM_001025366.1
8 COL4A1 Endogenous NM_001845.4 36 VEGFC Endogenous NM_005429.2
9 CTNNB1 Endogenous NM_001098210.1 37 VEGFD Endogenous NM_004469.2
10 CXCR4 Endogenous NM_003467.2 38 WNT7B Endogenous NM_058238.1
11 DLL4 Endogenous NM_019074.2 39 PSMB2 Housekeeping NM_002794.3
12 Endoglin(CD105) Endogenous NM_001114753.1 40 PSMB4 Housekeeping NM_002796.2
13 ERG Endogenous NM_001136155.1 41 SDHA Housekeeping NM_004168.1
14 ETS1 Endogenous NM_005238.3 42 VCP Housekeeping NM_007126.2
15 FLT1(VEGR1) Endogenous NM_002019.4 43 NEG_A Negative ERCC_00096.1
16 HIF1a Endogenous NM_001530.2 44 NEG_B Negative ERCC_00041.1
17 Jag1 Endogenous NM_000214.2 45 NEG_C Negative ERCC_00019.1
18 KDR(VEGFR2) Endogenous NM_002253.2 46 NEG_D Negative ERCC_00076.1
19 MMP2 Endogenous NM_004530.2 47 NEG_E Negative ERCC_00098.1
20 MMP9 Endogenous NM_004994.2 48 NEG_F Negative ERCC_00126.1
21 Notch1 Endogenous NM_017617.3 49 NEG_G Negative ERCC_00144.1
22 NOTCH3 Endogenous NM_000435.2 50 NEG_H Negative ERCC_00154.1
23 NRARP Endogenous NM_001004354.2 51 POS_A Positive ERCC_00117.1
24 NRCAM Endogenous NM_005010.4 52 POS_B Positive ERCC_00112.1
25 NRP1 Endogenous NM_003873.5 53 POS_C Positive ERCC_00002.1
26 PDGFA Endogenous NM_002607.5 54 POS_D Positive ERCC_00092.1
27 PDGFB Endogenous NM_033016.2 55 POS_E Positive ERCC_00035.1
28 PDGFR-beta Endogenous NM_002609.3 56 POS_F Positive ERCC_00034.1
Gene Name Gene Name
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Table 4.2. List of Genes Included in Custom CodeSet for Analysis of Macrophage mRNA. 
Class Name Accession No. Class Name Accession No.
1 BAX Endogenous NM_138761.3 35 PTGES Endogenous NM_004878.4
2 CABLES1 Endogenous NM_001100619.2 36 RAMP1 Endogenous NM_005855.2
3 CCL5 Endogenous NM_002985.2 37 RGS5 Endogenous NM_003617.2
4 CCR7 Endogenous NM_001838.2 38 STAB1 Endogenous NM_015136.2
5 CD163 Endogenous NM_004244.4 39 SYK Endogenous NM_003177.5
6 CD200R1 Endogenous NM_138806.3 40 TEK(TIE2) Endogenous NM_000459.3
7 CD34 Endogenous NM_001025109.1 41 TGFB1 Endogenous NM_000660.3
8 CD36 Endogenous NM_000072.3 42 TIMP1 Endogenous NM_003254.2
9 CD80 Endogenous NM_005191.3 43 TNF Endogenous NM_000594.2
10 CLEC10A Endogenous NM_182906.2 44 TNFRSF11A Endogenous NM_003839.3
11 CXCR4 Endogenous NM_003467.2 45 TP53 Endogenous NM_000546.2
12 DACT1 Endogenous NM_001079520.1 46 VCAN Endogenous NM_004385.3
13 DLL4 Endogenous NM_019074.2 47 VEGFA Endogenous NM_001025366.1
14 ETS1 Endogenous NM_005238.3 48 VEGFC Endogenous NM_005429.2
15 FLT1(VEGR1) Endogenous NM_002019.4 49 WNT5A Endogenous NM_003392.3
16 HIF1a Endogenous NM_001530.2 50 WNT7B Endogenous NM_058238.1
17 IDO1 Endogenous NM_002164.3 51 PSMB2 Housekeeping NM_002794.3
18 IL1B Endogenous NM_000576.2 52 PSMB4 Housekeeping NM_002796.2
19 IL6 Endogenous NM_000600.3 53 SDHA Housekeeping NM_004168.1
20 Jag1 Endogenous NM_000214.2 54 VCP Housekeeping NM_007126.2
21 LYVE1 Endogenous NM_006691.3 55 NEG_A Negative ERCC_00096.1
22 MARCO Endogenous NM_006770.3 56 NEG_B Negative ERCC_00041.1
23 MMP2 Endogenous NM_004530.2 57 NEG_C Negative ERCC_00019.1
24 MMP7 Endogenous NM_002423.3 58 NEG_D Negative ERCC_00076.1
25 MMP8 Endogenous NM_002424.2 59 NEG_E Negative ERCC_00098.1
26 MMP9 Endogenous NM_004994.2 60 NEG_F Negative ERCC_00126.1
27 MRC1 Endogenous NM_002438.2 61 NEG_G Negative ERCC_00144.1
28 Notch1 Endogenous NM_017617.3 62 NEG_H Negative ERCC_00154.1
29 NRP1 Endogenous NM_003873.5 63 POS_A Positive ERCC_00117.1
30 PDGFA Endogenous NM_002607.5 64 POS_B Positive ERCC_00112.1
31 PDGFB Endogenous NM_033016.2 65 POS_C Positive ERCC_00002.1
32 PECAM1(CD31) Endogenous NM_000442.3 66 POS_D Positive ERCC_00092.1
33 PLOD2 Endogenous NM_182943.2 67 POS_E Positive ERCC_00035.1
34 PTGER3 Endogenous NM_000957.2 68 POS_F Positive ERCC_00034.1
Gene Name Gene Name
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Figure 4.2. Endothelial gene expression in response to transwell co-culture with M0, M1, M2a, M2c, 
or M2f macrophages for 3 days. Data represent mean normalized counts ± SEM. Statistical 
analysis was performed on normalized gene expression data using two-way ANOVA and FDR post-
hoc analysis with Q = 0.1. # denotes discovery (p < 0.05) relative to the EC-only control. *adjusted 
p < 0.05; n = 4. 
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Figure 4.2. (Continued). 
 
 
 79 
 
Figure 4.2. (Continued). 
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Figure 4.3. M0-induced changes in endothelial gene expression by transwell co-culture for 3 days. 
Data represent mean normalized counts ± SEM. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1. # denotes 
discovery (p < 0.05) relative to the EC-only control. *adjusted p < 0.05; n = 4. 
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Figure 4.4. M1-induced changes in endothelial gene expression by transwell co-culture for 3 days. 
Data represent mean normalized counts ± SEM. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1. # denotes 
discovery (p < 0.05) relative to the EC-only control. *adjusted p < 0.05; n = 4. 
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Figure 4.5. M2a-induced changes in endothelial gene expression by transwell co-culture for 3 days. 
Data represent mean normalized counts ± SEM. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1. # denotes 
discovery (p < 0.05) relative to the EC-only control. *adjusted p < 0.05; n = 4. 
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Figure 4.6. M2c-induced changes in endothelial gene expression by transwell co-culture for 3 days. 
Data represent mean normalized counts ± SEM. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1. # denotes 
discovery (p < 0.05) relative to the EC-only control. *adjusted p < 0.05; n = 4. 
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Figure 4.7. M2f-induced changes in endothelial gene expression by transwell co-culture for 3 days. 
Data represent mean normalized counts ± SEM. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1. # denotes 
discovery (p < 0.05) relative to the EC-only control. *adjusted p < 0.05; n = 4. 
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Figure 4.8. Summary of macrophage gene expression for all angiogenic genes in response to 
transwell co-culture with endothelial cells for 3 days. Data represent mean normalized counts ± 
SEM. Statistical analysis was performed on normalized gene expression data by multiple t-test 
analysis via the Holm-Sidak method; *p < 0.01; n = 4. 
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Figure 4.8. (Continued). 
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Figure 4.9. Macrophage expression of M1 genes in response to transwell co-culture with 
endothelial cells for 1 (D1) and 3 (D3) days. Data represent mean normalized counts ± SEM. 
Statistical analysis was performed on normalized gene expression data by multiple t-test analysis 
via the Holm-Sidak method; *p < 0.01; n = 4. 
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Figure 4.10. Macrophage gene expression of M2a genes in response to transwell co-culture with 
endothelial cells for 1 (D1) and 3 (D3) days. Data represent mean normalized counts ± SEM. 
Statistical analysis was performed on normalized gene expression data by multiple t-test analysis 
via the Holm-Sidak method; *p < 0.01; n = 4. 
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Figure 4.11. Macrophage gene expression of M2c genes in response to transwell co-culture with 
endothelial cells for 1 (D1) and 3 (D3) days. Data represent mean normalized counts ± SEM. 
Statistical analysis was performed on normalized gene expression data by multiple t-test analysis 
via the Holm-Sidak method; *p < 0.01; n = 4. 
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Figure 4.12. Summary of all endothelial cell-induced changes in (A) M0, (B) M2a, and (C) M2c 
gene expression, relative to untreated phenotype controls. Transwell co-culture with HAMEC-dTom 
did not affect expression of genes by M1 or M2f macrophages. Data represent mean normalized 
counts ± SEM. Statistical analysis was performed on normalized gene expression data by multiple 
t-test analysis via the Holm-Sidak method; *p < 0.01; n = 4. 
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Figure 4.13. Expression of M1 genes by macrophage controls cultured in co-culture media only, 
without HAMEC-dTom, for 3 days. Data represent mean normalized counts ± SEM; y-value = 0 
represents the limit of detectable expression. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1; *adjusted p 
< 0.05 and n = 4.  
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Figure 4.14. Expression of M2a genes by macrophage controls cultured in co-culture media only, 
without HAMEC-dTom, for 3 days. Data represent mean normalized counts ± SEM; y-value = 0 
represents the limit of detectable expression. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1; *adjusted p 
< 0.05 and n = 4. 
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Figure 4.15. Expression of M2c genes by macrophage controls cultured in co-culture media only, 
without HAMEC-dTom, for 3 days. Data represent mean normalized counts ± SEM; y-value = 0 
represents the limit of detectable expression. Statistical analysis was performed on normalized 
gene expression data using two-way ANOVA and FDR post-hoc analysis with Q = 0.1; *adjusted p 
< 0.05 and n = 4.  
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CHAPTER 5: CONTRIBUTION OF MACROPHAGE PHENOTYPE TO TISSUE 
VASCULARIZATION IN VITRO 
 
5.1. Introduction 
Given the heterogeneity in macrophage responses to different biomaterial stimuli, 
it is critical to understand how changes in macrophage activation subsequently influence 
vascularization and integration of biomaterials upon implantation. In the previous aim, 
evidence was collected in support of the unique actions of macrophage phenotypes in 
stimulating angiogenic EC responses in vitro, at least at the gene expression level; though 
these findings support other reports implicating macrophages in angiogenesis in vivo, the 
distinct functional roles of macrophage phenotypes to biomaterial vascularization remain 
obscure. 
For instance, several studies have demonstrated that macrophages physically 
interact with blood vessels, and not only contribute to fusion of sprouting vessels [25, 45], 
but also mediate the repair of ruptured vascular though adhesion and mechanical traction 
[244]. Though the mechanisms behind anastomosis are still unknown, M2a macrophages 
have been shown to generate significantly more traction force compared to the M1 
phenotype [245]. Other studies have also discovered macrophage tunneling, in which 
monocytes and macrophages form tubular structures [92, 93] and functional vascular 
channels that lack endothelium [246]. Still, others have discovered that TIE1-expressing 
macrophages integrate into vessel walls and are recruited to sites of vascular remodeling 
[247]. CD206+ macrophages have also been shown to surround remodeling vessels [248]. 
In addition to these actions, macrophages are also known to influence angiogenesis via 
paracrine signaling, as discussed in the previous chapter, possibly related to the distinct 
secretory profiles of VEGF and FGF, PDGF, MMPs and OPN, and TGFB1 by M1, M2a, 
M2c, and M2f macrophages, respectively [70, 80, 180, 182].  
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Despite these reports, there is still a lack of consensus regarding the angiogenic 
potential of different macrophage phenotypes. While evidence suggests that M1 
macrophages promote endothelial tube formation in vitro [70], others report that M1 
macrophages secrete both pro- and anti-angiogenic factors and only M2 macrophages 
promote angiogenesis in vivo [96]. In contrast, both M1 and M2 macrophages have been 
reported to recruit vessel-associated stem cells in vitro via secretion of TNF and high 
mobility group box 1 (HMBG1, M1), and MMP9 (M2a and M2c) [249]. It is clear that the 
roles of macrophage phenotype in vascularization are poorly defined, perhaps because 
M1, M2a, M2c and M2f macrophages all function in angiogenesis, but in unique and 
synergistic ways. 
Indeed, several studies have shown that angiogenesis requires coordinated 
signaling of angiogenic factors for functional network development. For example, 
simultaneous delivery of VEGF and PDGF can initiate vessel sprouting, but is associated 
with reduced coverage of pericyte support cells, leading to vessel destabilization due to 
negative regulation of pericyte function by VEGF [250]. Likewise, sequential delivery of 
pro-angiogenic factors, VEGF and angiopoietin-1 (ANGPT1), with pro-maturation factors, 
PDGF and ANGPT2, has been shown to enhance vascular development, while 
simultaneous delivery inhibited vessel formation [43]. Based on the known interplay of the 
inflammatory response and angiogenesis, coupled with the data collected in the previous 
aim, it is conceivable that M1 and M2a macrophages act sequentially in angiogenesis to 
initiate sprouting and stabilize newly forming vessels, while M2c macrophages act at early 
and late stages to initiate sprouting and remodeling of the extracellular matrix. 
Therefore, the goal of this aim was to elucidate the impact of macrophage 
phenotype on vascular development in vitro. A previously established in vitro 3-
dimensional (3D) model of vascularization, developed by Frieman et al. [251], was 
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systematically adapted to facilitate the study of macrophage phenotype in angiogenesis. 
By self-assembly of ECs and MSCs on porous scaffolds in vitro, elongated immature 
vessels can be obtained within 4 days post-seeding, and well-developed vascular 
networks can be achieved by day 7 [251]. Importantly, these pre-vascularized constructs 
not only successfully anastomose with host tissue upon implantation, but also allow 
vascular morphogenesis to be studied in vitro [40] via live cell imaging. Therefore, these 
pre-vascularized constructs can be used not only in vitro by adding macrophages to this 
3D model of vascularization, but also in vivo to confirm the contribution of macrophages 
to angiogenesis and anastomosis between engineered and host tissue. 
In this work, an in vitro tri-culture system of ECs, MSCs and macrophages was first 
developed with the overarching goals of (1) probing the effects of macrophage phenotype 
on vascular morphogenesis, and (2) characterizing the crosstalk among macrophages, 
ECs and support cells required for blood vessel formation. The final 3D model of 
vascularization was expected to meet the following pre-established criteria: 
Criterion 1: Facilitates long-term culture of ECs and support cells that leads to 
vessel formation and allows for the addition of macrophage post-vasculogenesis. 
Criterion 2: Supports quantitative analysis of repeated measures, with respect to 
macrophage-blood vessel interactions, in 3 dimensions. 
Criterion 3: Enables isolation of individual cell populations for gene expression 
analysis as a means to characterize the effects of cellular crosstalk during angiogenesis. 
Thereafter, this tri-culture system was used to assess the effects of macrophage 
phenotype on tissue vascularization in vitro, and to test the hypothesis that temporal 
control over macrophage activation enhances angiogenesis. This work was completed in 
collaboration with the Stem Cell & Tissue Engineering Laboratory at the Technion-Israel 
Institute of Technology (PI: Prof. Shulamit Levenberg). 
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5.2. Experimental Section 
5.2.1. Cell Culture 
Endothelial Cells: Human adipose microvascular endothelial cells expressing 
either dTomato (HAMEC-dTom) or ZsGreen fluorescent protein (HAMEC-ZsGreen) were 
generously provided by the Levenberg Lab (Technion, Israel) and cultured at 5,000-7,000 
cells/cm2 in Endothelial Cell Medium (ECM, ScienCell, #1001) supplemented with 5% fetal 
bovine serum (FBS), 1% endothelial cell growth supplement, and 1% 
penicillin/streptomycin solution. Human umbilical vein endothelial cells expressing green 
fluorescent protein (HUVEC-GFP) were generously provided by the Levenberg Lab 
(Technion, Israel) and cultured at 5,000-7,000 cells/cm2 in Endothelial Cell Growth 
Medium (EGM-2TM-BulletKitTM, Lonza, #CC-3162). All endothelial cells were routinely 
subcultured via trypsinization at 90% confluency and used within 9 passages. 
Vascular Support Cells: Human adipose-derived mesenchymal stem cells (MSC) 
were purchased from Lonza and cultured at 5,000 cells/cm2 in Human Adipose Derived 
Stem Cell Growth BulletKitTM medium (Lonza, #PT-4503) according to the manufacturer’s 
instructions. MSC were routinely subcultured via trypsinization at 90% confluency and 
used within 7 passages. Human neonatal dermal fibroblasts (HNDF) were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, 1% non-
essential amino acids, 1% penicillin-streptomycin solution, and 0.2% b-mercaptoethanol. 
HNDF were routinely subcultured via trypsination at 90% confluency and used within 8 
passages. 
THP-1: Human THP-1 monocytes, which are thought to closely mimic the function 
of monocytes and macrophages [252], were used to study macrophage regulation of 
angiogenesis; the limited number of monocytes that can be obtained from a single donor 
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precluded the initial use of primary macrophages in this work, as the scale of each study 
required a large number of monocytes and donor-to-donor variability of pooled monocytes 
could diminish the effects of phenotype. THP-1 cells were generously provided by the 
Admon Lab (Technion, Israel), and expanded in suspension flasks at 200,000 – 400,000 
cells/mL in RPMI 1640 medium supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin solution. Media was replenished every 2-3 days by centrifugation 
of the cells at 200´g for 5 min. Following expansion, THP-1 cells were transferred to ultra-
low attachment culture flasks and stimulated with Phorbol 12-myristate-13-acetate (PMA, 
320 nM final concentration) for 16-24 h at 37°C and 5% CO2, to induce differentiation to 
M0 macrophages as previously described [160]. Following PMA treatment, M0 
macrophages were washed in 1X PBS. For differentiation into the M1, M2a, or M2c 
phenotypes, the cells were incubated for an additional 48 h in media supplemented with 
IFN-g (100 ng/mL) and LPS (100 ng/mL) for M1 activation, IL-4 (40 ng/mL) and IL-13 (20 
ng/mL) for M2a activation, or IL-10 (40 ng/mL) for M2c activation. Post-differentiation, the 
cells were gently scraped and collected for use, as indicated, in the studies described 
below. 
GFP-THP1: To visualize macrophages, THP-1 cells expressing Green Fluorescent 
Protein (GFP-THP1) were purchased from Angio-Proteomie (Boston, MA). GFP-THP1 
were expanded in ultra-low attachment flasks at 200,000 – 400,000 cells/mL in RPMI 1640 
media, supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin 
solution. Media was replenished every 2-3 days by centrifugation of the cells at 200´g for 
7 min. Differentiation into the M0, M1, M2a and M2c phenotypes was accomplished using 
the same procedure as described above for unlabeled THP-1 cells.  
All cells were cultured in a humidified chamber at 37°C and 5% CO2. 
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5.2.2. Development of In Vitro 3D Model of Vascularization with Macrophages 
5.2.2.1. Vascular Network Formation 
Previous work has demonstrated that endothelial cells and support cells can be 
seeded onto PLLA/PLGA scaffolds to generate self-assembled vascular networks in vitro 
[40, 251]; however, the ability to seed macrophages onto pre-vascularized PLLA/PLGA 
constructs may be hindered by the fibrin gel used during the initial endothelial and support 
cell seeding. Therefore, three different porous constructs were investigated in this work 
for their ability to generate vascular networks that facilitate macrophage seeding during 
later stages of vascularization. Specifically, PLLA/PLGA was compared to RGD-modified 
Alginate and Gelfoam® constructs; there were selected based on previous work 
demonstrating their utility as scaffolds that support vascular formation [253-255]. 
PLLA/PLGA Constructs: Three-dimensional (3D) porous poly-L-lactic acid 
(PLLA)/poly-lactic-co-glycolic acid (PLGA) constructs were fabricated using a salt-
leaching technique, as described previously [251]. Briefly, a 50% PLLA (Polysciences) 
50% PLGA (Boehringer Ingelheim) solution was prepared in chloroform and 0.24 mL of 
this solution was added to 0.4 g sodium chloride particles (200-600 µm diameter) 
maintained in Teflon-coated molds. The molds were sealed for 1 h, after which the 
chloroform was allowed to evaporate overnight. The polymer matrix was then removed 
from the molds and the salt was leached out in distilled water for 6-8 h, changing the water 
hourly. The resulting porous 3D scaffolds were stored at -80°C overnight, lyophilized and 
cut using an 8-mm diameter biopsy punch. PLLA/PLGA scaffolds were sterilized under 
UV for 15 min prior to cell seeding, and pre-wet in 1X PBS. Vascular networks were formed 
using previously established procedures [251]. First, a 5:1 ratio of HAMEC to MSC or 
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HUVEC to HNDF were mixed in 3.5 µL thrombin, followed by addition of 3.5 µL fibrinogen 
to the cell suspension. The suspension was mixed, seeded directly onto the PLLA/PLGA 
scaffolds, and incubated in a humidified chamber at 37°C and 5% CO2 for 30 min for cell 
attachment. Post-seeding, the scaffolds were transferred to a clean tissue-culture dish, 
and 2 mL of 1:1 endothelial cell media and support cell media were added to each scaffold. 
The scaffolds were incubated for 14 days, with media exchange every 2-3 days. 
Alginate-RGD and Gelfoam® Constructs: Alginate constructs were modified with 
RGD peptide by the Levenberg Lab. Sulfo-NHS, EDC, and RGD peptide were added to 
1% alginate in MES buffer and the reaction was allowed to proceed for 20 h with stirring. 
Hydroxyl amine was used to quench the reaction and the alginate was dialyzed for several 
days. The modified alginate was then mixed in a 2:1 ratio with active charcoal, filtered, 
frozen overnight and lyophilized. Alginate-RGD scaffolds were subsequently fabricated by 
mixing 2.5% alginate-RGD in MES buffer with adipic acid dihydrazide, 1-
hydroxybenzotriazole, and EDC crosslinkers. The mixture was cast between two glass 
slides and polymerized for 3 h. The resulting 3D scaffolds were cut using an 8-mm 
diameter biopsy punch, washed in distilled water, frozen and lyophilized. Alginate-RGD 
scaffolds were sterilized under UV for 15 min prior to cell seeding, and pre-wet in 1X PBS. 
Commercially available Size 100 Compressed Gelfoam® Sponge was purchased from 
Pfizer (New York, NY), cut using a sterile 8-mm diameter biopsy punch, and pre-wet in 1X 
PBS or media. 
Vascular networks were formed on Alginate-RGD and Gelfoam® scaffolds by 
seeding a 5:1 ratio of HAMEC to MSC or HUVEC to HNDF directly onto the scaffolds in 
10 µL endothelial cell media. The cell-seeded scaffolds were incubated for at least 30 min 
in a humidified chamber at 37°C and 5% CO2 to facilitate cell attachment; this processed 
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was repeated to achieve seeding on both sides of Gelfoam® scaffolds for all macrophage 
studies described in this aim. Post-seeding, all scaffolds were transferred to clean tissue-
culture dishes and immersed in a 1:1 solution of endothelial cell media and support cell 
media. The scaffolds were incubated for 14 days, with media exchange every 2-3 days.  
All vascular networks were cultured in endothelial and support cell co-culture 
media, which was verified to support THP-1 viability (> 99.5%) after 3 days in vitro via 
trypan blue exclusion. Macrophage media was omitted because its effects vessel 
development within the systems explored in this work are unknown.   
 
5.2.2.2. Visualization of Macrophages During Vascular Network Formation 
In order to visualize macrophage interactions with blood vessels, the ability to stain 
THP-1 cells using a Vybrant® DiD Cell Labeling solution was investigated. During later 
stages of this work, THP-1 cells expressing green fluorescent protein (GFP-THP1) 
became commercially available and were characterized as an alternative to DiD labeling. 
DiD: Where indicated, macrophages were labeled with Vybrant® DiD Cell Labeling 
solution (Thermo Fisher Scientific, Waltham, MA), according to the manufacturer’s 
instructions, immediately before seeding onto scaffolds. Effects of DiD on THP-1 viability 
were tested via trypan blue exclusion after 3 days of culture in vitro on tissue-culture plastic 
and the ability to visualize DiD-labeled M0 macrophages seeded on Gelfoam® scaffolds 
was assessed using confocal microscopy and image analysis tools.  
GFP-THP1: The ability to visualize GFP-macrophages was confirmed by 
differentiating GFP-THP1 cells into the M0 phenotype and seeding the cells directly onto 
Gelfoam® constructs in 10 µL media; GFP-M0 were visualized via confocal microscopy. 
To determine the effects of GFP-transfection on THP-1 cells, GFP-THP1 and THP-1 cells 
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were differentiated into the M0, M1 and M2a phenotypes in vitro, and lysed in 250 µL 
Buffer RLT (Qiagen) for gene expression analysis using a panel of markers indicative of 
the M1 and M2a phenotypes. RNA was extracted from cells, DNA was inactivated with 
DNAse I, and cDNA was prepared as previously described [83]. Quantitative RT-PCR was 
performed using 20 ng cDNA and Fast SYBR Green Master Mix (Applied Biosystems) 
according to the manufacturer’s protocol, with n=2 technical replicates. Mean 
quantification cycle (Cq) values were calculated and the expression of target genes was 
normalized to the reference gene, GAPDH. Data shown represent the mean fold change 
± SEM (n≥4). All primers (Table 3.1) were synthesized by Life Technologies; NRP1 
Forward (5’-3’): TGAGCCCTGTGGTTTATTCC, NRP1 Reverse (5’-3’): 
CGTACTCCTCTGGCTTCTGG; TIE2 Forward (5’-3’): TCCGCTGGAAGTTACTCAAGA, 
TIE2 Reverse (5’-3’): GAACTCGCCCTTCACAGAAATAA. 
 
5.2.2.3. Identification of Macrophage Seeding Density 
A range of macrophage concentrations was explored to determine the number of 
macrophages to seed on the scaffolds that would allow for visualization and 
characterization of macrophage-vessel interactions, as well as downstream gene 
expression analysis. THP-1 cells were differentiated to the M0 phenotype and stained for 
visualization with Vybrant® DiD fluorescent dye (Thermo Fisher Scientific, Waltham, MA) 
according to the manufacturer’s instructions. High (1:1 ratio of HAMEC to M0, 
corresponding to 300,000 M0), medium (2:1 ratio of HAMEC to M0, corresponding to 
150,000 macrophages), and low (1:1 ratio of MSC to M0, corresponding to 60,000 M0) 
macrophage densities, together with a 5:1 ratio of HAMEC-ZsGreen to MSC, were seeded 
on Alginate-RGD and Gelfoam® scaffolds. The scaffolds were maintained in co-culture 
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media, refreshed every 2-3 days, and incubated at 37°C and 5% CO2 for 14 days. 
Changes in vascularization were assessed via confocal microscopy; n = 3 scaffolds per 
group.  
 
5.2.2.4. Identification of Macrophage Seeding Time 
Macrophages were seeded on Gelfoam® scaffolds at different stages of vessel 
development to determine the effects of seeding time on vascularization. In this work, 
three time points were evaluated: Day 0, Day 3, and Day 6 of vessel development. For 
Day 0 seeding, THP-1 cells were differentiated to the M0 phenotype and mixed with 
HAMEC-ZsGreen and MSC in a ratio of 5:1:2.5 (HAMEC: MSC: M0), based on the 
previous study, in endothelial cell media. The cell suspension was seeded directly onto 
the scaffolds as described above. For Day 3 and Day 6 seeding, Gelfoam® scaffolds were 
pre-seeded with a 5:1 ratio of HAMEC to MSC on day 0, and incubated in the absence of 
macrophages. On day 3 or 6, the media was aspirated from these scaffolds and M0 
macrophages were seeded in a 2:1 ratio of HAMEC to M0. All samples were maintained 
in co-culture media, refreshed every 2-3 days, and incubated at 37°C and 5% CO2 for 14 
days. Changes in vascularization were assessed via confocal microscopy; n = 3 scaffolds 
per group. 
 
5.2.3. Contribution of Macrophage Phenotype to Vascularization  
To test the hypothesis that M1 macrophages stimulate vessel sprouting and M2a 
macrophages promote vessel branching and stabilization, the contribution of macrophage 
phenotype on vascularization was explored using the in vitro tri-culture system developed 
through earlier work, as described above. THP-1 macrophages were differentiated into 
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the M0, M1 and M2a phenotypes. Gelfoam® scaffolds were pre-seeded with a 5:1 ratio of 
HAMEC-dTom and MSC to initiate vessel formation, and, on day 3, the scaffolds were 
imaged via confocal microscopy as a baseline measurement of vessel growth. Post-
imaging, M0, M1, or M2a macrophages were seeded directly onto the constructs in 10 µL 
of co-culture media. Control scaffolds without macrophages were seeded with 10 µL of 
media alone. All samples were incubated for 30 min to allow cell attachment, and 
subsequently transferred to clean 24-well tissue culture plastic for continued incubation in 
co-culture media. Changes in vascular network formation were monitored over 10 days in 
vitro using confocal microscopy. In an effort to capture effects of macrophages on 
angiogenesis, rather than vasculogenesis, this study was repeated with macrophage 
seeding on day 6 of vascularization, at which point elongated vessels were visible. M2c 
macrophages were also included in this follow-up investigation. For both studies n³3 
scaffolds were included per group. 
Additionally, to visualize macrophage morphology and co-localization with 
developing blood vessels, GFP-macrophages differentiated into the M0, M1, M2a and M2c 
phenotypes were seeded on Gelfoam® scaffolds on day 6 of vascularization in the same 
manner as described above. Confocal microscopy was performed after 1 and 3 days of 
macrophage-vessel interactions (n ³ 3 scaffolds for M0, M1 and M2a; n = 1 scaffold for 
M2c). 
 
5.2.4. Effects of Sequential M1-to-M2a Activation on Vascularization 
To test the hypothesis that sequential M1-to-M2a activation enhances 
vascularization, macrophages differentiated into the M1 and M2a phenotypes were 
seeded on Gelfoam® scaffolds on day 3 and 6 of vascularization, respectively. Gelfoam® 
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scaffolds were pre-seeded with a 5:1 ratio of HAMEC-dTom and MSC to initiate vessel 
formation, and, on day 3, the scaffolds were imaged via confocal microscopy as a baseline 
measurement of vessel growth. Post-imaging, 50,000 M1 or M2a macrophages, or media 
alone, were seeded directly onto the constructs in 10 µL of co-culture media. All samples 
were incubated for 30 min to allow cell attachment, and subsequently transferred to clean 
24-well tissue culture plastic for continued incubation in co-culture media. Scaffolds were 
imaged on days 4 and 6. Post-imaging on day 6, 50,000 M1 or M2a macrophages, or 
media alone, were again seeded directly onto the scaffolds in 10 µL of co-culture media 
and incubated for cell attachment. The effects of this sequential seeding were measured 
on days 7 and 10 using confocal microscopy. Experimental groups included: Control (no 
macrophages), M1-media, M1-M1, M1-M2a, media-M2a, M2a-M2a; n=3 per group.  
This sequential study was repeated to confirm preliminary findings, as well as to 
include additional controls (M1-M0, M0-M2a, M1+M2a). Scaffolds (n = 3 per group) were 
prepared under the same conditions as described above. For both studies, aliquots of 
differentiated macrophages were lysed in 250 µL Buffer RLT (Qiagen) at the time of 
macrophage seeding to confirm phenotype via gene expression analysis, as described 
earlier. 
 
5.2.5. Confocal Microscopy  
Network development within the scaffolds was monitored over 14 days using live 
confocal imaging. Prior to imaging, each scaffold was rinsed in 1X PBS and transferred to 
a sterile glass-bottom dish. Images were captured using a Zeiss LSM700 inverted laser 
scanning confocal microscope (Zeiss, Germany) equipped with 10x and 20x objectives. 
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The z-stack was defined to capture the maximum field-of-view in the z-axis. Tiled z-stack 
images were acquired and stitched using Zen software (Zeiss, Germany). 
 
5.2.6. Quantitative Image Analysis 
Confocal images were processed in Fiji [256] to adjust brightness and contrast, 
with gamma set to 0.65. Maximum intensity projections of the z-stacks were analyzed in 
2D using AngioTool software [257], in terms of vessel area, length, diameter, number of 
junctions and number of endpoints. Where indicated, Matlab® (MathWorks, Natick, MA) 
was also used to measure network complexity (vessel elongation) in 2D as described 
previously [251].  
Although AngioTool is commonly used to assess vascularization, its limit to 2D 
analysis may not accurately represent the 3D network morphology. Therefore, z-stacks 
were also analyzed in 3D in Matlab® (MathWorks, Natick, MA) using a custom 
computational image analysis code developed by the Computational Image Sequence 
Analysis Lab at Drexel University (PI: Dr. Andrew Cohen) [258]. Briefly, metadata from z-
stack images were extracted, and images were converted to a binary image using media 
filter to remove background noise and Otsu thresholding in 3D. Images were then 
skeletonized using Phi Max tools and vessel structures were quantified. Original and 
skeletonized images were then concatenated to inspect the accuracy of the skeleton in 
3D. Structures were characterized in terms of total number of vessels, number of 
connected vessels, vessel diameter, number of nodal connections (vessels attached at 
the same junction), and average connected vessel size.  
 Imaris software (Bitplane, Switzerland) was also explored as a tool to quantify 
vascularization dynamics in 3D. Although Imaris is effective in reconstructing and 
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segmenting z-stacks, the software is not widely available and data interpretation in terms 
of angiogenesis is challenging.  
 
5.2.7. Investigation of Cell Isolation Techniques 
To further elucidate the effects of macrophage phenotype on vascularization, it is 
of interest to investigate changes in cell behavior resulting from crosstalk between 
endothelial cells, support cells, and macrophages. As a first step in this analysis, methods 
to isolate enriched populations of HAMEC-dTom, MSC, and macrophages of different 
phenotypes were investigated. 
 
5.2.7.1. Scaffold Digestion 
Collagenase 4 (Worthington, #LS004188) was reconstituted in 1X PBS and diluted 
to a working concentration of 2.5-5 mg/mL. Prior to digestion, vascularized Gelfoam® 
scaffolds were washed twice in 1X PBS and transferred to sterile Eppendorf tubes. 
Collagenase was added to the tubes and the scaffolds were incubated at 37°C for up to 
45 min on a Thermo ScientificTM Tube Revolver/Rotator set to 12 rpm with oscillation. 
Post-digestion, cold media containing serum was added to each sample to terminate 
enzymatic activity, and the samples were centrifuged at 200´g for 5 min. The supernatant 
was aspirated and cells were re-suspended in cold sorting buffer for further processing, 
as described below. 
 
5.2.7.2. Bead-Based Sorting 
To test the hypothesis that THP1-derived macrophage could be positively isolated, 
S-pluribeads (PluriSelect, San Diego, CA) against CD11b were used, according to the 
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manufacturer’s protocol, to target CD11b+ macrophages from CD11b- endothelial and 
support cells. However, due to poor macrophage expression of CD11b (< 30% via flow 
cytometric analysis), as well as CD14 (< 16%), alternative targets were identified using 
flow cytometry. M0, M1, and M2a macrophages, as well as HAMEC-dTom and MSC were 
evaluated for CD31 and CD146 staining via flow cytometry.  
Cells were blocked in 80 µL of Blocking Buffer (2% BSA in 1 mM EDTA) and 20 
µL FcR Blocking Reagent (Miltenyi Biotec) for 15 min at 4°C, and subsequently washed 
and re-suspended in FACS Buffer (0.5% BSA in 1 mM EDTA). Cells were incubated with 
CD31-Biotin (Miltenyi Biotec, #130-098-68, 1:10 dilution) or Mouse Anti-IgG1-Biotin 
isotype control (Miltenyi Biotech, # 130-093-018) for 20 min at 4°C, washed and re-
suspended in FACS Buffer. Anti-Biotin-APC (Miltenyi Biotec, #130-098-679, 1:10 dilution) 
was added to the suspension and incubated for 40 min at 4°C with periodic vortexing. 
CD146 was detected via labeling with Alexa Fluor®488 anti-human CD146 (Biolegend, 
#342007, 1:20 dilution) or Alexa Fluor®488 Mouse IgG2a, k isotype control (Biolegend, 
#400114) for 40 min at 4°C. Post-staining, cells were fixed in BD CytoFix for 15 min at 
4°C, washed, and re-suspended in FACS Buffer. Unstained controls were included for all 
cells. Labeled cells were analyzed using a BD FACSCanto Flow Cytometer (BD 
Biosciences, Franklin Lakes, NJ) and data were processed using FlowJo Software.  
Based on the flow cytometry data, it was hypothesized that sequential targeting of 
CD31 and CD146 would yield enriched populations of MSC, HAMEC, and macrophages. 
To test this hypothesis, pre-vascularized scaffolds containing macrophages were digested 
and labeled with biotinylated CD31 (Miltenyi Biotec) and magnetically labeled using an 
Anti-Biotin MultiSort Kit (Miltenyi Biotec), according to the manufacturer’s instructions. 
Labeled cells were magnetically sorted through LS columns via a MidiMacs separator 
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(Miltenyi Biotec), yielding CD31- and CD31+ cell fractions, and the MultiSort MicroBeads 
were removed from the cells. Subsequently, magnetic labeling with CD146 MicroBeads 
(Miltenyi Biotec) was performed on the CD31+ cell fraction, and the labeled cells were 
magnetically sorted, yielding CD31+CD146- and CD31+CD146+ cell populations. All 
fractions were analyzed via flow cytometry.  
 
5.2.7.3. FACS-Based Sorting 
As an alternative to bead-based sorting, fluorescence-activated cell sorting 
(FACS) was investigated for scaffolds seeded with HAMEC-dTom, MSC, and GFP-
expressing macrophages. It was hypothesized that the cells could be sorted based on 
their inherent fluorescence, without the need for additional processing. Single cell 
suspensions obtained after scaffold digestion were incubated with LIVE/DEAD Fixable 
Dead Cell Stain (Thermo Fisher Scientific, Waltham, MA) for 15 min on ice. The cells were 
washed and sorted on a BD FACSAria Fusion flow cytometer (BD Biosciences, Franklin 
Lakes, NJ), with the assistance of Dr. El Haddad’s Lab (Drexel University). Pure 
populations of HAMEC-dTom, MSC, and GFP-expressing macrophages were cultured in 
vitro and used as compensation controls. Sorted cells were collected directly into lysis 
buffer for subsequent gene expression analysis. 
To determine the minimum number of cells needed to obtain detectable levels of 
RNA for multiplex gene expression analysis, serial dilutions ranging from 500,000 to 976 
THP-1 cells were prepared and lysed in Buffer RLT. Lysates were mixed with an equal 
volume of 70% ethanol and loaded directly onto an RNeasy mini-spin column (RNeasy 
Micro Kit, Qiagen) for purification, according to the manufacturer’s instructions. RNA was 
eluted in a final volume of 14 µL RNase-free water and stored at -80°C. RNA was later 
thawed on ice and quantified using a BioAnalyzer 2100 RNA 6000 Nano kit (Agilent 
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Technologies, Santa Clara, CA), according to the manufacturer’s protocol. For all 
samples, RNA Integrity Number exceeded 9.0.   
 
5.2.7.4. Effects of Collagenase and FACS on Gene Expression 
The extent to which collagenase digestion and subsequent FACS isolation of the 
cells alters their gene expression profiles was analyzed to confirm the efficacy of this 
approach in assessing crosstalk among HAMEC-dTom, MSC, and GFP-macrophages 
during vascularization. Gelfoam® scaffolds were pre-vascularized for 6 days in vitro, as 
described above, and seeded with M1 or M2a macrophages derived from GFP-THP1 cells 
on day 6. The scaffolds were incubated at 37°C and 5% CO2 for an additional 2 days, after 
which the samples were digested and processed for FACS isolation of the cells. Sorted 
cells were collected directly in Buffer RLT (Qiagen) and re-pooled for gene expression 
analysis; lysates were thawed on ice, vortexed briefly, mixed with an equal volume of 70% 
ethanol and directly loaded onto an RNeasy mini-spin column (Qiagen) for purification.  
As a control, scaffolds prepared in the same manner were immersed in TRIzol for 
rapid lysis of the entire cell population. TRIzol-treated scaffolds were homogenized using 
a Mini BeadBeater-16 (BioSpec Products, Bartlesville, OK) with two 2.3 mm stainless steel 
beads for 2 cycles of 10 s. Chloroform was added to the suspensions and vigorously 
shaken by hand for 15 s. After an additional 3 min at room temperature, the samples were 
centrifuged at 12,000´g and 4°C for 15 min. The aqueous layer was collected, mixed with 
an equal volume of 70% ethanol and the precipitated RNA was purified on an RNeasy 
mini-spin column (Qiagen). 
RNA was quantified using a NanoDrop 1000 (Thermo Scientific) and BioAnalyzer 
2100 RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA), and multiplex gene 
 111 
expression analysis was performed via NanoString using an nCounter® Myeloid Innate 
Immunity Panel (NanoString Technologies, Seattle, WA), inclusive of 730 immunology-
related endogenous genes, 40 housekeeping genes, 8 External RNA Control Consortium 
(ERCC) negative controls, and 6 ERCC positive controls. Hybridization reactions were 
prepared with 100 ng RNA for all samples, according to the manufacturer’s instructions. 
Raw count data were extracted using nSolverTM Analysis Software 3.0 (NanoString 
Technologies, Seattle, WA), imported into R studio and normalized using the 
voomWithQualityWeights function within the limma package, which assigns a weight 
factor to each sample before performing a global normalization [184]. Prior to analysis, 
genes not expressed above the ERCC negative controls were identified via a 1-tailed 2-
sample Welch’s t-test with p < 0.05. Differential expression analysis between samples 
subjected to digestion and sorting vs. TRIzol-treated controls was performed via linear 
modeling within limma, and gene expression comparisons were performed with a global 
Benjamini-Hochberg adjusted multiple comparisons t-test. Genes with adjusted p < 0.05 
were considered significant. In addition, PCA was performed using Matlab® software 
(MathWorks, Natick, MA) on all genes not differentially expressed between the sorted and 
untreated groups to confirm data clustering by macrophage phenotype. 
 
5.2.8. Statistical Analysis 
All data are represented as mean ± SEM. Statistical analysis was performed in 
GraphPad Prism 7.0 (GraphPad Software, Inc., La Jolla, CA). Quantitative image analysis 
was assessed using repeated measures (RM) two-way ANOVA, with Tukey’s or 
Bonferroni’s multiple comparisons test, as indicated. Macrophage gene expression data 
were analyzed using one-way ANOVA, with Tukey’s post-hoc analysis. For all studies, n 
≥ 3 and p < 0.05 was considered significant. 
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5.3. Results and Discussion 
5.3.1. Development of In Vitro 3D Model of Vascularization with Macrophages 
5.3.1.1. Identification of 3D Scaffold and Cell Combination for Vascular Formation 
In order to assess the contribution of macrophage phenotype to angiogenesis, a 
previously established 3D model of vascularization within PLLA/PLGA scaffolds was 
modified. It was anticipated that the ability to seed macrophages onto these pre-
vascularized constructs would be hindered by the fibrin gel used during the initial 
endothelial and support cell seeding. As a result, two alternative porous constructs to 
PLLA/PLGA, Alginate-RGD and Gelfoam®, were tested for their ability to both support the 
self-assembly of vascular networks and support macrophage seeding onto the scaffolds 
several days after vascularization is initiated. In addition, previous work has demonstrated 
that co-culture of HAMEC and MSC on 3D scaffolds in vitro yields more organized and 
complex vasculature, in a reduced period of time, relative to scaffolds seeded with HUVEC 
and HNDF support cells [251]; however, the effects of this cell combination on Alginate-
RGD or Gelfoam® constructs are unknown. In this work, vessel networks generated via 
fluorescently labeled HAMEC/MSC or HUVEC/HNDF cell combinations on PLLA/PLGA, 
Alginate-RGD, or Gelfoam® scaffolds were examined over 14 days in vitro using confocal 
microscopy. 
 Consistent with earlier findings, HUVEC/HNDF appeared to initially form cell 
clusters, which subsequently sprouted to generate vessel networks on all scaffolds 
(Figure 5.1). While these clusters were absent from PLLA/PLGA scaffolds seeded with 
HAMEC/MSC, cells seeded in this combination tended to form large agglomerates on both 
Alginate-RGD and Gelfoam® from which vessels began to sprout after 7 days in vitro; 
however, cell agglomerates were still visible after 14 days. These differences were 
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quantified in terms of network complexity, representing the extent of vessel elongation, 
based on a previously described algorithm [251]. As shown in Figure 5.1, vessel 
structures generated by HUVEC/HNDF exhibited significantly greater weighted mean 
complexity when seeded on PLLA/PLGA constructs, relative to those on Alginate-RGD or 
Gelfoam® after 3 days in vitro. In contrast, the HAMEC/MSC combination produced more 
complex structures on Gelfoam®, and to a lesser extent on Alginate-RGD, compared to 
vessels generated on PLLA/PLGA scaffolds after 3 days in vitro. For both cell 
combinations, differences in vessel elongation among the scaffolds were abolished as 
vascularization progressed. Given the ability of HAMEC/MSC to produce more elongated 
vessel structures relative to HUVEC/HNDF, this cell combination was selected for the 
development of an in vitro 3D model of vascularization with macrophages. 
To determine if PLLA/PLGA scaffolds can be used to introduce macrophages at 
later stages of vessel development, these constructs were seeded with additional 
endothelial cells labeled with a different fluorescent protein, allowing these cells to be 
distinguished from those already present in the tissue, after 14 days of vascularization in 
vitro. As expected, the newly seeded cells were not detectable via confocal microscopy at 
any location on or within the scaffolds (data not shown). Therefore, PLLA/PLGA scaffolds 
were not suitable constructs for studying the role of macrophages in biomaterial 
vascularization, and were excluded from further model development. 
 
5.3.1.2. Visualization of Macrophages During Vascular Network Formation 
In order to visualize macrophage distribution throughout the scaffolds during 
angiogenesis, the ability to label the THP1-derived macrophages was first assessed using 
a fluorescent Vybrant® DiD cell-labeling solution, which integrates into phospholipid cell 
membranes. Confocal microscopy of the cells 3 days post-treatment revealed uniform 
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uptake of DiD by THP-1 cells, which was clearly absent from untreated cells (Figure 5.2a). 
Visualization of the cells on 3D scaffolds was also confirmed using THP-1 derived M0 
macrophages labeled with DiD; these cells were visible post-seeding on Gelfoam® 
scaffolds and appeared distributed throughout the entire construct. Moreover, Trypan blue 
exclusion of THP-1 cells treated with DiD was performed to confirm cell viability, which 
was determined to be 92.7%, compared to 99.5% for untreated THP-1 after 3 days in vitro 
on ultra-low attachment plastic. 
Although DiD labeling is a rapid (requires less than 30 min) and effective approach 
to visualize macrophages via confocal microscopy, it is possible for DiD to leak from non-
viable cells and localize to other adjacent cells [259]. This was observed in preliminary 
studies investigating macrophage-vessel interactions. As a result, commercially available 
GFP-expressing THP-1 macrophages were investigated as an alternative approach. GFP-
THP1 consistently exhibited viability comparable to unlabeled THP-1 cells in vitro, and 
were visible and uniformly distributed following seeding on Gelfoam® scaffolds 
(Figure 5.2b).  
To confirm that GFP-labeling does not alter the phenotypic behavior of the cells, 
GFP-THP1 cells were differentiated into M1 and M2a macrophages and gene expression 
analysis was performed for a panel of markers indicative of macrophage phenotype [70]. 
Importantly, the gene expression profiles of GFP-THP1 were consistent with unlabeled 
THP-1 cells (Figure 5.2c), suggesting that transfection of the cells with GFP does not alter 
phenotype. As expected, GFP-THP1 stimulated with LPS and IFN-g up-regulated M1 
markers, TNF, IL1B, and CCR7; whereas, stimulation with IL4 and IL13 induced up-
regulation of M2a markers, CCL22 and PDGFB. Although not established as markers of 
macrophage phenotype, NRP1 and TIE2 were included in this panel because of reports 
implicating their association with macrophages interacting with blood vessels [25, 246]. 
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While these markers were not differentially expressed between M0, M1 or M2a 
macrophages stimulated in vitro, it is possible that NRP1 and TIE2 expression are induced 
by other stimuli present in vivo or by hybrid M1/M2 phenotypes not included in this assay. 
Overall, these data suggest that GFP-THP1 cells can be used to study the 
contribution of macrophage phenotype to angiogenesis. 
 
5.3.1.3. Effects of Macrophage Seeding Density 
Though it is well established that a 5:1 ratio of endothelial cells to support cells are 
optimal to generate self-assembled vascular structures on porous scaffolds [40, 251, 260], 
this work represents the first time that incorporation of macrophages into this system has 
been explored. Prior to seeding macrophages in combination with HAMEC and MSC, the 
ability of macrophages to survive in the co-culture media necessary for vascular 
development was tested. Trypan blue exclusion confirmed that M0 macrophages cultured 
in equal parts HAMEC media and MSC media displayed > 99.9% viability. Therefore, a 
1:1 ratio of endothelial cell and support cell media was used for all vascularization studies 
described in this work. 
Next, the seeding density of macrophages was investigated on both Alginate-RGD 
and Gelfoam® scaffolds in combination with HAMEC and MSC. Three seeding densities 
were examined, including a 1:1 ratio of HAMEC to macrophages (defined as high), a 2.5:1 
ratio of HAMEC to macrophages (defined as low), and a 5:1 ratio of HAMEC to 
macrophages (defined as low). The numbers of HAMEC and MSC were held constant for 
all scaffolds. As shown in Figure 5.3a, vascular networks assembled on Gelfoam® 
appeared to develop uniformly across all seeding densities; in contrast, vessel networks 
generated on Alginate-RGD scaffolds appeared less developed and displayed 
inconsistent organization both within and between groups (Figure 5.3b). Regardless of 
 116 
seeding density, DiD-labeled M0 macrophages appeared dispersed throughout the 
scaffolds, with visible localization to endothelial cell clusters within Alginate-RGD. Analysis 
of vessel structures revealed only a minor increase on day 3 in vessel complexity for 
medium densities on both Gelfoam® and Alginate-RGD scaffolds, relative to the same 
scaffold seeded with a high or low number of macrophages (Figure 5.3c). However, 
vascular structures within Gelfoam® scaffolds were significantly more complex than those 
within Alginate-RGD after 3 days in vitro when seeded with a medium or low number of 
macrophages. 
Based on these findings, a 2.5:1 ratio of HAMEC to macrophages was selected for 
further investigation, coupled with commercially available Gelfoam® constructs as the 
scaffolding for vessel formation by HAMEC and MSC. Given the uncontrollable variability 
in network formation observed for Alginate-RGD scaffolds, these constructs were not 
considered reliable for the study of macrophages in angiogenesis. Variability in vascular 
development may have resulted from batch effects in preparing and modifying these 
constructs with RGD peptide. As a commercially available medical device, Gelfoam® is 
expected to meet strict quality control standards, which would minimize scaffold-induced 
batch effects on vascularization and facilitate experimental reproducibility. 
 
5.3.1.4. Effects of Macrophage Seeding Time 
The dynamics of macrophage seeding in combination with HAMEC and MSC on 
Gelfoam® scaffolds were also studied with respect to seeding time. M0 macrophages 
were seeded on day 0, 3, or 6 of vascularization and network formation was compared to 
HAMEC/MSC control constructs without macrophages. Interestingly, simultaneous 
seeding of all three cell populations on day 0 inhibited network development (Figure 5.4); 
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whereas, addition of macrophages on days 3 and 6, when vessels were already formed, 
appeared to cause vessel regression over 14 days in vitro. 
Since the goal of this investigation was to delineate the contribution of 
macrophages to angiogenesis, which involves the sprouting of new blood vessels from 
pre-existing vessels, all future studies involved pre-seeding HAMEC and MSC on 
Gelfoam® on day 0 to initiate vessel formation, with subsequent addition of macrophages 
to the pre-vascularized scaffolds after at least 3 days of network development. 
Additionally, the presence of elongated vessel structures was confirmed via confocal 
microscopy prior to macrophage seeding for all succeeding experiments. 
  
5.3.2. Effects of Macrophage Phenotype on Vascularization 
Following the development of the 3D tri-culture model of tissue vascularization 
described above, this system was then applied to elucidate the effects of macrophage 
phenotype on angiogenesis; a representative schematic of the study design for this 
investigation is provided in Figure 5.5. 
 
5.3.2.1. Early Effects of Macrophage-Vessel Interactions 
THP1-derived M0, M1, and M2a macrophages were seeded on Gelfoam® 
scaffolds pre-vascularized for 3 days, and changes in network morphology were evaluated 
after 1-3 days of macrophage-vessel interactions, as shown in Figure 5.6a. For all groups, 
HAMEC-dTom formed small clusters from which vessels were sprouting on day 4 (1-day 
post-macrophage seeding). While differences in network morphology were difficult to 
discern from the z-stack projections, M1-seeded macrophages appeared to enhance 
vascularization, within 1-day post-seeding, relative to the HAMEC/MSC control and 
scaffolds treated with the M0 and M2a phenotypes. Analysis in 2D of the projected z-stack 
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images using AngioTool confirmed a significant increase in both vessel density and the 
density of junctions/nodes by M1 macrophages, relative to control vessels without 
macrophages and those treated with an unactivated M0 phenotype, after 1 day 
(Figure 5.6b). Vessels treated with M1 macrophages also exhibited significantly more 
endpoints than control constructs, which may correspond to increased vessel sprouting. 
Interestingly, these phenotypic differences were abolished by day 6 (3-days post-
macrophages seeding), at which point there were no significant differences in vessel 
density or the number of junctions among the groups. However, M1-treated vessels were 
significantly shorter in length relative to control vessels and those treated with M2a 
macrophages, and had significantly more vessel endpoints than vasculature treated with 
other macrophage phenotypes.  
Extending this analysis to 3 dimensions using a custom algorithm further 
established the contribution of the M1 phenotype vascularization, and also revealed 
morphological changes in vessel structure induced by M2a macrophages after 1 day of 
macrophage-vessel interaction (Figure 5.6c). For example, both M1 and M2a 
macrophages increased the total number of vessels within the scaffolds and the number 
of connected vessels throughout the network on day 4. Consistent with these changes, 
both phenotypes also reduced the average vessel length relative to control networks 
without macrophages, as well as the number of vessels joined by the same junction/node 
relative to M0-treated scaffolds. These findings suggest that both M1 and M2a 
macrophages are pro-angiogenic and can enhance tissue vascularization in terms of 
vessel sprouting and branching. 
To verify the effects of macrophage phenotype on angiogenesis, this study was 
repeated with macrophage addition on day 6 rather than day 3 and M2c macrophages 
were included in the analysis. Additionally, changes in network morphology were 
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normalized to baseline morphology imaged on day 6, and compared after 1, 3 and 4 days 
post-macrophage seeding. Allowing HAMEC-dTom and MSC to organize into vessels for 
6 days in vitro provided more developed networks than those of the previous study 
(Figure 5.7). However, in contrast to seeding macrophages on day 3, incorporation of 
macrophages on day 6 of vascularization appeared to reduce vessel growth relative to 
control scaffolds without macrophages. Quantification via image analysis revealed 
reduced (though not significantly) vessel density, junctions density, and vessel length for 
M1-, M2a, and M2c-treated vasculature (Figure 5.8a). M2a macrophages caused the 
greatest reduction in vessel length and, correspondingly, a significant increase in the 
number of vessel endpoints relative to control scaffolds over time, which is consistent with 
the visible vessel regression in the confocal images (Figure 5.7). 
Similarly, analysis of the z-stacks in 3D showed a significant reduction in vessel 
length caused by M2a macrophages 1-3 days post-seeding (Figure 5.8b), in addition to 
significant reductions in the mean connected vessel size 3-days post-seeding (day 9), and 
the number of vessels connected at the same junction 4-days post-macrophage seeding 
(day 10). 
In general, analysis in 3D of the confocal z-stacks was consistent with the findings 
of the 2D AngioTool analysis, though analysis in 3D would be expected to have greater 
accuracy in characterizing the three-dimensional network morphology. Indeed, by 
preserving the native structures of the vessels, changes in vascular dynamics induced by 
both M1 and M2a phenotypes were detected. Though these trends resembled that of the 
2D analysis, many of the differences between macrophage phenotypes were 
undiscovered via AngioTool tracing. These findings emphasize the importance of 
analyzing vascular structures in their intrinsic 3D form. 
 120 
These data are consistent with the changes in gene expression observed in aim 
2, which suggested that M1 and M2c macrophages promote tip cell behavior, as well as 
previous work demonstrating the angiogenic potential of M1, M2a, and M2c macrophages 
in a tube formation assay [70]. More recently, an in vitro bead-based capillary sprouting 
assay was used to demonstrate that pro-inflammatory macrophages increase the number 
and density of endothelial sprouts, dependent on Notch signaling [261]. However, in the 
present study, M1 and M2 macrophages were associated with a decrease in vessel length 
that corresponding with an increase in the extent of branching and number of connections, 
suggesting that macrophages both stimulated sprouting and fusion of vessels. The 
beneficial effects induced by M2a could be due to the elevated levels of PDGFB that are 
characteristic to this phenotype; indeed, PDGFB is known to enhance angiogenesis, and 
plays a role in directing the differentiation of MSCs into vascular support cells [262]. 
The differences in vascularization when seeding macrophages on day 6 versus 
day 3 were interesting. The data suggest that seeding macrophages at earlier times of 
vessel development has a greater impact on vascular formation compared to seeding on 
day 6. It is possible that by day 6, the extensive vessel growth precludes the ability to 
detect subtle changes induced by macrophages, and perhaps a greater number of 
macrophages are needed to visualize their contributions.  
  
5.3.2.2. Late Effects of Macrophage-Vessel Interactions 
In addition to the studies above, which highlight the immediate changes in vessel 
development in response to macrophages, network morphology was assessed after 
prolonged times of M0 macrophage-vessel interactions. In this study, M0 macrophages 
were seeded on Gelfoam® scaffolds pre-vascularized for 6 days in vitro, and vascular 
dynamics were assessed after 1 (day 7), 4 (day 10), and 8 (day 14) days later. 
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Similar to the earlier results described above, a dramatic reduction in the extent of 
vascularization was observed after 4 days of vessel exposure to M0 macrophages 
(Figure 5.9a). These changes were strikingly obvious after an extended period of time, 
especially compared to vessels formed in the absence of macrophages, which appeared 
well-developed. Quantification of the vessel structures corroborated these observations, 
confirming a significant reduction in vessel density, the number of vessel junctions, and 
average vessel length after prolonged exposure to M0 macrophages (Figure 5.9b). 
Consistent with the changes, M0 macrophages also caused a significant increase in the 
number of vessel endpoints over time, which correlates with the vessel fragmentation and 
regression visible in the images. While similar changes were observed in other studies for 
M1 and M2a macrophages, discussed below, these effects were not thoroughly 
characterized in this work. Nevertheless, these findings suggest a role of macrophages in 
vessel regression and remodeling, which occurs during angiogenesis as vessels mature 
[35, 263]. Though it is not known if the changes induced in this case are beneficial or 
harmful for biomaterial-mediated tissue regeneration, unpublished in vivo work indicates 
an indispensable role of macrophages in vascular remodeling and integration between 
pre-vascularized constructs and host tissue (data collected by the Levenberg Lab). This 
is consistent with early work revealing the macrophages are recruited to sites of 
remodeling during developmental angiogenesis [247]. However, these findings seem to 
be controversial, or perhaps context-dependent, as other work suggests that 
macrophages play a protective role in limiting remodeling induced by TGFB2 in vivo. 
Therefore, additional work is needed to ascertain the interplay of EC apoptosis, vessel 
remodeling, and macrophage phenotype. 
 
 122 
5.3.2.3. Co-localization of Macrophages During Vascular Formation 
To gain a better understanding of how macrophage phenotype contributes to the 
changes in network morphology observed in this work, macrophage-vessel interactions 
were visualized over 1-3 days using GFP-expressing M0, M1, M2a, and M2c 
macrophages. Phenotypic differences in macrophage morphology, as well as co-
localization and interactions with vessel structures were apparent after both 1 day 
(Figure 5.10) and, to a lesser extent, 3 days (Figure 5.11) in vitro. In general, M0, M1 and 
M2c macrophages appeared more rounded in structure compared to M2a macrophages, 
which tended to form large clusters of elongated cells surrounding the vessels. M0 
macrophages were seen in both close proximity with and positioned on top of vessels, 
and occasionally displaying an elongated morphology, perhaps to guide vessel formation. 
Similarly, M1 macrophages appeared rounded when localized on top of the vessels, but 
also displayed occasional elongation between vessels, which may suggest a role for M1 
in bridging sprouting vessels. In contrast, M2a macrophages were more frequently found 
wrapping around vessels and extending between endothelial vessels. M2c macrophages 
also appeared to be in direct contact with the vessels, as well as in close proximity, and 
were found to elongate with extended processes between vessel structures, with 
occasional wrapping around vessels, though less frequently compared to the M2a 
phenotype. 
These phenotypic patterns were still present 3 days post-seeding (Figure 5.11). 
M0 and M1 macrophages appeared predominantly rounded in morphology, but elongation 
between and near vessels was clearly visible. In some cases, macrophages formed what 
appeared to be tube-like structures, but the presence of a lumen was not tested. M2a 
macrophages were still seen wrapping around vessels, and what appeared to be bridging 
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between adjacent structures. M2c macrophages were also still interacting directly with the 
vessels after 3 days.    
These data are consistent with observations reported by others. Macrophages 
have been observed on several occasions to wrap around vessels and bridge nearby tip 
cells [25, 45]. The findings shown here suggest that M2a macrophages play a more 
predominant role in these actions relative to other macrophage phenotypes. Studies have 
also shown that macrophages may form tunnels to direct leading tip cells [92], which may 
be related to the actions of M1 and M2c macrophages. Finally, it was recently 
demonstrated that macrophages can form functional vascular channels in the absence of 
ECs [246]; however, macrophage-derived channels were not apparent for the phenotypes 
investigated in the present study.  
 
5.3.3. Effects of Sequential M1-to-M2 Activation on Vascularization 
Based on the data presented in this work and by others [70], suggesting that 
macrophage phenotypes play unique but synergistic roles in angiogenesis, it was 
hypothesized that temporal control over macrophage activation would lead to enhanced 
tissue vascularization. To test this hypothesis, M1 and M2a macrophages, along with the 
corresponding controls, were added sequentially to pre-vascularized Gelfoam® scaffolds 
after 3 and 6 days, respectively. These time points were selected based on earlier studies 
demonstrating phenotypic-differences induced in vessel structures by macrophages 
seeded on day 3 of vascularization. 
Remarkably, all constructs seeded with macrophages, regardless of phenotype, 
appeared to have greater vessel density relative to untreated vessels over time 
(Figure 5.12a-b). Moreover, constructs seeded with macrophages at both time points, 
appeared to have greater vascular development compared to those with macrophage 
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seeded on only day 3 or 6, suggesting that macrophages promoted vessel growth. The 
most notable difference in vascularization was observed by sequentially adding M1 to M2a 
macrophages. Image analysis corroborated these qualitative observations (Figure 5.12c). 
Sequential M1 and M2a activation significantly increased vessel density and the extent of 
vessel branching, in terms of number of junctions, relative to vessels exposed to M2a at 
either time point. M1-to-M2a addition also enhanced vessel length on average, relative to 
scaffolds vascularized without macrophages or those exposed to M2a on only day 6. 
Likewise, vessels exposed to M1 macrophages, without M2a addition, had significantly 
more endpoints than those exposed to M2a macrophages, without M1 addition. For all 
scaffolds seeded with M2a macrophages at any time, the number of endpoints was 
significantly lower than those of the control vessels. These data are consistent with the 
previous findings that M1 macrophages promote sprouting and M2a macrophages 
increase vessel length, and suggest that temporal control over macrophage behavior can 
be used to manipulate biomaterial vascularization. 
This study was later repeated with additional controls, including simultaneous 
addition of M1 and M2a macrophages at both time points, to test the importance of 
temporal regulation on the synergistic effects of these phenotypes. Surprisingly, the 
effects of sequential M1 and M2a activation were not consistent with the previous study. 
In this case, vessels were well-developed in the absence of macrophages, and sequential 
incorporation of either M0, M1, or M2a macrophages appeared to reduce vascularization 
regardless of phenotype (Figure 5.13a), though M1-to-M1 appeared to retain more 
vascular structures relative to all other macrophage-treated scaffolds on day 7. By day 10, 
vessels exposed sequentially to M1 and M2a phenotypes displayed significant vessel 
regression relative to all other groups investigated (Figure 5.13b). Image analysis in both 
2D (Figure 5.14a) and 3D (Figure 5.14b) confirmed these qualitative observations. Only 
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modest differences in vessel development were detected by day 7; whereas, by day 10, 
all macrophage-seeded scaffolds had reduced vessel densities, numbers of junctions, and 
average vessel lengths compared to untreated vessels via AngioTool analysis. M1-treated 
scaffolds induced these changes to a greater extent, though not significantly, than those 
with M2a addition. These differences were more apparent via 3D image analysis, which 
indicated a significant reduction in vessel length for vessels exposed to only M1 
macrophages first. 
In an effort to identify the discrepancy in the results between these two studies, 
gene expression analysis was performed on all macrophage lysates collected immediately 
prior to seeding on both days 3 and 6, using a panel of markers indicative of macrophage 
phenotype to confirm the successful differentiation of M1 and M2a. As Figure 5.15 shows, 
gene expression profiles for M1 and M2a macrophages were consistent between study 1 
(S1) and study 2 (S2) for both time points, and in line with respect to phenotype. M1 
macrophages up-regulated M1 markers, TNF, CCR7, and IL1B, while M2a macrophages 
up-regulated M2a markers, CCL22, and PDGF, in addition to TIE2. These data suggest 
that the discrepancies between the two sequential studies were not attributed to altered 
macrophage behavior at the time of seeding.  
There are several other possible causes for the discrepancies observed between 
the two studies, many of which were tested. For example, the control scaffolds appeared 
poorly developed in the first study, which may indicate abnormal behavior of the HAMEC 
and/or MSC. The passage number of the cells, as well as the Lots from which they were 
derived, may impact vessel development. To rule out these factors, sequential addition of 
M1 and M2a macrophages was again tested, using Gelfoam® scaffolds pre-vascularized 
with HAMEC-dTom and MSC of the same passage as the first study. The first study used 
MSC at passage 7 (P.7), which was consistently observed to cause cell-aggregation and 
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inhibit vessel growth. Nevertheless, the original findings were not reproduced. 
Unfortunately, the HAMEC and MSC, and their corresponding media, used in the original 
study were kindly provided by the Levenberg Lab (Technion, Israel), for which the lot 
numbers were not available. Therefore, the cell source (donor) could not be eliminated as 
a potential source of variability, which could also be related to altered kinetics in vessel 
development. As an initial step to explore the effects of vascular kinetics, a final study was 
completed with sequential M1 and M2a macrophages incorporated on days 6 and 9 of 
vascularization. The results were consistent with those shown in Figure 5.14, and did not 
reproduce the original findings that demonstrated enhanced vascularization with temporal 
control over macrophage activation. It is also plausible that subtle environmental changes 
influenced the results, especially considering that the first study was completed in Israel, 
while all follow-up work was performed at the U.S. at Drexel. 
Clearly, additional work is needed to validate the effects of sequential M1 and M2a 
activation on vascularization. Nevertheless, these preliminary studies demonstrate that 
temporal control over macrophage phenotype has potential to promote vessel 
development within 3D scaffolds in vitro. These findings are supported by recent in vivo, 
in which sequential delivery of VEGF and PDGFB from a fibrin gel were proven to enhance 
revascularization of cardiac tissue post-myocardial infarction [42].  
 
5.3.4. Development of Cell Isolation Techniques 
To better understand the contributions of macrophage phenotype that lead to 
changes in vascular formation, the impacts of cell communication need to be explored. 
While it is not uncommon to use immunohistochemistry (IHC) to assess development and 
maturation of fixed vessel networks [251, 260], there is a lack of reliable markers that can 
be used to discern macrophage behavior in vitro, thereby prohibiting the use of this 
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approach. To overcome this limitation, several methods were explored to isolate enriched 
HAMEC-dTom, MSC and macrophage populations from the vascularized tissue for further 
characterization. Prior to cell isolation, all Gelfoam® scaffolds were digested in a 
collagenase solution (Figure 5.16a), as reported in literature [254]. 
 
5.3.4.1. Magnetic Bead-based Isolation of HAMEC-dTom, MSC, and Macrophages 
It was expected that enriched populations of HAMEC, MSC, and macrophages 
could be obtained by sequentially targeting surface markers specific to the cells. While 
CD31 is considered to be a robust marker of endothelial cells, preliminary work comparing 
the gene expression profiles of HAMEC-dTom and macrophages revealed surprisingly 
high expression of CD31 by macrophages (data not shown here). Though not widely 
appreciated in literature, these findings were consistent with several other reported studies 
[246, 264, 265]. Additionally, CD146 is considered to be indicative of endothelial cell 
lineage [266], and is not expected to be highly expressed by macrophages. Therefore, it 
was anticipated that CD31 could be used to positively target HAMEC-dTom and 
macrophages, indirectly isolating MSC from the tri-culture. Then, CD146 could be used to 
positively target HAMEC-dTom, indirectly isolating macrophages from the co-culture. 
Before proceeding, surface expression of CD31 and CD146 on HAMEC-dTom, MSC, and 
M1, M1 and M2a macrophages was compared via flow cytometric analysis.    
As shown in Figure 5.16b, >99% of endothelial cells stained positively for CD31, 
while > 80% of M0, M1 and M2a macrophages were positive for CD31. In contrast, 
approximately 7% of MSC displayed positive CD31 staining. Expectedly, HAMEC-dTom 
were also positive (roughly 97%) for CD146, but macrophages and MSC exhibited 
substantially lower levels of CD146 staining, suggesting that CD31 and CD146 can be 
used to obtain highly enriched cell populations. Hence, magnetic beads targeting CD31, 
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followed by those targeting CD146 were tested on the tri-culture obtained after digestion 
of vascularized Gelfoam®, as illustrated in Figure 5.16c-d. As anticipated, cells that were 
not bound by CD31-targeting beads (CD31- fraction) displayed low CD31 intensity, which 
would be expected of MSC (Figure 5.16c). In contrast, the majority of the cells that were 
collected in the CD31+ fraction displayed positive CD31 staining. Upon removal of the 
magnetic beads from the CD31+ fraction and subsequent labeling with magnetic beads 
against CD146, flow cytometric analysis demonstrated distinct CD31+CD146- and 
CD31+CD146+ cell populations, conceivably representing enriched macrophage and 
endothelial cell populations, respectively (Figure 5.16d). Importantly, this approach 
provides only enriched, but not pure, cell populations; as a result, gene expression 
analysis would be needed to confirm that characteristic gene profiles of these populations 
can be achieved before further analysis is performed. It is possible that cell enrichment 
could be improved by targeting other surface markers, such as CD18, but this was not 
tested for the system described here. 
This sequential magnetic bead-based cell isolation approach is also associated 
with other drawbacks. For instance, it takes more than 5 hours to isolate the cells per 
batch of samples processed together, which in this case was limited to 4 samples because 
of the magnetic separator utilized. Furthermore, the samples are subjected to a significant 
amount of processing during this time, including multiple washes and centrifugations, as 
well as being plunged through multiple separator tubes, which may adversely alter the 
gene expression profiles of the cells. 
 
5.3.4.2. FACS-Based Isolation of HAMEC-dTom, MSC, and Macrophages 
Due to the significant amount of time and processing required to isolate enriched 
cell populations from the tri-culture used in this work, FACS-based isolation was 
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investigated as an alternative approach. Since the fluorophores associated with HAMEC-
dTom and GFP-macrophages can be excited and detected at different wavelengths, it was 
expected that FACS could be used to isolate HAMEC and macrophages via their 
associated fluorophores, with MSC distinguished as unlabeled cells. Therefore, single cell 
suspensions containing HAMEC-dTom, GFP-macrophages, and MSC were obtained by 
collagenase digestion of vascularized Gelfoam®, and the cells were subjected to FACS. 
As shown in Figure 5.17, three distinct cell populations were observed based on PE 
(dTomato) and AlexaFluor488 (GFP) intensities, suggesting that FACS is suitable for 
isolation of the cells used in this work. 
Still, FACS is associated with several limitations worth noting. For instance, of the 
approximate 920,000 cells isolated following scaffold digestion, only about 51% of the 
cells were retrieved via sorting after selecting for live, singlet cell populations. Of this 
relatively small cell population, only 1.2% were identified as macrophages based on GFP 
expression, while 31.7% and 57.6% of the population were identified as HAMEC and 
MSC, respectively. Consequently, multiple scaffolds may need to be pooled in order to 
obtain enough RNA for subsequent gene expression analysis. Indeed, a standard curve 
of detectable RNA concentration as a function of cell number revealed that > 10,000 
macrophages are needed to achieve adequate RNA concentrations using the methods 
described in this work (Figure 5.18). Aside from these challenges, it takes approximately 
30-45 min per sample to complete the sorting process, which limits the number of samples 
that can be processed within a single day, especially considering the time required to 
prepare the cytometer.  
On the other hand, FACS requires significantly less processing relative to the 
bead-based approach described above, and would thus be expected to have less impact 
on gene expression of the cells. Moreover, the purity of cells isolated using this strategy 
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is likely greater than that obtained via magnetic beads, which rely on efficient antibody 
targeting. Despite these advantages, this approach requires access to a FACS sorter, 
which is not readily available at all institutions.     
 
5.3.4.3. Effects of Cell Isolation on Gene Expression 
Based on the ease and efficiency of cell sorting using FACS, this method was 
further validated to determine the extent that collagenase digestion of the scaffolds and 
FACS isolation of the cells affects gene expression, which was compared to vascularized 
Gelfoam® tri-cultures immersed directly in lysis buffer (Figure 5.19a). From a myeloid 
panel of 730 genes, 588 genes were expressed above the negative controls and were 
included in the analysis. As Figure 5.19b illustrates, gene expression between cells 
subjected to digestion and sorting was strongly and positively correlated with that of 
TRIzol-treated controls for both M1- and M2a- seeded constructs, though M2a 
macrophages appeared marginally more affected (r = 0.89) by the treatment relative to 
M1 macrophages (r = 0.93). Still, several genes were observed in distant proximity from 
these linear correlations, suggesting an impact of the isolation approach. Analysis of 
differentially expressed genes via a global Benjamini-Hochberg adjusted multiple 
comparisons t-test revealed that 297 genes were altered (p < 0.05) in M1-seeded 
scaffolds, and 357 genes were affected in M2a-seeded scaffolds. Consequently, only 194 
genes (33% of the 588 genes expressed) were determined to be unaffected by 
collagenase digestion together with FACS treatment. Removing the genes differentially 
expressed between the treated and control groups resulted in high positive correlations, 
with all genes localized to the linear correlations (Figure 5.19c). For additional validation, 
gene expression for all remaining genes was visualized using PCA, which showed that 
the data clustered along PC 1 by macrophage phenotype, representing 27.6% of the 
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variance within the data. However, differences in treatment were still notable even after 
removal of the differentially expressed genes, as the data clustered by treatment along 
PC 2, representing 14.6% of the variance within the data (Figure 5.19d). Collectively, 
these findings confirm that collagenase digestion, together with FACS sorting, can alter 
gene expression; therefore, it is prudent to perform this analysis for all genes of interest in 
future studies. 
 
It should be acknowledged that there were several limitations in this investigation. 
First and foremost, the effects of macrophages on vascularization were only studied within 
the in vitro 3D system developed in this aim, which utilized a gelatin-based material. 
Though Gelfoam® has been shown to support the viability, attachment and proliferation 
of ECs in vitro [254], as well as angiogenesis in vivo [253], the effects of Gelfoam on the 
angiogenic behavior of endothelial cells were not investigated in this work, and it is well 
established that tissue microenvironment in which the cells are seeded can profoundly 
influence vascularization [267]. For example, it has been demonstrated that altering 
substrate stiffness not only affects EC sprouting behavior in vitro [268], but also impacts 
the ability of ECs to respond to angiogenic stimuli, such as VEGF [269]. Consistent with 
these findings, it has been shown that the ability of ECs to sprout in response to VEGF 
gradients is related to the density of the surrounding tissue matrix [270]. Based on these 
findings, it is possible that the Gelfoam system used in this study influenced the response 
of ECs to difference macrophage phenotypes. Additional work is needed to confirm the 
translation of these observations, especially in the context of specific tissue applications, 
such as bone repair. 
In addition to these limitations, changes in macrophage phenotype were not 
measured over time. Although the phenotypic profiles were confirmed prior to seeding on 
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pre-vascularized Gelfoam® constructs, macrophages would not be expected to retain 
their phenotype in the presence of polarizing stimuli present in the surrounding 
microenvironment. This includes signals not only from the cells within the constructs, but 
also the construct itself. As a result, changes in network morphology may not necessarily 
result from the macrophage phenotype stimulated on ultra-low attachment plastic. This 
may, in part, account for the fact that effects of macrophage phenotype were observed at 
the earliest time investigated post-seeding, but diminished thereafter. Additionally, the co-
culture media used to support vascular formation contained growth factors specific to the 
cells, as well as serum. As in the previous aim, it is possible that the presence of these 
molecules may interfere and/or mask the effects induced by macrophages on vessel 
development. Furthermore, the effects of macrophages on supporting MSCs were not 
explicitly studied, though crosstalk between these cells has been well established [271-
273]. It is possible that macrophages play a major role in recruiting and directing the 
behavior of these vascular support cells, which would be expected to profoundly affect 
vascular formation. 
  
5.4. Conclusions 
In this study, a 3D tri-culture model of vascularization in vitro was developed by 
seeding microvascular ECs together with MSC support cells on Gelfoam® constructs, 
which supported the addition of a third cell type at later stages of vascular formation. This 
system was applied to the study of macrophages in angiogenesis in order to better 
delineate the contributions of different phenotypes to this process. Most notably, addition 
of M1, and to a lesser extent M2a, macrophages to pre-vascularized constructs enhanced 
vessel sprouting and the extent of connected vessels relative to vascular formation in the 
absence of macrophages. These effects were most prominent within 1 day of seeding, 
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and abolished after 3 days; moreover, long-term culture of macrophages with vascularized 
constructs induced vessel regression, independent of phenotype, supporting a role for 
macrophages in vessel remodeling. In addition to these findings, this work has 
demonstrated the potential for temporal control over M1 and M2a activation to enhance 
tissue vascularization. The findings presented here are consistent with previous work, 
suggesting that both M1 and M2 macrophages contribute to angiogenesis, but in unique 
ways. Additionally, this work provided the foundation needed to characterize cell-specific 
changes in gene expression and protein secretion with respect to vascular dynamics in 
3D. 
Given that biomaterial implantation inherently causes an inflammatory response, 
understanding the complex interplay between macrophages – the regulators of this 
process, and angiogenesis can provide the insight needed to overcome one of the biggest 
challenges currently facing regenerative medicine. 
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Figure 5.1a. Comparison of vascular formation by HUVEC/HNDF or HAMEC/MSC on RGD-
modified alginate, Gelfoam®, and PLLA/PLGA scaffolds over 14 days in vitro. Representative 
maximum intensity projections from n = 3; scale bar = 500 µm.  
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Figure 5.1b. Quantitative comparison of vascular formation by HUVEC/HNDF or HAMEC/MSC on 
RGD-modified alginate, Gelfoam®, and PLLA/PLGA scaffolds over 14 days in vitro. Data represent 
weighted mean complexity ± SEM (n = 3). Statistical analysis performed using RM two-way ANOVA 
with Tukey’s post-hoc analysis. *p < 0.05.  
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Figure 5.2. (A) Comparison of DiD-labeled and unlabeled THP1-derived macrophages on tissue 
culture plastic, and maximum intensity projection of DiD-labeled macrophages seeded on 
Gelfoam®. (B) Maximum intensity projection of GFP-THP1 macrophages seeded on Gelfoam®. 
(C) Effects of GFP on THP-1 gene expression for a panel of markers indicative of M1 and M2a 
activation. Statistical analysis performed using one-way ANOVA with Tukey’s multiple comparisons 
test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n = 3. 
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Figure 5.3. Effects of macrophage seeding density on HAMEC/MSC vascular formation on (A) 
Gelfoam® and (B) RGD-modified alginate scaffolds over 14 days in vitro. M0 macrophages were 
seeded at a high (5:1:5), medium (5:1:2.5), or low (5:1:1) density of HAMEC: MSC: M0. 
Representative maximum intensity projections from n = 3. HAMEC-dTom shown in green, DiD-M0 
shown in magenta; scale bar = 500 µm. (C) Quantification of vascular formation in terms of 
weighted mean complexity. Data represent weighted mean complexity ± SEM (n = 3). Statistical 
analysis performed using RM two-way ANOVA with Tukey’s post-hoc analysis. **p < 0.01. “a” and 
“b” denote differences (p < 0.05) relative to all other time points. 
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Figure 5.4. Effects of macrophage seeding time on vascular formation by HAMEC/MSC on 
Gelfoam® scaffolds over 14 days in vitro. Representative maximum intensity projections of tile 
scans from n = 3. HAMEC-dTom shown in red, DiD-M0 shown in green; scale bar = 500 µm for 5x 
images and 150 µm for 10x images.  
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Figure 5.5. (A) Schematic of study design used to investigate macrophages contributions to tissue 
vascularization. Gelfoam® scaffolds were pre-vascularized using a 5:1 of HAMEC to MSC on day 
0. Macrophages were seeded on day 3 or 6 of vessel development, and changes in network 
morphology were monitored via confocal microscopy over time. (B) Schematic of quantitative image 
analysis. Maximum intensity projections were analyzed in 2D via AngioTool; z-stacks were 
analyzed in 3D via a custom code in Matlab. Reconstructed vessels shown in green (3D viewer); 
skeletonized vessels shown in red (analysis).   
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Figure 5.6. Early effects of M0, M1, and M2a on Gelfoam® vascularization in vitro. Macrophages 
seeded on day 3 of vessel growth. (A) Representative images from n = 3; scale bar = 500 µm. (B) 
Quantification of vascular development in 2D and (C) 3D. Statistical analysis performed using RM 
two-way ANOVA with Tukey’s post-hoc analysis; p < 0.05. 
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Figure 5.7. Early effects of M0, M1, M2a, and M2c on Gelfoam® vascularization in vitro. 
Macrophages seeded on day 6 of vessel growth. Representative maximum intensity projections 
from n = 3; scale bar = 500 µm.  
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Figure 5.8. Quantification of M0-, M1-, M2a-, and M2c-induced changes in vascular development 
in (A) 2D and (B) 3D. Macrophages seeded on day 6 of vessel development. Statistical analysis 
performed using RM two-way ANOVA with Tukey’s post-hoc analysis; n³3 and p<0.05. 
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Figure 5.9. Late effects of M0 macrophages on Gelfoam® vascularization in vitro. Macrophages 
seeded on day 6 of vessel growth. (A) Representative images from n = 3; scale bar = 500 µm. (B) 
Quantification of vascular development in 2D. Statistical analysis performed using RM two-way 
ANOVA with Bonferroni’s multiple comparisons test; p < 0.05. 
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Figure 5.10. Macrophage-vessel interactions 1-day post-seeding. Representation maximum 
intensity projections of macrophage-vessel interactions from n ³ 3 scaffolds 1-day post-seeding 
with M0, M1, M2a or M2c (n = 1 scaffold) macrophages. Macrophages seeded on day 6 of vascular 
formation; images acquired on day 7. Scale bar = 500 µm. HAMEC-dTom shown in red; GFP-
macrophages shown in green.  
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Figure 5.11. Macrophage-vessel interactions 3-days post-seeding. Representation maximum 
intensity projections of macrophage-vessel interactions from n ³ 3 scaffolds 3-days post-seeding 
with M0, M1, M2a or M2c (n = 1 scaffold) macrophages. Macrophages seeded on day 6 of vascular 
formation; images acquired on day 9. Scale bar = 500 µm. HAMEC-dTom shown in red; GFP-
macrophages shown in green. 
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Figure 5.12. Effects of sequential M1 and M2a activation of vascularization (study 1). (A) Schematic 
of study design; M1 or M2a macrophages, or media alone, seeded on days 3 and 6 of vessel 
development and changes in network morphology assessed via confocal microscopy over time. (B) 
Representative images from n = 3 on day 7 and (C) day 10; scale bar = 500 µm. (D) Quantification 
of vascular development in 2D. Statistical analysis performed using RM two-way ANOVA with 
Tukey’s post-hoc analysis; p < 0.05. 
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Figure 5.13. Effects of sequential M1 and M2a activation of vascularization (study 2). M0, M1, or 
M2a macrophages, or media alone, seeded on days 3 and 6 of vessel development and changes 
in network morphology assessed via confocal microscopy on (A) day 7 and (B) day 10. 
Representative images from n = 3; scale bar = 500 µm. 
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Figure 5.14. Quantification of changes in vascular development induced by sequential M1 and M2a 
activation (study 2). (A) Analysis of projections in 2D via AngioTool. (B) Analysis of z-stacks in 3D 
via Matlab. Statistical analysis performed using RM two-way ANOVA with Tukey’s post-hoc 
analysis; n = 3 and p < 0.05. 
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Figure 5.15. Gene expression of M1 and M2a macrophages stimulated in vitro, for markers 
indicative of M1 (TNF, CCR7, IL1b) and M2a activation (CCL22, PDGF). Data represent 
macrophage gene expression at the time of seeding on days 3 and 6 for studies investigating 
sequential M1-to-M2a activation. S1 = study 1; S2 = study 2.   
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Figure 5.16. Bead-based sorting of HAMEC-dTom, THP1-derived macrophages and MSC. (A) 
Vascularized Gelfoam® scaffolds digested in collagenase, yielding single cell suspensions. (B) 
Surface expression of CD31 and CD146 by HAMEC-dTom, THP-1 macrophages and MSC, 
measured via flow cytometry. (C) Magnetic beads targeting CD31 used to negatively select for 
CD31- MSC within cell suspension, yielding suspension of CD31+ HAMEC-dTom and 
macrophages. (D) Beads bound to CD31 removed, and magnetic beads targeting CD146 used to 
negatively select for CD31+CD146- macrophages, yielding an enriched suspension of 
CD31+CD146+ HAMEC-dTom. Flow cytometry used to confirm population enrichment in all 
fractions. 
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Figure 5.17. FACS-based sorting of HAMEC-dTOM, GFP-THP1-derived macrophages, and MSC. 
(A) Schematic of sorting process; vascularized Gelfoam® scaffolds digested in collagenase, 
yielding single cell suspensions, and subsequently sorted based on inherent dTomato and GFP 
expression. (B) Single cells identified from parent scatter population; live cells distinguished based 
on intensity of dead cell stain, and subsequently sorted according to dTomato and GFP expression 
using a BD FACSAria Fusion flow cytometer. Macrophages represented less than 2% of the sorted 
population collected, while HAMEC-dTOM and MSC represented 31.7% and 57.6% of the sorted 
cells collected, respectively. 
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Figure 5.18. Effect of THP-1 cell number on RNA yield according to BioAnalyzer 2100 RNA 6000 
Nano kit. Linear regression fit to the data, with r2 = 0.9953, indicating goodness of fit. 
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Figure 5.19. Effects of collagenase digestion and FACS-based sorting on gene expression of cells 
isolated from vascularized Gelfoam® scaffolds containing M1 or M2a macrophages; 730 myeloid 
genes analyzed. (A) Schematic of isolation process for treated vs. control scaffolds lysed in TRIzol. 
Correlation analysis comparing gene expression between groups (B) for all genes, and (C) after 
removal of genes differentially expressed between sorted and control scaffolds. (D) PCA 
demonstrating clustering of remaining genes according to phenotype by PC 1 and treatment by PC 
2, representing 27.6% and 14.6% of the variance, respectively.   
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CHAPTER 6: CONCLUSIONS AND RECOMMENDATIONS 
 
6.1. Conclusions 
The overarching goals of this work were to (1) understand how materials 
successful in regenerating tissue in vivo impact the microenvironment to influence 
macrophage behavior in vitro and (2) determine how changing macrophage phenotype 
affects biomaterial vascularization. To this end, macrophage activation was examined in 
response to direct contact with bone substitutes that have been proven to promote 
regeneration in critical size defects relative to less successful scaffolds. Using cluster 
analysis to visualize differences among scaffold-induced macrophage activation revealed 
major changes in gene expression over time for all scaffolds, as well as scaffold-specific 
effects on macrophage behavior. In contrast to clinically utilized TCP-HA scaffolds that 
induced sustained up-regulation of pro-inflammatory markers indicative of M1 activation, 
along with significant down-regulation of M2 activation, Baghdadite and Sr-HT-Gahnite 
scaffolds demonstrated increased M2a- and M2c-like activation over time.  
Because macrophages are known to rapidly change their phenotype in response 
to different stimuli, including mechanical and structural scaffold properties, and soluble 
factors present in the microenvironment, a transwell assay was performed to compare 
macrophage activation when physical contact with the scaffolds was obstructed. 
Surprisingly, there were few differences in macrophage responses to ions released by the 
scaffolds despite differences in chemical composition of the scaffolds, indicating that direct 
cell-scaffold contact was primarily responsible for modulating macrophage phenotype. In 
an attempt to identify potential mechanisms leading to the M2 responses observed, grain 
size was varied within Baghdadite scaffolds; however, only modest effects on macrophage 
 155 
protein production were observed. This work provided evidence that scaffolds more 
successful in regenerating bone in vivo modulate macrophage behavior. 
It was not clear how this modulation correlates with vascularization, which plays 
an indispensable role in biomaterial-mediated tissue repair. Therefore, the next step was 
to ascertain how changes in macrophage phenotype affect the angiogenic potential of 
endothelial cells. Primary human monocyte-derived M0, M1, M2a, M2c and M2f 
phenotypes were co-cultured with microvascular ECs in a transwell system, allowing for 
cellular crosstalk via paracrine signaling. After 1 and 3 days, gene expression was 
assessed to identify the physiological state of the cells. ECs had surprisingly modest 
effects on macrophage phenotype, even after 3 days without exogenous addition of 
macrophage stimulating factors, which was attributed to differences in cell number 
between ECs and macrophages.  
In contrast, macrophage phenotype induced significant changes in EC expression 
of genes related to vessel sprouting, stabilization and maturation, and remodeling. M0 
macrophages caused down-regulation of genes related to vessel morphogenesis, cell 
migration, and the positive regulation of vascular smooth muscle cells, which likely 
signifies an anti-angiogenic contribution to vascularization. M1 macrophages induced up-
regulation of several genes associated with positive regulation of chemotaxis, sprouting, 
and adherens junction organization, suggesting a pro-angiogenic contribution to 
vascularization that may be related to tip cell regulation. Similar results were observed for 
M2c macrophages, which also stimulated up-regulation of genes associated with VEGF 
signaling, the response to VEGF, branching and EC proliferation. Based on these findings, 
M2c are proposed to mediate pro-angiogenic EC responses related to tip cell selection 
and regulation. M2a macrophages induced changes related to branching, and M2f 
affected genes associated with ECM disassembly, EC migration and the response to 
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mechanical stimuli and hypoxia, which may implicate this phenotype in vessel regression. 
This study advanced the current understanding of macrophage-EC crosstalk during 
angiogenesis. 
To further ascertain the functional consequences of macrophage control over EC 
behavior, a 3D in vitro model of vascularization was developed. This model utilized 
microvascular ECs and MSC support cells, which self-assembled into vascular networks 
on porous Gelfoam® constructs that were selected based on the ability to introduce cells 
into the system at varying stages of blood vessel development. The seeding ratio of 
macrophages relative to ECs and MSCs was optimized for quantification of vascular 
dynamics, from which a 2.5:1 ratio of ECs to macrophages was measured to yield more 
complex vasculature compared to higher seeding densities. Subsequently, the seeding 
time of macrophages was varied over days 0-6. Seeding times of day 3 or 6 were chosen 
based on the presence of tubular structures in combination with the inhibitory effects 
observed from simultaneous seeding of macrophages with ECs. In order to visualize 
macrophage-vessel interactions using live cell imaging, the ability to label macrophages 
with Vybrant® DiD cell labeling solution was explored, and compared to the use of GFP-
expressing macrophages. Analysis of GFP-macrophages confirmed that the cells retain 
the same phenotypic profiles as unlabeled macrophages when stimulated in vitro; 
because of potential DiD leaking and uptake by adjacent cells, GFP-macrophages 
represent a more stable approach for imaging macrophages in culture over extended 
periods of time. 
With this system, the contributions of M0, M1, M2a and M2c macrophages on 
network development were investigated. Consistent with the gene expression data 
resulting from macrophage-EC crosstalk, M1 macrophages enhanced vessel density and 
branching relative to vessels without macrophages and those exposed to the M0 
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phenotype. Similar changes were observed for M2a macrophages, but to a lesser extent. 
Importantly, phenotype-induced changes were rapidly abolished and all macrophage-
seeded constructs led to eventual vessel regression. These effects seemed to be 
accelerated by later seeding times, highlighting the importance of investigating early time 
points. High-magnification imaging of macrophage-vessel interactions further 
demonstrated that M2a macrophages wrap around vessels and facilitate bridging between 
adjacent tip cells, while M1 and M2c macrophages displayed a rounded morphology with 
only occasional elongation. Nevertheless, M1 and M2c macrophages were also seen on 
top of vessels, and near branching sites. A preliminary investigation of sequential M1 and 
M2a activation demonstrated the potential of temporal control over macrophage behavior 
to improve vascularization relative to constructs without macrophages; however, 
additional work is needed to confirm these early findings. 
Lastly, methods to isolate macrophages, ECs and MSCs from vascularized 
Gelfoam® identified were explored as a foundation for assessing cellular crosstalk among 
all three populations of cells at various stages of vascular formation. A magnetic bead-
based approach using sequential targeting of CD31 and CD146 was established, yielding 
enriched but not pure populations of each cell type. Because of extensive processing and 
time required to achieve this separation, FACS-based isolation of fluorescently-tagged 
ECs and macrophages were also assessed and found effective in achieving highly 
enriched cell populations, though only small quantities of cells could be collected from a 
single scaffold. To confirm that digestion of Gelfoam® and subsequent FACS isolation of 
ECs, MSCs, and macrophages can be used to measure gene expression profiles without 
jeopardizing or altering the cells, gene expression was compared between sorted 
scaffolds and those subjected to immediate lysis of the entire cell population. Based on a 
myeloid panel of 730 genes, isolation of the cells in this manner significantly altered > 67% 
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of the genes, emphasizing the importance of testing the effects of processing conditions 
on cell behavior prior to comparing gene expression profiles of the cells. This investigation 
has laid the groundwork for future studies to thoroughly characterize crosstalk between 
ECs, MSCs, and macrophages during tissue vascularization in vitro. 
 
6.2. Recommendations for Future Work 
This research has exciting implications for controlling vascularization, both in 
biomaterial-mediated tissue repair and disease. Future work should utilize the tri-culture 
system developed in aim 3 to characterize the crosstalk between macrophages, ECs and 
MSCs. Preliminary in vitro work in 2D has demonstrated that the angiogenic behavior of 
ECs is differentially stimulated by macrophage phenotype. Conducting this analysis in 3D, 
in the presence of developing blood vessels, may shed light on the factor(s) that contribute 
to macrophage-mediated anastomosis. Functional consequences of silencing or inhibiting 
potential factors of anastomosis could then be analyzed with respect to network 
morphology using this system. In addition to characterizing the crosstalk among the cells 
via gene expression, whole-mount immunohistochemistry should be used on pre-
vascularized scaffolds exposed to macrophages of different phenotypes to better 
elucidate the spatiotemporal effects on MSC support cells, which were not visualized in 
this work, and EC phenotypes with respect to macrophage localization. Markers of interest 
include those related to vessel stability (e.g. a-smooth muscle actin, aSMA) and tip and 
stalk cell differentiation (e.g. DLL4, VEGFR2, NRARP). Alternatively, the phenotypic 
contributions of macrophages in angiogenesis can also be explored by conducting time-
lapse imaging over 24 – 48 h of GFP-expressing macrophages seeded on HAMEC-
dTom/MSC-derived vascular networks. This would enable tracking of individual cells with 
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respect to macrophage phenotype, which would enhance our understanding of the 
dynamic interactions between macrophages and development vessels.  
Other areas that warrant further investigation include the effects of sequential 
activation of M1 and M2a macrophages. In this work, the time between macrophage 
seeding was not varied, but it is possible that, because macrophages undergo rapid 
phenotypic changes, M2a macrophages should be seeded within 1 day of M1 addition. 
Likewise, temporal control over M2c and M2f was not yet explored. Mounting evidence, 
collected through this work and by others [70, 80], suggests that M2c macrophages 
contribute to early stages of vessel sprouting, and perhaps late stages of network 
remodeling.  
Moreover, the consequences of macrophage modulation by regenerative 
biomaterials in vascularization outcomes is of interest, particularly due to the ability of 
these biomaterials to induce hybrid phenotypes that are not generally achieved via 
traditional in vitro activation of macrophages. This could be achieved by applying 
conditioned media collected from macrophage-seeded constructs to the 3D in vitro model 
of vascular formation. However, this would require careful optimization to be able to study 
vascular dynamics using conditioned media without comprising EC and MSC survival. 
Aside from these recommended studies, there are several areas of interest that 
are known to have a major impact on angiogenesis that should be considered in future 
analyses. First, the experiments conducted in this work were completed under normal 
oxygen levels, but it is well established that hypoxia is a major driver of angiogenesis, 
especially in the context of implanted tissues that lack a functional vasculature supply. 
Moreover, hypoxia is not only thought to influence macrophage behavior [274] and 
regulate macrophage-EC interactions during angiogenesis [275], but also plays a role in 
the recruitment of immune cells [276]. Hypoxia is also affected by mechanical activation, 
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such as that induced by fluid flow in perfused vessels, which subsequently alters [38, 39]. 
Therefore, investigating the contribution of macrophages to angiogenesis in a dynamic 
environment should also be considered. To better understand the mechanisms behind 
macrophage-vessel crosstalk that lead to the changes observed in this work, future 
studies should also analyze cell communication through exosomes, or extracellular 
vesicles. Indeed, recent work has demonstrated that macrophages can be modulated by 
MSC-secreted vesicles [272], which contribute to vascular regeneration [277]. Exosomes 
have also been implicated in macrophage-EC crosstalk with respect to angiogenesis [178, 
278]; thus, it is conceivable that macrophage-mediated anastomosis and vessel 
stabilization is related to production of these vesicles, perhaps through production of 
PDGFB or TGFB [183, 203]. 
Lastly, the in vivo translation of this work should be ascertained; this could be 
achieved via macrophage depletion at various times post-implantation of pre-vascularized 
constructs in a dorsal window chamber, allowing for live imaging and tracking of graft-host 
vascular integration. Then, in vitro-stimulated M1 and M2 macrophages could be added 
locally to the engineered tissue to confirm that contributions of macrophage phenotype 
observed in vitro in the present work. 
Ultimately, this work is expected to have important implications for tissue 
engineering; establishing the role of macrophages in tissue vascularization can be used 
to both inform the design of biomaterials that promote vascularization, and aid in the 
treatment of tissues characterized by abnormal vascularization. 
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CHAPTER 7: SUPPLEMENTAL INVESTIGATION OF MONOCYTE ISOLATION AND 
CRYOPRESERVATION ON MACROPHAGE BEHAVIOR 
 
7.1. Introduction 
The ultimate goal of this work was to extensively characterize the role of human 
macrophages in the context of tissue regeneration and vascularization. This is commonly 
performed using primary monocytes, isolated from whole blood and differentiated into 
macrophages in vitro. However, monocytes can also be purchased from a number of 
different sources and isolated using a variety of different methods, though the cost, effort 
and ensuing monocyte purity vary substantially. To date, there is a lack of research 
systematically analyzing the differences in monocyte isolation on macrophage 
polarization, despite reports that highlight functional differences in macrophages [279] and 
monocytes [280] with respect to isolation procedures. 
Moreover, experiments requiring a large number of macrophages require a large 
number of monocytes, but only a finite number can be obtained from a single donor. As a 
result, multiple donors are often used to study macrophage behavior, which may introduce 
large donor-to-donor variability and potentially confound results, although the effects of 
donor on macrophage behavior have not been described. One way to circumvent this 
variability is to cryopreserve monocytes from one donor and use the same donor’s cells in 
multiple studies. Despite their widespread commercial availability, cryopreserved 
monocytes are not often used, perhaps because of cost (commercially available frozen 
monocytes are roughly 8 times more expensive than in-house isolation via density 
gradient centrifugation) and/or a lack of information regarding their robustness in 
comparison to freshly isolated monocytes. While findings reported in the literature suggest 
that cryopreservation does not alter the biological activities of monocytes [281-283] or 
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monocyte-derived dendritic cells [284], others report modified responses [285, 286], and 
the effects on macrophage phenotype have not been described. 
Therefore, the goal of this work was to directly investigate the differences between 
negatively selected and density gradient centrifugation-derived monocytes on 
macrophage activation, and further to test the potential to cryopreserve monocytes without 
adversely impacting their functional differentiation into macrophages. First the level of 
donor-to-donor variability within each method of isolation on macrophage gene expression 
was assessed. Then the differences between negative selection and sequential density 
gradient centrifugation were analyzed. Finally, the effects of monocyte cryopreservation 
on macrophage function were evaluated to determine if monocytes can be frozen for use 
in conducting sequential experiments and to minimize donor-to-donor variability. 
 
7.2. Experimental Section 
7.2.1. Experimental Design 
A schematic of the experimental design is provided in Figure 7.1. Study 1. 
Monocytes were isolated from a total of 10 donors by either negative selection or 
sequential density gradient centrifugation and subsequently differentiated into 
macrophages in vitro for 7 days. The effect of isolation method on macrophage gene 
expression was evaluated. Study 2. The effects of cryopreservation were evaluated by 1) 
comparing macrophage gene expression from cryopreserved monocytes from 4 donors 
to that from freshly isolated monocytes, and 2) directly comparing the effect of 
cryopreservation on macrophage gene expression for monocytes derived from a single 
donor, to eliminate any potential variability due to donor. Macrophage gene expression 
and protein secretion were quantified after 7 days. 
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7.2.2. Monocyte Isolation 
7.2.2.1. Negative selection 
Primary human monocytes isolated via negative selection were purchased from 
the University of Pennsylvania Human Immunology Core. Monocytes were isolated and 
purified from a leukapheresis product using a RosetteSepä Human Monocyte Enrichment 
Cocktail (STEMCELL Technologies Inc., Vancouver, BC, Canada). 
 
7.2.2.2. Sequential density gradient centrifugation 
Primary human monocytes were isolated from blood (obtained from the New York 
Blood Center) using sequential density gradient centrifugation of Ficoll-PaqueTM PLUS 
and 46% PercollTM PLUS (GE Healthcare, Piscataway, NJ, USA) as we have previously 
described [70, 83]. 
 
7.2.3. Monocyte Cryopreservation and Thawing 
Negatively selected monocytes for cryopreservation were resuspended at a 
density of 1´107 cells/mL in cold freezing medium (10% DMSO in fetal bovine serum). 
Cryovials were transferred to a Cryo 1°C Freezing Container (Thermo Scientific) and 
stored at -80°C overnight. Later, cryopreserved cells were thawed rapidly in a 37°C water 
bath and subsequently transferred into pre-warmed RPMI 1640 media containing 10% 
heat-inactivated human serum and 1% penicillin streptomycin. The cells were washed 
twice in pre-warmed media and viability was assessed using a Countess® Automated Cell 
Counter with trypan blue staining; cell viability was typically ³ 98%. 
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7.2.4. Macrophage Differentiation 
Monocytes were seeded in ultra-low attachment flasks (Corning) at a density of 
1´106 cells/mL and cultured for 5 days in RPMI 1640 media, supplemented with 10% heat-
inactivated human serum, 1% penicillin streptomycin and 20 ng/mL macrophage colony 
stimulating factor (MCSF) for macrophage differentiation. The media was changed on 
days 3 and 5. On day 5, macrophages were gently scraped, collected and counted using 
a Countess® Automated cell Counter with trypan blue staining. Macrophages were 
seeded at 1´106 cells/mL in a 24 well ultra-low attachment plate. Differentiation was 
achieved by addition of IFN-g (100 ng/mL) and LPS (100 ng/mL) for M1 activation, IL-4 
(40 ng/mL) and IL-13 (20 ng/mL) for M2a activation, and IL-10 (40 ng/mL) for M2c 
activation. M0 macrophages cultured in MSCF alone were used as a control. After 48 h, 
RNA was extracted for gene expression analysis using RT-PCR. 
 
7.2.5. RNA Extraction and cDNA Synthesis 
Extracted RNA was purified on an RNAqueous-Micro Kit spin column (Ambion) 
according to the manufacturer’s instructions. Purified RNA was quantified on a NanoQuant 
plate (Tecan) and treated with DNAse I, Amplification Grade (Invitrogen) for DNA removal 
according to the manufacturer’s protocol. cDNA was synthesized from 1 µg RNA (A260/280 
> 1.8) using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) 
according to the manufacturer’s instructions and stored at -80°C until analysis. 
 
7.2.6. Quantitative RT-PCR 
Quantitative RT-PCR was performed using 20 ng cDNA and Fast SYBR Green 
Master Mix (Applied Biosystems) according to the manufacturer’s instructions. Mean 
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quantification cycle, Cq, values were calculated from technical replicates (n = 2). The 
expression of target genes was then normalized to the reference gene, GAPDH, and, 
where indicated, subsequently normalized to the M0 control (2-∆∆Ct). All primers (Table 3.1) 
were synthesized by Life Technologies. 
 
7.2.7. Principal Component Analysis 
Gene expression data were further evaluated using PCA to identify patterns in 
gene expression and major sources of variation within data sets. PCA was implemented 
using Matlab® software (The MathWorks, Inc., Natick, MA). Prior to analysis, the data were 
standardized to enable comparison across the data set. PCA was then performed for each 
method of isolation and preservation to derive the principal components. 
 
7.2.8. Protein Secretion 
Supernatants from cryopreserved and control macrophages were collected on Day 
7 of macrophage differentiation and polarization, and analyzed for the presence of human 
tumor necrosis factor (TNF), vascular endothelial growth factor A (VEGFA), interleukin 10 
(IL10) and interleukin 1 receptor antagonist (IL1Ra). Protein secretion was measured 
using commercially available Mini Enzyme-Linked Immunosorbent Assay (ELISA) 
Development Kits (PeproTech, NJ, USA) according to the manufacturer’s instructions. 
 
7.2.9. Statistical Analysis 
Data are represented as mean ± SEM. Prior to analysis, fold change data were 
log-transformed and statistical analysis was performed in GraphPad Prism 6.0 (GraphPad 
Software, Inc., La Jolla, CA) using two-way ANOVA with Tukey’s multiple comparison 
post-hoc analysis, as indicated; p < 0.05 was considered significant. Inter-donor variability 
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was assessed by computing the interquartile range (IQR), indicative of data scatter; IQR 
was calculated as the difference between the 25% percentile and 75% percentile. 
 
7.3. Results and Discussion 
7.3.1. Donor-to-Donor Variability 
Gene expression by macrophages generated from negatively selected monocytes 
from multiple donors is shown in Figure 7.2. The IQR for all genes ranged from 0.21 to 
1.06, indicating variability within the data. Despite this donor-to-donor variability, the 
expected M1, M2a and M2c gene expression trends were conserved across donors. Pro-
inflammatory M1 macrophages were characterized by high expression of the pro-
inflammatory markers CCR7 and IL1B (Figure 7.2a), while M2a and M2c macrophages 
upregulated the anti-inflammatory markers CCL22 (Figure 7.2b) and CD163 
(Figure 7.2c), respectively. Comparable trends were observed for macrophages derived 
from monocytes isolated by density gradient centrifugation (Figure 7.3), as well as 
negatively selected monocytes subjected to cryopreservation (Figure 7.4). However, 
density gradient centrifugation resulted in IQR values ranging from 0.33 to 1.75 for all 
genes, indicating greater spread of the data and inter-donor variability compared to 
negatively selected monocytes. Similarly, the data were more scattered when negatively 
selected monocytes were subjected to cryopreservation, resulting in a range of IQR values 
between 0.50 and 2.38. This variability in scatter may be due to the reduced number of 
donors used when assessing density gradient centrifugation and the effects of 
preservation. 
To further assess the impact of donor-to-donor variability on macrophage 
responses and our ability to detect results, we conducted PCA on macrophage responses 
following isolation and polarization (Figure 7.2d, Figure 7.3d, Figure 7.4d). For all 
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isolation and preservation methods investigated, PC1 accounted for ≥ 34.0% of the 
variance in the data and separated M1 and M2a responses. Interestingly, donor variability 
appeared to confound gene expression by M0 and M2a macrophages derived from 
negatively selected monocytes (Figure 7.2d), as PC2 clearly distinguished donor 
populations, which accounted for 22.7% of the variance in the data. However, further 
extending the analysis to PC3 revealed M0 and M2a phenotypes as the third leading 
source of variance in macrophage differentiation (data not shown). Together, the first three 
principal components captured 77.2% of the variation in the data from negatively selected 
monocytes, and grouped macrophage responses into the M0, M1, M2a, and M2c 
phenotypes. 
Although donor variability was also detected in macrophage responses from 
density gradient centrifugation-derived monocytes, and those that were negatively 
selected and cryopreserved, this variability did not supersede the separation of M0 and 
M2a responses by PC1 and PC2 (Figure 7.3d, Figure 7.4d). Variability in donor 
responses did, however, represent the third leading source of variance in density gradient 
centrifugation-derived macrophages (data not shown). This trend was also observed, to 
an extent, in negatively selected monocytes subjected to cryopreservation prior to 
macrophage differentiation and polarization (data not shown). Together, the first three 
principal components captured 87% and 75% of the variance from density gradient 
centrifugation and cryopreservation, respectively.  
Despite noticeable donor variability in immune responses, the chosen markers 
differentiated between macrophages polarized to the M0, M1, M2a and M2c phenotypes 
following isolation and preservation by all methods investigated.  
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7.3.2. Comparison of Negative Selection and Density Gradient Centrifugation 
In order to reduce the donor-to-donor variability in macrophage behavior, gene 
expression by M1, M2a and M2c macrophages was normalized to the M0 control for each 
donor (Figure 7.5a-c) and log transformed for analysis. Comparison of macrophage 
phenotypes within each method indicated that gene expression trends were conserved 
between negative selection and density gradient centrifugation of monocytes. In both 
cases, M1 macrophages upregulated CCR7 and IL1B, M2a macrophages upregulated 
CCL22, and M2c macrophages upregulated CD163. 
PCA further confirmed that isolation method did not alter gene expression patterns 
by M0, M1, M2a and M2c macrophages (Figure 7.5d). Indeed, PC1 and PC2 captured 
macrophage phenotype, which accounted for 53% of the variance in the data. Extending 
the analysis to PC3 (data not shown) revealed donor variability as another leading source 
of variation, indicating the importance of normalizing macrophage responses for each 
donor. Together, these principal components captured 73% of the variance, with no 
distinction between methods of isolation. 
These findings suggest that no difference exists between monocytes isolated by 
negative selection and density gradient centrifugation with respect to macrophage 
behavior.  
 
7.3.3. Effects of Cryopreservation on Macrophage Behavior 
Cryopreservation of negatively selected monocytes did not alter the gene 
expression trends of polarized macrophages (Figure 7.6). M1 macrophages were still 
distinguishable by expression of CCR7, while M2a macrophages exhibited marked 
upregulation of CCL22 and M2c macrophages exhibited prominent expression of CD163. 
Although comparable trends were observed for M1 expression of IL1B, the upregulation 
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was not found to be significant following cryopreservation. However, the lack of 
significance was attributed to donor-to-donor variability, as opposed to technical variability, 
because all trends in macrophage behavior were conserved between cryopreserved and 
control monocytes isolated from a single donor, with considerably less error (Figure 7.7).  
Again, PCA was applied to the gene expression data to determine if 
cryopreservation affected gene expression of polarized macrophages (Figure 7.6d). PC1 
and PC2 captured macrophage phenotype as the main source of variance in gene 
expression, with no distinction between macrophages differentiated from freshly isolated 
and cryopreserved monocytes. Donor-to-donor variability accounted for the third major 
source of variance in the data (not shown). Together, these principal components captured 
71% of the variance in macrophage responses. Consistent with earlier findings, 
macrophage phenotype was captured by PC1 and PC2, and there were no overlaps in 
macrophage phenotype within each method, confirming the ability to cryopreserve 
monocytes without subsequent loss of function in polarized macrophages.  
To further test the effects of cryopreservation on macrophage behavior, protein 
secretion by macrophages derived from a single donor was quantified; monocytes from a 
single donor were used in this analysis to eliminate the influence of donor-to-donor 
variability. As shown in Figure 7.8, cryopreservation did not alter the expected protein 
secretion profile of macrophages. Pro-inflammatory M1 macrophages exhibited distinct 
secretion of the angiogenic mediator VEGFA and the inflammatory cytokine TNF, which 
has been previously described [83], regardless of whether or not they were cryopreserved. 
Contrary to many publications [287-289], IL1RN (also known as IL1Ra) and IL10 were not 
secreted at different levels by polarized macrophages; however, these differences may be 
attributed to variations in macrophage culture conditions and stimulating factors. Notably, 
reports of IL10 secretion by polarized M2 macrophages measure protein secretion 
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following LPS stimulation [288, 289], which consequently enhanced secretion of IL10. LPS 
also induces IL1RN secretion and has been shown to act synergistically with IL4 [290], 
which may account for elevated production by M2 macrophages. Moreover, it has been 
shown that media containing serum can reduce cytokine production [291]. Finally, in 
studies that use MCSF and IL10 to polarize M2c macrophages [291], an IL10 control was 
not included to verify that the cell secretes the IL10 detected. In this study, there was no 
increase in IL10 levels in the cell culture media above that of the polarizing media for M2c 
macrophages. 
Overall, these findings indicate that cryopreservation does not impact macrophage 
behavior, at least for the genes studied here. Although cryopreservation does not 
overcome the limitation of cell quantity, the ability to freeze monocytes from the same 
donor enables multiple studies to be conducted with cells without the confounding effect 
of donor-to-donor variability. 
 
It should be noted that there were several limitations to this investigation. Positive 
selection was omitted from this work because it was presumed that the presence of 
magnetic beads would influence macrophage behavior. In addition, ELISA was performed 
on only a few, select markers related to tissue repair. Moreover, TNF was the only marker 
also evaluated at the protein level; it is possible that the other genes investigated are not 
expressed at the level of protein secretion. 
 
7.4. Conclusions 
In this study, the effects of monocyte isolation and cryopreservation on expression 
of prototypical markers of M1, M2a and M2c macrophages were systematically 
characterized. There were no detectable differences between negatively selected 
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monocytes and those isolated by density gradient centrifugation; moreover, this work 
confirmed that monocytes can be cryopreserved without altering macrophage behavior. 
Most notably, this analysis revealed significant inter-donor variability, which suggests that 
cells from a single donor should be cryopreserved for use in sequential experiments as a 
means to abolish donor-to-donor variability and ensure accurate interpretation of data. 
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Figure 7.1. Schematic of study design. (A) Study 1: Monocytes were isolated by negative selection 
or sequential density gradient centrifugation and subsequently differentiated into macrophages in 
vitro for 7 days. The effect of isolation method on macrophage gene expression was evaluated. 
Study 2: The effects of cryopreservation were evaluated by 1) comparing macrophage gene 
expression from cryopreserved monocytes from mulitple donors to that from freshly isolated 
monocytes, and 2) directly comparing the effect of cryopreservation on macrophage gene 
expression for monocytes derived from a single donor, to eliminate potential inter-donor variability. 
(B) Macrophage differentiation scheme; gene expression and protein secretion were quantified 
after 7 days.  
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Figure 7.2. (A-C) Tukey box-and-whiskers plots showing donor-to-donor variability in gene 
expression by macrophages derived from negatively selected monocytes (not cryopreserved). Data 
represent fold change over GAPDH. (D) Principal component analysis of gene expression by 
macrophages derived from negatively selected monocytes. Score plot of principal components 1 
and 2 depicted, capturing 42.8% and 32.3% of the variance within the data, respectively. 
Macrophage phenotype indicted by black (M0), blue (M1), red (M2a) or green (M2c) shading. Solid 
line circles indicate variability across donors. 
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Figure 7.3. (A-C) Tukey box-and-whiskers plots showing donor-to-donor variability in gene 
expression by macrophages derived from monocytes isolated by density gradient centrifugation 
(not cryopreserved). Data represent fold change over GAPDH. (D) Principal component analysis 
of gene expression by macrophages derived from monocytes isolated by density gradient 
centrifugation. Score plot of principal components 1 and 2 depicted, capturing 40.4% and 30.0% of 
the variance within the data, respectively. Macrophage phenotype indicted by black (M0), blue 
(M1), red (M2a) or green (M2c) shading. Solid line circles indicate variability across donors. 
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Figure 7.4. (A-C) Tukey box-and-whiskers plots showing donor-to-donor variability in gene 
expression by macrophages derived from negatively selected monocytes and subjected to 
cryopreservation. Data represent fold change over GAPDH. (D) Principal component analysis of 
gene expression by macrophages derived from negatively selected monocytes and cryopreserved. 
Score plot of principal components 1 and 2 depicted, capturing 31.8% and 24.7% of the variance 
within the data, respectively. Macrophage phenotype indicted by black (M0), blue (M1), red (M2a) 
or green (M2c) shading. Solid line circles indicate variability across donors. 
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Figure 7.5. (A-C) Comparison between gene expression trends by negatively selected monocytes 
and monocytes isolated by density gradient centrifugation. Data represent mean fold change over 
M0 ± SEM. Statistical analysis was performed on log-transformed data using two-way ANOVA with 
Tukey’s post hoc analysis. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 relative to all other 
groups; n ³ 4. (D) Principal component analysis comparing gene expression between macrophages 
derived from negatively selected (NS) monocytes or via density gradient centrifugation (DG). Score 
plot of principal components 1 and 2 depicted, capturing 40.8% and 27.1% of the variance within 
the data, respectively. Macrophage phenotype indicted by blue (M0), red (M1), green (M2a) or 
black (M2c) shading. 
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Figure 7.6. (A-C) Comparison between gene expression by cryopreserved macrophages and fresh 
macrophages from multiple donors; all cells were derived from negatively selected monocytes. 
Data represent mean change over M0 ± SEM. Statistical analysis was performed on log-
transformed data using two-way ANOVA with Tukey’s post hoc analysis. *p < 0.05, **p < 0.01, ****p 
< 0.0001 relative to all other groups; n ³ 3. (D) PCA comparing gene expression between freshly 
isolated and cryopreserved macrophages. Score plot of principal components 1 and 2 depicted, 
capturing 36.9% and 24.1% of the variance within the data, respectively. Macrophage phenotype 
indicted by blue (M0), red (M1), green (M2a) or black (M2c) shading. 
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Figure 7.7. (A-C) Effects of cryopreservation on gene expression by macrophages derived from 
negatively selected monocytes from a single donor. Data represent mean fold change over GAPDH 
± SEM. Statistical analysis was performed on log-transformed data using two-way ANOVA with 
Tukey’s post hoc analysis. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 relative to all other 
groups; n ³ 3. (D) PCA comparing gene expression between freshly isolated and cryopreserved 
macrophages. Score plot of principal components 1 and 2 depicted, capturing 48.7% and 29.8% of 
the variance within the data, respectively. Macrophage phenotype indicted by blue (M0), red (M1), 
green (M2a) or black (M2c) shading. 
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Figure 7.8. Effects of cryopreservation on protein secretion by macrophages derived from 
negatively selected monocytes. Data represent mean ± SEM. Corresponding letters indicate p < 
0.05 using two-way ANOVA with Tukey’s post hoc analysis; n ³ 3. 
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